Document:

exv4w1

Exhibit
4.1

Execution

 

LIFEPOINT HOSPITALS, INC.

as Issuer

Each of the Guarantors Named Herein

and

THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.

as Trustee

 

INDENTURE

Dated as of September 23, 2010

 

6.625% Senior Notes due 2020

 

 

 

 

CROSS-REFERENCE TABLE*

	 	 	 	 	 	 	 	 
	Trust Indenture	 	 
	Act Section	 	Indenture Section
	310

	(a)
	(1	)	 	 	7.10	 
	 

	(a)
	(2	)	 	 	7.10	 
	 

	(a)
	(3	)	 	 	N.A.	 
	 

	(a)
	(4	)	 	 	N.A.	 
	 

	(a)
	(5	)	 	 	7.10	 
	 

	(b)
	 	 	 	 	7.03; 7.10	 
	 

	(c)
	 	 	 	 	N.A.	 
	311

	(a)
	 	 	 	 	7.11	 
	 

	(b)
	 	 	 	 	7.11	 
	 

	(c)
	 	 	 	 	N.A.	 
	312

	(a)
	 	 	 	 	2.05	 
	 

	(b)
	 	 	 	 	12.03	 
	 

	(c)
	 	 	 	 	12.03	 
	313

	(a)
	 	 	 	 	7.06	 
	 

	(b)
	(1	)	 	 	N.A.	 
	 

	(b)
	(2	)	 	 	7.06; 7.07	 
	 

	(c)
	 	 	 	 	7.06; 12.02	 
	 

	(d)
	 	 	 	 	7.06	 
	314

	(a)
	 	 	 	 	4.03	 
	 

	(b)
	 	 	 	 	N.A.	 
	 

	(c)
	(1	)	 	 	12.04	 
	 

	(c)
	(2	)	 	 	12.04	 
	 

	(c)
	(3	)	 	 	N.A.	 
	 

	(d)
	 	 	 	 	N.A.	 
	 

	(e)
	 	 	 	 	12.05	 
	 

	(f)
	 	 	 	 	N.A.	 
	315

	(a)
	 	 	 	 	7.01	 
	 

	(b)
	 	 	 	 	7.05, 12.02	 
	 

	(c)
	 	 	 	 	7.01	 
	 

	(d)
	 	 	 	 	7.01	 
	 

	(e)
	 	 	 	 	6.11	 
	316

	(a)
	(last sentence)
	 	 	2.09	 
	 

	(a)
	(1	)(A)	 	 	6.05	 
	 

	(a)
	(1	)(B)	 	 	6.04	 
	 

	(a)
	(2	)	 	 	N.A.	 
	 

	(b)
	 	 	 	 	6.07	 
	 

	(c)
	 	 	 	 	2.12	 
	317

	(a)
	(1	)	 	 	6.08	 
	 

	(a)
	(2	)	 	 	6.09	 
	 

	(b)
	 	 	 	 	2.04	 
	318

	(a)
	 	 	 	 	12.01	 
	 

	(b)
	 	 	 	 	N.A.	 
	 

	(c)
	 	 	 	 	12.01	 

 

N.A. means not applicable. *

This Cross Reference Table is not part of this Indenture.

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	ARTICLE 1. DEFINITIONS AND INCORPORATION BY REFERENCE
	 	 	1	 
	 
	 	 	 	 
	Section 1.01. Definitions
	 	 	1	 
	Section 1.02. Other Definitions
	 	 	27	 
	Section 1.03. Incorporation by Reference of Trust Indenture Act
	 	 	28	 
	Section 1.04. Rules of Construction
	 	 	28	 
	 
	 	 	 	 
	ARTICLE 2. THE NOTES
	 	 	28	 
	 
	 	 	 	 
	Section 2.01. Form and Dating
	 	 	28	 
	Section 2.02. Execution and Authentication
	 	 	29	 
	Section 2.03. Registrar and Paying Agent
	 	 	30	 
	Section 2.04. Paying Agent to Hold Money in Trust
	 	 	30	 
	Section 2.05. Holder Lists
	 	 	30	 
	Section 2.06. Transfer and Exchange
	 	 	30	 
	Section 2.07. Replacement Notes
	 	 	42	 
	Section 2.08. Outstanding Notes
	 	 	42	 
	Section 2.09. Treasury Notes
	 	 	43	 
	Section 2.10. Temporary Notes
	 	 	43	 
	Section 2.11. Cancellation
	 	 	43	 
	Section 2.12. Payment of Interest
	 	 	43	 
	Section 2.13. Persons Deemed Owners
	 	 	44	 
	Section 2.14. Computation of Interest
	 	 	44	 
	Section 2.15. CUSIP or ISIN Numbers
	 	 	44	 
	Section 2.16. Issuance of Additional Notes
	 	 	44	 
	 
	 	 	 	 
	ARTICLE 3. REDEMPTION AND PREPAYMENT
	 	 	45	 
	 
	 	 	 	 
	Section 3.01. Notices to Trustee
	 	 	45	 
	Section 3.02. Selection of Notes to Be Redeemed
	 	 	45	 
	Section 3.03. Notice of Redemption to Holders
	 	 	45	 
	Section 3.04. Effect of Notice of Redemption
	 	 	46	 
	Section 3.05. Deposit of Redemption or Purchase Price
	 	 	46	 
	Section 3.06. Notes Redeemed or Purchased in Part
	 	 	47	 
	Section 3.07. Optional Redemption
	 	 	47	 
	Section 3.08. Mandatory Redemption
	 	 	47	 
	Section 3.09. Offer to Purchase by Application of Excess Proceeds
	 	 	48	 
	 
	 	 	 	 
	ARTICLE 4. COVENANTS
	 	 	49	 
	 
	 	 	 	 
	Section 4.01. Payment of Notes
	 	 	49	 
	Section 4.02. Maintenance of Office or Agency
	 	 	49	 
	Section 4.03. Reports
	 	 	50	 
	Section 4.04. Compliance Certificate
	 	 	50	 
	Section 4.05. Restricted Payments
	 	 	51	 
	Section 4.06. Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries
	 	 	54	 
	Section 4.07. Incurrence of Indebtedness and Issuance of Preferred Stock
	 	 	56	 
	Section 4.08. Asset Sales
	 	 	59	 
	Section 4.09. Transactions with Affiliates
	 	 	61	 
	Section 4.10. Liens
	 	 	62	 
	Section 4.11. Offer to Repurchase Upon Change of Control
	 	 	63	 
	Section 4.12. Additional Subsidiary Guarantees
	 	 	64	 
	Section 4.13. Designation of Restricted and Unrestricted Subsidiaries
	 	 	64	 

i

 

	 	 	 	 	 
	 	 	Page	 
	Section 4.14. Limitation on Sale and Leaseback Transactions
	 	 	64	 
	Section 4.15. Suspension of Covenants
	 	 	64	 
	Section 4.16. Limitation on Secured Indebtedness
	 	 	65	 
	Section 4.17. Corporate Existence
	 	 	66	 
	Section 4.18. Stay, Extension and Usury Laws
	 	 	66	 
	 
	 	 	 	 
	ARTICLE 5. SUCCESSORS
	 	 	66	 
	 
	 	 	 	 
	Section 5.01. Merger, Consolidation or Sale of Assets
	 	 	66	 
	Section 5.02. Successor Corporation Substituted
	 	 	67	 
	 
	 	 	 	 
	ARTICLE 6. DEFAULTS AND REMEDIES
	 	 	67	 
	 
	 	 	 	 
	Section 6.01. Events of Default
	 	 	67	 
	Section 6.02. Acceleration
	 	 	69	 
	Section 6.03. Other Remedies
	 	 	69	 
	Section 6.04. Waiver of Past Defaults
	 	 	69	 
	Section 6.05. Control by Majority
	 	 	70	 
	Section 6.06. Limitation on Suits
	 	 	70	 
	Section 6.07. Rights of Holders of Notes to Receive Payment
	 	 	70	 
	Section 6.08. Collection Suit by Trustee
	 	 	70	 
	Section 6.09. Trustee May File Proofs of Claim
	 	 	70	 
	Section 6.10. Priorities
	 	 	71	 
	Section 6.11. Undertaking for Costs
	 	 	71	 
	 
	 	 	 	 
	ARTICLE 7. TRUSTEE
	 	 	72	 
	 
	 	 	 	 
	Section 7.01. Duties of Trustee
	 	 	72	 
	Section 7.02. Rights of Trustee
	 	 	73	 
	Section 7.03. Individual Rights of Trustee
	 	 	74	 
	Section 7.04. Trustee’s Disclaimer
	 	 	74	 
	Section 7.05. Notice of Defaults
	 	 	74	 
	Section 7.06. Reports by Trustee to Holders of the Notes
	 	 	74	 
	Section 7.07. Compensation and Indemnity
	 	 	74	 
	Section 7.08. Replacement of Trustee
	 	 	75	 
	Section 7.09. Successor Trustee by Merger, etc.
	 	 	76	 
	Section 7.10. Eligibility; Disqualification
	 	 	76	 
	Section 7.11. Preferential Collection of Claims Against Company
	 	 	76	 
	 
	 	 	 	 
	ARTICLE 8. LEGAL DEFEASANCE AND COVENANT DEFEASANCE
	 	 	76	 
	 
	 	 	 	 
	Section 8.01. Option to Effect Legal Defeasance or Covenant Defeasance
	 	 	76	 
	Section 8.02. Legal Defeasance and Discharge
	 	 	77	 
	Section 8.03. Covenant Defeasance
	 	 	77	 
	Section 8.04. Conditions to Legal or Covenant Defeasance
	 	 	78	 
	Section 8.05. Deposited Money and Government Securities to be Held in Trust; Other
Miscellaneous Provisions
	 	 	79	 
	Section 8.06. Repayment to Company
	 	 	79	 
	Section 8.07. Reinstatement
	 	 	80	 
	 
	 	 	 	 
	ARTICLE 9. AMENDMENT, SUPPLEMENT AND WAIVER
	 	 	80	 
	 
	 	 	 	 
	Section 9.01. Without Consent of Holders of Notes
	 	 	80	 
	Section 9.02. With Consent of Holders of Notes
	 	 	81	 
	Section 9.03. Compliance with Trust Indenture Act
	 	 	82	 
	Section 9.04. Revocation and Effect of Consents
	 	 	82	 
	Section 9.05. Notation on or Exchange of Notes
	 	 	82	 
	Section 9.06. Trustee to Sign Amendments, etc.
	 	 	82	 
	Section 9.07. Effect of Supplemental Indentures
	 	 	83	 

ii

 

	 	 	 	 	 
	 	 	Page	 
	ARTICLE 10. GUARANTEES
	 	 	83	 
	 
	 	 	 	 
	Section 10.01. Guarantee
	 	 	83	 
	Section 10.02. Subsidiary Guarantors May Consolidate, etc. on Certain Terms
	 	 	84	 
	Section 10.03. Limitation on Guarantor Liability
	 	 	84	 
	Section 10.04. Releases
	 	 	85	 
	 
	 	 	 	 
	ARTICLE 11. SATISFACTION AND DISCHARGE
	 	 	85	 
	 
	 	 	 	 
	Section 11.01. Satisfaction and Discharge
	 	 	85	 
	Section 11.02. Application of Trust Money
	 	 	86	 
	 
	 	 	 	 
	ARTICLE 12. MISCELLANEOUS
	 	 	87	 
	 
	 	 	 	 
	Section 12.01. Trust Indenture Act Controls
	 	 	87	 
	Section 12.02. Notices
	 	 	87	 
	Section 12.03. Communication by Holders of Notes with Other Holders of Notes
	 	 	88	 
	Section 12.04. Certificate and Opinion as to Conditions Precedent
	 	 	88	 
	Section 12.05. Statements Required in Certificate or Opinion
	 	 	89	 
	Section 12.06. Rules by Trustee and Agents
	 	 	89	 
	Section 12.07. No Personal Liability of Directors, Officers, Employees and Stockholders
	 	 	90	 
	Section 12.08. Governing Law
	 	 	90	 
	Section 12.09. No Adverse Interpretation of Other Agreements
	 	 	90	 
	Section 12.10. Successors
	 	 	90	 
	Section 12.11. Severability
	 	 	90	 
	Section 12.12. Waiver of Jury Trial
	 	 	90	 
	Section 12.13. Force Majeure
	 	 	90	 
	Section 12.14. Counterpart Originals
	 	 	91	 
	Section 12.15. Table of Contents, Headings, etc
	 	 	91	 

EXHIBITS

	 	 	 
	Exhibit A
	 	FORM OF NOTE
	Exhibit B
	 	FORM OF CERTIFICATE OF TRANSFER
	Exhibit C
	 	FORM OF CERTIFICATE OF EXCHANGE
	Exhibit D
	 	FORM OF SUPPLEMENTAL INDENTURE TO BE DELIVERED BY SUBSEQUENT GUARANTORS

iii

 

     INDENTURE dated as of September 23, 2010 among LifePoint Hospitals, Inc., a Delaware
corporation (the “Company”), the Guarantors (as defined below) and The Bank of New York Mellon
Trust Company, N.A., a national banking association, as trustee (the “Trustee”).

     The Company, the Guarantors and the Trustee agree as follows for the benefit of each other and
for the equal and ratable benefit of the Holders (as defined herein) of (a) the $400,000,000
aggregate principal amount of the Company’s 6.625% Senior Notes due 2020 (the “Initial Notes”), (b)
any Additional Notes (as defined herein) that may be issued after the date hereof and (c) if and
when issued pursuant to the Registration Rights Agreement (as defined herein), the Company’s
Exchange Notes (as defined herein) issued in the Exchange Offer (as defined herein) in exchange for
any outstanding Initial Notes or Additional Notes (all such securities in clauses (a), (b) and (c)
being referred to collectively as the “Notes”).

ARTICLE 1.

DEFINITIONS AND INCORPORATION

BY REFERENCE

Section 1.01. Definitions.

     “144A Global Note” means a Global Note substantially in the form of Exhibit A hereto bearing
the Global Note Legend and the Private Placement Legend and deposited with or on behalf of, and
registered in the name of, the Depositary or its nominee that shall be issued in a denomination
equal to the outstanding principal amount of the Notes sold in reliance on Rule 144A.

     “3.25% Convertible Senior Subordinated Debentures due 2025” means the $225 million in
aggregate principal amount of 3.25% Convertible Senior Subordinated Debentures due 2025 issued by
the Company pursuant to an indenture dated August 10, 2005 between the Company and Citibank, N.A.,
as trustee.

     “3.5% Convertible Senior Subordinated Notes due 2014” means the $575 million in aggregate
principal amount of 3.5% Convertible Senior Subordinated Notes due 2014 issued by the Company
pursuant to an indenture dated May 29, 2007 between the Company and The Bank of New York Mellon
Trust Company, N.A., as trustee.

     “Acquired Debt” means, with respect to any specified Person:

     (1) Indebtedness of any other Person existing at the time such other Person is merged
with or into or became a Restricted Subsidiary of such specified Person, whether or not such
Indebtedness is incurred in connection with, or in contemplation of, such other Person
merging with or into, or becoming a Restricted Subsidiary of, such specified Person; and

     (2) Indebtedness secured by a Lien encumbering any asset acquired by such specified
Person (limited to the maximum amount of liability of the specified Person with respect to
such Lien).

     “Additional Notes” means additional Notes (other than the Initial Notes) issued under this
Indenture in accordance with Sections 2.16 and 4.07 hereof, as part of the same series as the
Initial Notes.

     “Affiliate” of any specified Person means any other Person directly or indirectly controlling
or controlled by or under direct or indirect common control with such specified Person. For
purposes of this
definition, “control”, as used with respect to any Person, means the possession, directly or
indirectly, of the power to direct or cause the direction of the management or policies of such
Person, whether through the

1

 

ownership of voting securities, by agreement or otherwise; provided
that beneficial ownership of 10% or more of the Voting Stock of a Person shall be deemed to be
control. For purposes of this definition, the terms “controlling,” “controlled by” and “under
common control with” have correlative meanings.

     “Agent” means any Registrar, Paying Agent or co-registrar.

     “Applicable Procedures” means, with respect to any transfer or exchange of or for beneficial
interests in any Global Note, the rules and procedures of the Depositary, Euroclear and Clearstream
that apply to such transfer or exchange.

     “Applicable Redemption Premium” means, with respect to any Note on any Redemption Date, the
excess of

     (1) the present value at such Redemption Date of the Redemption Price of such Note if
such Note were redeemed on October 1, 2015, plus all required interest payments due on such
Note through October 1, 2015 (not including any portion of such payments of interest accrued
to the Redemption Date), computed using a discount rate equal to the Treasury Rate at such
redemption date plus 50 basis points, over

     (2) the then-outstanding principal amount of the Note.

     “Asset Sale” means:

     (1) the sale, lease, conveyance or other disposition by the Company or any of its
Restricted Subsidiaries of any assets, other than sales of products and services in the
ordinary course of business consistent with past practices; provided that the sale,
conveyance or other disposition of all or substantially all of the assets of the Company and
its Restricted Subsidiaries taken as a whole will be governed by Section 4.11 and/or Section
5.01 of this Indenture and not by the provisions of Section 4.08 of this Indenture; and

     (2) the issuance of Equity Interests (other than directors’ qualifying shares) by any
Restricted Subsidiary or the sale of Equity Interests in any Restricted Subsidiary.

     Notwithstanding the preceding, the following items will not be deemed to be Asset Sales:

     (1) any single transaction or series of related transactions that involves assets
having a fair market value of less than $30.0 million;

     (2) a transfer of assets between or among the Company and one or more Restricted
Subsidiaries;

     (3) an issuance of Equity Interests by a Restricted Subsidiary to the Company or to
another Restricted Subsidiary;

     (4) the sale, lease, assignment, sublease, or other disposition of equipment,
inventory, accounts receivable or other assets in the ordinary course of business;

     (5) the sale or other disposition of cash or Cash Equivalents;

2

 

     (6) a Restricted Payment (or Payment that would constitute a Restricted Payment but for
the exclusions from the definition thereof) or Permitted Investment that is permitted by
Section 4.05 hereof;

     (7) a sale or other disposition of accounts receivable and related assets in connection
with a financing transaction involving such assets (including, without limitation, in
connection with a securitization or similar financing);

     (8) any disposition of property in the ordinary course of business by the Company or
any Restricted Subsidiary that, in the good faith judgment of management of the Company, has
become obsolete, worn out, damaged or no longer useful in the conduct of the business of the
Company or the Restricted Subsidiaries;

     (9) any Asset Swap;

     (10) any sale of securities constituting Equity Interests that are issued by a
subsidiary trust or other financing vehicle in a transaction permitted under Section 4.07
hereof;

     (11) the discount or forgiveness of accounts receivable in the ordinary course of
business in connection with the collection or compromise thereof;

     (12) licenses and sublicenses by the Company or any of its Restricted Subsidiaries of
software or intellectual property in the ordinary course of business or consistent with past
practice;

     (13) a Sale and Leaseback Transaction, provided that at least 75% of the consideration
paid to the Company or the Restricted Subsidiary for such Sale and Leaseback Transaction
consists of cash received at closing;

     (14) the sale, transfer or other disposition of Hedging Obligations incurred pursuant
to Section 4.07 hereof;

     (15) the creation of any Permitted Lien and dispositions in connection with Permitted
Liens;

     (16) dispositions of assets resulting from the assertion by federal, state or local
governmental authorities (or similarly empowered Persons) of rights of eminent domain,
condemnation or expropriation or similar rights;

     (17) long-term leases of Hospitals to another Person; provided that the aggregate book
value of all such properties subject to such leases does not exceed 10% of the Total Assets
of the Company;

     (18) sales of assets received by the Company or any of its Restricted Subsidiaries upon
the foreclosure on a Lien; and

     (19) the disposition of Receivables and Related Assets in a Qualified Securitization
Transaction.

3

 

     “Asset Swap” means an exchange by the Company or any Restricted Subsidiary of property or
assets for property or assets of another Person; provided that (i) the Company or the applicable
Restricted Subsidiary, as the case may be, receives consideration at the time of such exchange at
least equal to the fair market value of the assets or other property sold, issued or otherwise
disposed of (as evidenced by a resolution of the Company’s Board of Directors), and (ii) at least
75% of the consideration received in such exchange constitutes assets or other property of a kind
usable by the Company and its Restricted Subsidiaries in a Permitted Business; provided, further,
that any cash and Cash Equivalents received by the Company or any of its Restricted Subsidiaries in
connection with such an exchange shall constitute Net Proceeds subject to the provisions of Section
4.08 hereof.

     “Attributable Debt” means, in respect of a Sale and Leaseback Transaction, the present value,
discounted at the interest rate implicit in the Sale and Leaseback Transaction, of the total
obligations of the lessee for rental payments during the remaining term of the lease in the Sale
and Leaseback Transaction.

     “Bankruptcy Law” means Title 11, U.S. Code or any similar federal or state law for the relief
of debtors.

     “Beneficial Owner” has the meaning assigned to such term in Rule 13d-3 and Rule 13d-5 under
the Exchange Act, except that in calculating the beneficial ownership of any particular “person”
(as that term is used in Section 13(d)(3) of the Exchange Act), such “person” shall be deemed to
have beneficial ownership of all securities that such “person” has the right to acquire by
conversion or exercise of other securities, whether such right is currently exercisable or is
exercisable only upon the occurrence of a subsequent condition. The terms “Beneficially Owns” and
“Beneficially Owned” have a corresponding meaning.

     “Board of Directors” means:

     (1) with respect to a corporation, the board of directors of the corporation (or any
duly authorized committee thereof);

     (2) with respect to a partnership, the Board of Directors (or any duly authorized
committee thereof) of the general partner of the partnership;

     (3) with respect to a limited liability company, the managing member or members or any
controlling committee of managing members thereof; and

     (4) with respect to any other Person, the board or committee of such Person serving a
similar function.

     “Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant
Secretary of the Company to have been duly adopted by the Board of Directors and to be in full
force and effect on the date of such certification, and delivered to the Trustee.

     “Broker-Dealer” has the meaning set forth in the Registration Rights Agreement.

     “Business Day” means any day other than a Saturday or Sunday or a day on which banks in New
York, New York are authorized or obligated by law or executive order to remain closed or a day on
which the Corporate Trust Office of the Trustee is closed for business.

     “Capital Lease Obligation” means, at the time any determination is to be made, the amount of
the liability in respect of a capital lease that would at that time be required to be capitalized
on a balance sheet in accordance with GAAP.

4

 

     “Capital Stock” means:

     (1) in the case of a corporation, corporate stock;

     (2) in the case of an association or business entity, any and all shares, interests,
participations, rights or other equivalents (however designated) of corporate stock;

     (3) in the case of a partnership or limited liability company, partnership or
membership interests (whether general or limited); and

     (4) any other interest or participation that confers on a Person the right to receive a
share of the profits and losses of, or distributions of assets of, the issuing Person.

     “Cash Equivalents” means:

     (1) United States dollars;

     (2) securities constituting direct obligations of the United States or any agency or
instrumentality of the United States, the payment or guarantee of which constitutes a full
faith and credit obligation of the United States, maturing in three years or less from the
date of acquisition thereof;

     (3) securities constituting direct obligations of any State or municipality within the
United States maturing in three years or less from the date of acquisition thereof which, in
any such case, at the time of acquisition by the Company or any Restricted Subsidiary, is
accorded one of the two highest long-term or short-term, as applicable, debt ratings by S&P
or Moody’s or any other United States nationally recognized credit rating agency of similar
standing;

     (4) certificates of deposit with a maturity of one year or less or bankers’ acceptances
issued by a bank or trust company having capital, surplus and undivided profits aggregating
at least $500.0 million and having a short-term unsecured debt rating of at least “P-1” by
Moody’s or “A-1” by S&P;

     (5) eurodollar time deposits with maturities of one year or less and overnight bank
deposits with any bank or trust company having capital, surplus and undivided profits
aggregating at least $500.0 million and having a short-term unsecured debt rating of at
least “P-1” by Moody’s or “A-1” by S&P;

     (6) repurchase obligations with a term of not more than thirty days for underlying
securities of the types described in clauses (2), (3), (4) and (5) of this definition
entered into with any financial institution meeting the qualifications specified in such
clauses above;

     (7) commercial paper maturing in 365 days or less from the date of issuance which, at
the time of acquisition by the Company or any Restricted Subsidiary, is accorded a rating of
“A2” or better by S&P or “P2” or better by Moody’s or any other United States nationally
recognized credit rating agency of similar standing; and

     (8) any fund or other pooling arrangement at least 95% of the assets of which
constitute Investments described in clauses (1) through (7) of this definition.

     “Change of Control” means the occurrence of any of the following:

5

 

     (1) the direct or indirect sale, transfer, conveyance or other disposition (other than
by way of merger or consolidation), in one or a series of related transactions, of all or
substantially all of the properties or assets of the Company and its Restricted Subsidiaries
taken as a whole to any “person” (as that term is used in Section 13(d)(3) of the Exchange
Act);

     (2) the adoption of a plan relating to the liquidation or dissolution of the Company;

     (3) the Company becomes aware of (by way of a report or other filing pursuant to
Section 13(d) of the Exchange Act, proxy, written notice or otherwise) the consummation of
any transaction (including, without limitation, any merger or consolidation) the result of
which is that any “person” (as defined above), becomes the Beneficial Owner, directly or
indirectly, of more than 50% of the Voting Stock of the Company, measured by voting power
rather than number of shares;

     (4) the first day on which a majority of the members of the Board of Directors of the
Company are not Continuing Directors; or

     (5) a change of control under the 3.25% Convertible Senior Subordinated Debentures due
2025 or the 3.5% Convertible Senior Subordinated Notes due 2014.

     “Clearstream” means Clearstream Banking, S.A.

     “Code” means the Internal Revenue Code of 1986, as amended.

     “Company” means LifePoint Hospitals, Inc., and any and all successors thereto pursuant to
Article 5 hereof.

     “Company Order” means a written order signed in the name of the Company by an Officer and
delivered to the Trustee or, with respect to Sections 2.02, 2.06, 2.07, 2.10 and 9.05 herein any
other employee of the Company named in an Officers’ Certificate delivered to the Trustee.

     “Consolidated Assets” of any Person as of any date means the total assets of such Person and
its Restricted Subsidiaries on a consolidated basis at such date, as determined in accordance with
GAAP.

     “Consolidated Cash Flow” means, with respect to any specified Person for any period, the
Consolidated Net Income of such Person for such period plus:

     (1) an amount equal to any extraordinary, unusual or non-recurring loss plus any net
loss realized by such Person or any of its Restricted Subsidiaries in connection with an
Asset Sale
(without regard to the dollar limitation in the definition thereof), to the extent such
losses were deducted in computing such Consolidated Net Income; plus

     (2) provision for taxes based on income or profits of such Person and its Restricted
Subsidiaries for such period, to the extent that such provision for taxes was deducted in
computing such Consolidated Net Income; plus

     (3) consolidated interest expense of such Person and its Restricted Subsidiaries for
such period, whether paid or accrued and whether or not capitalized (including, without
limitation, amortization of debt issuance costs and original issue discount, non-cash
interest payments, the interest component of any deferred payment obligations, the interest
component of all payments associated with Capital Lease Obligations, commissions, discounts
and other fees

6

 

and charges incurred in respect of letter of credit or bankers’ acceptance
financings, and net of the effect of all payments made or received pursuant to Hedging
Obligations), to the extent that any such expense was deducted in computing such
Consolidated Net Income; plus

     (4) depreciation, amortization (including amortization of goodwill and other
intangibles but excluding amortization of prepaid cash expenses that were paid in a prior
period) and other non-cash expenses (excluding any such non-cash expense to the extent that
it represents an accrual of or reserve for cash expenses in any future period or
amortization of a prepaid cash expense that was paid in a prior period) of such Person and
its Restricted Subsidiaries for such period to the extent that such depreciation,
amortization and other non-cash expenses were deducted in computing such Consolidated Net
Income; plus

     (5) severance payments related to management employment contracts, non-cash stock-based
compensation expense, and net income attributable to non-controlling interests in the
Company’s non-wholly-owned Subsidiaries; minus

     (6) any amortization of discounts of convertible debt instruments resulting from the
application of APB 14-1 “Accounting for Convertible Debt Instruments;” minus

     (7) non-cash items increasing such Consolidated Net Income for such period, other than
the accrual of revenue in the ordinary course of business,

in each case, on a consolidated basis and determined in accordance with GAAP.

     Notwithstanding the preceding, the provision for taxes based on the income or profits of, and
the depreciation and amortization and other non-cash expenses of, a Restricted Subsidiary will be
added to Consolidated Net Income to compute Consolidated Cash Flow of the Company only to the
extent that a corresponding amount would be permitted at the date of determination to be dividended
to the Company by such Restricted Subsidiary without prior governmental approval (that has not been
obtained), pursuant to the terms of its charter and all agreements, instruments, judgments,
decrees, orders, statutes, rules and governmental regulations applicable to that Restricted
Subsidiary or its stockholders.

     “Consolidated Net Income” means, with respect to any specified Person for any period, the
aggregate of the Net Income of such Person and its Restricted Subsidiaries for such period, on a
consolidated basis, determined in accordance with GAAP; provided that:

     (1) the Net Income (but not loss) of any Person that is not a Restricted Subsidiary or
that is accounted for by the equity method of accounting will be included only to the extent
of the amount of dividends or distributions paid in cash to the specified Person or a
Restricted Subsidiary of the Person;

     (2) the Net Income of any Restricted Subsidiary will be excluded to the extent that the
declaration or payment of dividends or similar distributions by that Restricted Subsidiary
of that Net Income is not at the date of determination permitted without any prior
governmental approval (that has not been obtained) or, directly or indirectly, by operation
of the terms of its charter or any agreement, instrument, judgment, decree, order, statute,
rule or governmental regulation applicable to that Restricted Subsidiary or its
stockholders;

     (3) for purposes of Section 4.05 hereof, the Net Income of any Person acquired in a
pooling of interests transaction for any period prior to the date of such acquisition will
be excluded; and

7

 

     (4) the cumulative effect of a change in accounting principles will be excluded.

     “Consolidated Secured Debt Ratio” as of the date of any event for which a calculation is
required (the “date of determination”) means the ratio of (a) the aggregate amount of all
Indebtedness of the Company and its Restricted Subsidiaries that is secured by Liens as of the date
of determination to (b) the Consolidated Cash Flow of the Company for the most recently ended four
full fiscal quarters for which internal financial statements are available immediately preceding
the date of determination, in each case with such pro forma adjustments as are appropriate and
consistent with the pro forma adjustment provisions set forth in the definition of “Consolidated
Senior Leverage Ratio”.

     “Consolidated Senior Leverage Ratio” means, as of the date of any event for which a
calculation is required (the “date of determination”), the ratio (x) of the aggregate amount of all
Indebtedness (other than Subordinated Indebtedness) of the Company and its Restricted Subsidiaries
and preferred stock of Restricted Subsidiaries that are not Guarantors as of the date of the
determination to (y) the Consolidated Cash Flow of the Company for the most recently ended four
full fiscal quarters for which internal financial statements are available immediately preceding
the date of determination.

     In addition, for purposes of calculating the Consolidated Senior Leverage Ratio, pro forma
effect will be given to:

     (1) acquisitions of any operations or businesses or assets (other than assets acquired
in the ordinary course of business) that have been made by the specified Person or any of
its Restricted Subsidiaries, including through purchases or through mergers or
consolidations and including any related financing transactions, during the four-quarter
reference period or subsequent to such reference period and on or prior to the date of
determination, as if they had occurred on the first day of the four-quarter reference
period; and

     (2) the discontinuance of operations or businesses and dispositions of operations or
businesses or assets (other than assets disposed of in the ordinary course of business)
during the four quarter reference period or subsequent to such reference period and on or
prior to the date of determination, as if they had occurred on the first day of the four
quarter reference period.

     For purposes of this definition, whenever pro forma effect is to be given to a transaction,
the pro forma calculations shall be determined in good faith by a responsible financial or
accounting officer of the Company.

     “Continuing Directors” means, as of any date of determination, any member of the Board of
Directors of the Company who:

     (1) was a member of such Board of Directors immediately after the annual stockholders
meeting of the Company following the Issue Date; or

     (2) was nominated for election or elected to such Board of Directors with the approval
of a majority of the Continuing Directors who were members of such Board at the time of such
nomination or election.

     “Corporate Trust Office of the Trustee” means the designated office of the Trustee at which
the corporate trust business of the Trustee shall at any particular time be administered, which
office at the date of original execution of this Indenture is located at 900 Ashwood Parkway, Suite
425, Atlanta, Georgia 30338, Attention: Corporate Finance.

     “Credit Agreement” means the Credit Agreement, dated as of April 15, 2005, by and among the
Company, as borrower, the lenders parties thereto, Citicorp North America, Inc., as administrative
agent, Bank of America, N.A., CIBC World Markets Corp., SunTrust Bank, UBS Securities LLC, as
co-

8

 

syndication agents and Citigroup Global Markets, Inc. as sole lead arranger and sole bookrunner,
including any related notes, guarantees, collateral documents, instruments and agreements executed
in connection therewith, and in each case as amended (including, without limitation, as to
principal amount), modified, renewed, refunded, replaced or refinanced from time to time (whether
or not with the original agents or lenders and whether or not contemplated under the original
agreement relating thereto).

     “Credit Facilities” means one or more debt facilities (including, without limitation, the
Credit Agreement), note purchase agreements, commercial paper facilities or indentures, in each
case with banks, institutional or other lenders or a trustee providing for revolving credit loans,
term loans, receivables financing (including through the sale of receivables to such lenders or to
special purpose entities formed to borrow from such lenders against such receivables), letters of
credit or debt securities, in each case, as amended (including, without limitation, as to principal
amount), restated, modified, renewed, refunded, replaced or refinanced in whole or in part from
time to time (whether or not with the original agents or lenders or parties and whether or not
contemplated under the original agreement relating thereto).

     “Default” means any event that is, or with the passage of time or the giving of notice or both
would be, an Event of Default.

     “Definitive Note” means a certificated Note registered in the name of the Holder thereof and
issued in accordance with Section 2.06 hereof, substantially in the form of Exhibit A hereto except
that such Note shall not bear the Global Note Legend and shall not have the “Schedule of Exchanges
of Interests in the Global Note” attached thereto.

     “Depositary” means, with respect to the Notes issuable or issued in whole or in part in global
form, the Person specified pursuant to Section 2.03 hereof as the Depositary with respect to the
Notes, and any and all successors thereto appointed as depositary hereunder and having become such
pursuant to the applicable provision of this Indenture.

     “Designated Non-cash Consideration” means any non-cash consideration received by the Company
or one of its Restricted Subsidiaries in connection with an Asset Sale that is designated as
Designated Non-cash Consideration pursuant to an Officers’ Certificate executed by the principal
financial officer and any of the other executive officers of the Company or such Restricted
Subsidiary at the time of such Asset Sale. Any particular item of Designated Non-cash Consideration
will cease to be considered to be outstanding once it has been sold for cash or Cash Equivalents.

     “Disqualified Stock” means any Capital Stock that, by its terms (or by the terms of any
security into which it is convertible, or for which it is exchangeable, in each case at the option
of the holder of the Capital Stock), or upon the happening of any event, matures or is mandatorily
redeemable, pursuant to a sinking fund obligation or otherwise, or redeemable at the option of the
holder of the Capital Stock, in whole or in part, on or prior to the date that is 91 days after the
date on which the Notes mature. Notwithstanding the preceding sentence, any Capital Stock that
would constitute Disqualified Stock solely because the holders of the Capital Stock have the right
to require the Company to repurchase such Capital Stock upon the occurrence of a change of control
with respect to the Company or an asset sale by the Company or its Restricted Subsidiaries will not
constitute Disqualified Stock if the terms of such Capital Stock provide that the Company may not
repurchase or redeem any such Capital Stock pursuant to such provisions unless such repurchase or
redemption complies with Section 4.05 hereof.

     “Domestic Subsidiary” means any Restricted Subsidiary organized under the laws of the United
States or any state of the United States or the District of Columbia.

9

 

     “Equity Interests” means Capital Stock and all warrants, options or other rights to acquire
Capital Stock (but excluding any debt security that is convertible into, or exchangeable for,
Capital Stock).

     “Equity Offering” means any public or private sale by the Company for cash of its common stock
or preferred stock (excluding Disqualified Stock).

     “Euroclear” means Euroclear Bank, S.A.N.V., as operator of the Euroclear system.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended.

     “Exchange Notes” means the debt securities of the Company issued pursuant to this Indenture in
exchange for the Notes in compliance with the terms of the Registration Rights Agreement.

     “Exchange Offer” has the meaning set forth in the Registration Rights Agreement.

     “Exchange Offer Registration Statement” has the meaning set forth in the Registration Rights
Agreement.

     “Exchange Subsidiary Guarantees” means the guarantees of the obligation of the Company under
this Indenture and the Notes issued pursuant to this Indenture in exchange for the Subsidiary
Guarantees in compliance with the terms of the Registration Rights Agreement.

     “Excluded Subsidiaries” means those Domestic Subsidiaries that are designated by the Company
as Domestic Subsidiaries that will not be Guarantors; provided, however, that in no event will the
Excluded Subsidiaries, either individually or collectively, hold more than 25% of the consolidated
assets of the Company and its Domestic Subsidiaries as of the end of any fiscal quarter or account
for more than 25% of the consolidated revenue of the Company and its Domestic Subsidiaries during
the most recent four-quarter
period (in each case determined as of the most recent fiscal quarter for which the Company has
internal financial statements available); provided, further, that any wholly owned Domestic
Subsidiary that guarantees any Indebtedness incurred pursuant to clause (a) of the second paragraph
of Section 4.07 hereof may not be designated as or continue to be an Excluded Subsidiary. In the
event any Domestic Subsidiaries, individually or collectively, previously designated as Excluded
Subsidiaries cease to meet the requirements of the previous sentence, the Company will, within 60
calendar days following such event, cause one or more of such Domestic Subsidiaries to become
Guarantors so that the requirements of the previous sentence are complied with. On the Issue Date,
all of the Domestic Subsidiaries of the Company that are not parties to this Indenture, with the
exception of Point of Life Indemnity, LTD (which is an Unrestricted Subsidiary as of the Issue
Date), shall be Excluded Subsidiaries. After the Issue Date, the Company may designate Domestic
Subsidiaries as Excluded Subsidiaries by an Officers’ Certificate submitted to the Trustee.

     “Existing Indebtedness” means Indebtedness of the Company and its Restricted Subsidiaries
(other than Indebtedness under the Credit Agreement) in existence on the Issue Date, until such
amounts are repaid.

     “Fixed Charges” means, with respect to any specified Person for any period, the sum, without
duplication, of:

     (1) the consolidated interest expense of such Person and its Restricted Subsidiaries
for such period, whether paid or accrued, including, without limitation, amortization of
debt issuance costs and original issue discount, non-cash interest payments, the interest
component of any deferred payment obligations, the interest component of all payments
associated with Capital Lease Obligations, commissions, discounts and other fees and charges
incurred in respect of letter

10

 

of credit or bankers’ acceptance financings, and net of the
effect of all payments made or received pursuant to Hedging Obligations; plus

     (2) the consolidated interest of such Person and its Restricted Subsidiaries that was
capitalized during such period; plus

     (3) any interest expense on Indebtedness of another Person that is Guaranteed by such
Person or one of its Restricted Subsidiaries or secured by a Lien on assets of such Person
or one of its Restricted Subsidiaries, to the extent such Guarantee or Lien is called upon;
plus

     (4) the product of (a) all dividends, whether paid or accrued and whether or not in
cash, on any series of preferred stock of such Person or any of its Restricted Subsidiaries,
other than dividends on Equity Interests payable solely in Equity Interests of the Company
(other than Disqualified Stock) or to the Company or a Restricted Subsidiary, times (b) a
fraction, the numerator of which is one and the denominator of which is one minus the then
current combined federal, state and local statutory tax rate of such Person, expressed as a
decimal, in each case, on a consolidated basis and in accordance with GAAP; minus

     (5) any amortization of discounts of convertible debt instruments resulting from the
application of APB 14-1 “Accounting for Convertible Debt Instruments”.

     “Fixed Charge Coverage Ratio” means with respect to any specified Person for any period, the
ratio of the Consolidated Cash Flow of such Person for such period to the Fixed Charges of such
Person for such period. In the event that the specified Person or any of its Restricted
Subsidiaries incurs, assumes, Guarantees, repays, repurchases or redeems any Indebtedness (other
than ordinary working capital
borrowings) or issues, repurchases or redeems preferred stock subsequent to the commencement
of the period for which the Fixed Charge Coverage Ratio is being calculated and on or prior to the
date on which the event for which the calculation of the Fixed Charge Coverage Ratio is made (the
“Calculation Date”), then the Fixed Charge Coverage Ratio will be calculated giving pro forma
effect to such incurrence, assumption, Guarantee, repayment, repurchase or redemption of
Indebtedness, or such issuance, repurchase or redemption of preferred stock, and the use of the
proceeds therefrom as if the same had occurred at the beginning of the applicable four-quarter
reference period.

     In addition, for purposes of calculating the Fixed Charge Coverage Ratio, pro forma effect
will be given to:

     (1) acquisitions of any operations or businesses or assets (other than assets acquired
in the ordinary course of business) that have been made by the specified Person or any of
its Restricted Subsidiaries, including through purchases or through mergers or
consolidations and including any related financing transactions, during the four-quarter
reference period or subsequent to such reference period and on or prior to the Calculation
Date, as if they had occurred on the first day of the four-quarter reference period; and

     (2) the discontinuance of operations or businesses and dispositions of operations or
businesses or assets (other than assets disposed of in the ordinary course of business)
during the four quarter reference period or subsequent to such reference period and on or
prior to the Calculation Date, as if they had occurred on the first day of the four quarter
reference period.

     If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the
interest on such Indebtedness shall be calculated as if the rate in effect on the Calculation Date
had been the applicable rate for the entire period. Interest on a Capital Lease Obligation shall be
deemed to accrue at an interest rate reasonably determined by a responsible financial or accounting
officer of the Company to be the

11

 

rate of interest implicit in such Capital Lease Obligation in
accordance with GAAP. For purposes of making the computation referred to above, interest on any
Indebtedness under a revolving credit facility computed on a pro forma basis shall be computed
based upon the average daily balance of such Indebtedness during the applicable period. Interest on
Indebtedness that may optionally be determined at an interest rate based upon a factor of a prime
or similar rate, a eurocurrency interbank offered rate, or other rate, shall be deemed to have been
based upon the rate actually chosen, or, if none, then based upon such optional rate chosen as the
Company may designate.

     For purposes of this definition, whenever pro forma effect is to be given to an acquisition of
assets, the amount of income or earnings relating thereto and the amount of consolidated interest
expense associated with any Indebtedness incurred in connection therewith, the pro forma
calculations shall be determined in good faith by a responsible financial or accounting officer of
the Company. In addition, any such pro forma calculation may include adjustments appropriate, in
the reasonable determination of the Company as set forth in an officers’ certificate, to reflect
operating expense reductions reasonably expected to result from any acquisition or merger.

     “GAAP” means generally accepted accounting principles in the United States as in effect as of
the Issue Date, including those set forth in:

     (1) the Financial Accounting Standards Board’s FASB Accounting Standards Codification;
and

     (2) the rules and regulations of the SEC with respect to generally accepted accounting
principles, including those governing the inclusion of financial statements in periodic
reports required to be filed pursuant to Section 13 of the Exchange Act, including opinions
and pronouncements in staff accounting bulletins and similar written statements from the
accounting staff of the SEC.

     “Global Note” or “Global Notes” means, individually and collectively, each of the Restricted
Global Notes and the Unrestricted Global Notes deposited with or on behalf of and registered in the
name of the Depositary or its nominee, substantially in the form of Exhibit A hereto and that bears
the Global Note Legend and that has the “Schedule of Exchanges of Interests in the Global Note”
attached thereto, issued in accordance with Section 2.01, 2.06(b)(3), 2.06(b)(4), 2.06(d)(1),
2.06(d)(2), 2.06(d)(3) or 2.06(f) hereof.

     “Global Note Legend” means the legend set forth in Section 2.06(g)(2) hereof, which is
required to be placed on all Global Notes issued under this Indenture.

     “Government Securities” means securities that are:

     (1) direct obligations of the United States of America for the timely payment of which
its full faith and credit is pledged; or

     (2) obligations of a Person controlled or supervised by and acting as an agency or
instrumentality of the United States of America the timely payment of which is
unconditionally guaranteed as a full faith and credit obligation by the United States of
America,

which, in either case, are not callable or redeemable at the option of the issuers thereof, and
shall also include a depository receipt issued by a bank (as defined in Section 3(a)(2) of the
Securities Act), as custodian with respect to any such Government Securities or a specific payment
of principal of or interest on any such Government Securities held by such custodian for the
account of the holder of such depository receipt; provided that (except as required by law) such
custodian is not authorized to make any deduction from the amount payable to the holder of such
depository receipt from any amount received by

12

 

the custodian in respect of the Government
Securities or the specific payment of principal of or interest on the Government Securities
evidenced by such depository receipt.

     “Guarantee” means a guarantee other than by endorsement of negotiable instruments for
collection in the ordinary course of business, direct or indirect, in any manner including, without
limitation, by way of a pledge of assets or through letters of credit or reimbursement agreements
in respect thereof, of all or any part of any Indebtedness.

     “Guarantors” means each of:

     (1) the Domestic Subsidiaries of the Company as of the Issue Date other than Excluded
Subsidiaries; and

     (2) any other Subsidiary that executes a Subsidiary Guarantee in accordance with the
provisions of this Indenture (which shall be evidenced by the execution of a supplemental
indenture in the form of Exhibit D hereto), and their respective successors and assigns;
provided that upon the release and discharge of any Person from its Subsidiary Guarantee in
accordance with this Indenture, such Person shall cease to be a Guarantor.

     “Hedging Obligations” means, with respect to any specified Person, the obligations of such
Person under:

     (1) interest rate swap agreements, interest rate cap agreements and interest rate
collar agreements; and

     (2) other agreements or arrangements designed to protect such Person against
fluctuations in interest rates or foreign exchange rates.

     “Holder” means a Person in whose name a Note is registered.

     “Hospital” means a hospital, outpatient clinic, outpatient surgical center, long-term care
facility, diagnostic facility, medical office building or other facility or business that is used
or useful in or related to the provision of healthcare services.

     “Indebtedness” means, with respect to any specified Person, any indebtedness of such Person,
whether or not contingent:

     (1) in respect of borrowed money;

     (2) evidenced by bonds, notes, debentures or similar instruments or letters of credit
(or reimbursement agreements in respect thereof);

     (3) in respect of banker’s acceptances;

     (4) representing Capital Lease Obligations of such Person and Attributable Debt in
respect of Sale and Leaseback Transactions entered into by such Person;

     (5) representing the balance deferred and unpaid of the purchase price of any property;
or

     (6) representing any Hedging Obligations,

13

 

if and to the extent any of the preceding items (other than letters of credit and Hedging
Obligations) would appear as a liability upon a balance sheet of the specified Person prepared in
accordance with GAAP. In addition, the term “Indebtedness” includes all Indebtedness of others
secured by a Lien on any asset of the specified Person (whether or not such Indebtedness is assumed
by the specified Person) and, to the extent not otherwise included, the Guarantee by the specified
Person of any indebtedness of any other Person, in each case limited to the maximum amount of
liability of the specified Person with respect to such Lien or Guarantee on the date in question.
Notwithstanding anything in the foregoing to the contrary, Indebtedness shall not include trade
payables or accrued expenses for property or services incurred in the ordinary course of business,
any liability for federal, state, local or other taxes or any settlements or judgments relating to
governmental litigations and/or investigations. The amount of any Indebtedness issued with original
issue discount will be the accreted value of such Indebtedness.

     “Indenture” means this Indenture, as amended or supplemented from time to time.

     “Indirect Participant” means a Person who holds a beneficial interest in a Global Note through
a Participant.

     “Initial Notes” has the meaning assigned to it in the preamble to this Indenture.

     “Initial Purchasers” means Barclays Capital Inc., Banc of America Securities LLC, Citigroup
Global Markets Inc., Goldman, Sachs & Co., SunTrust Robinson Humphrey, Inc., Morgan Keegan &
Company, Inc., Credit Agricole Securities (USA) Inc., RBC Capital Markets Corporation, Fifth Third
Securities, Inc. and U.S. Bancorp Investments, Inc.

     “Insurance Subsidiary” means a Subsidiary of the Company or any Restricted Subsidiary
established for the purpose of insuring the businesses or facilities owned or operated by the
Company or any of its Subsidiaries or any joint venture to which they are a party or any Person
employed by or on the staff of any such business or facility.

     “Interest Payment Date,” when used with respect to any Note, means the Stated Maturity of an
installment of interest on such Note.

     “Investment Grade” means (1) with respect to S&P, any of the rating categories from and
including AAA to and including BBB- and (2) with respect to Moody’s, any of the rating categories
from and including Aaa to and including Baa3.

     “Investments” means, with respect to any Person, all direct or indirect investments by such
Person in other Persons (including Affiliates) in the forms of loans (including Guarantees or other
obligations), advances or capital contributions (excluding commission, travel and similar advances
to directors, officers and employees made in the ordinary course of business), purchases or other
acquisitions for consideration of Indebtedness, Equity Interests or other securities, together with
all items that are or would be classified as investments on a balance sheet prepared in accordance
with GAAP. If the Company or any Restricted Subsidiary sells or otherwise disposes of any Equity
Interests of any direct or indirect Restricted Subsidiary such that, after giving effect to any
such sale or disposition, such Person is no longer a Restricted Subsidiary, the Company will be
deemed to have made an Investment on the date of any such sale or disposition equal to the fair
market value of the Equity Interests of such Restricted Subsidiary not sold or disposed of in an
amount determined as provided in the final paragraph of Section 4.05 hereof; provided that the
Company shall not have been deemed to have made an Investment pursuant to the foregoing if the
Company shall have previously or concurrently therewith been deemed to have made an Investment in
connection with such Equity Interests. The acquisition by the Company or any Restricted Subsidiary
of a Person that holds an Investment in a third Person will be deemed to be an Investment by the
Company or such Restricted

14

 

Subsidiary in such third Person in an amount equal to the fair market
value of the Investment held by the acquired Person in such third Person in an amount determined as
provided in the final paragraph of Section 4.05 hereof; provided, the Company or such Restricted
Subsidiary shall not have been deemed to have made an Investment pursuant to the foregoing if the
Company or any Restricted Subsidiary shall have previously or concurrently therewith been deemed to
have made an Investment in connection with such acquisition. “Investments” shall exclude extensions
of trade credit.

     “Issue Date” means the original issue date for the first issuance of Notes offered hereby
under this Indenture.

     “Letter of Transmittal” means the letter of transmittal to be prepared by the Company and sent
to all Holders of the Notes for use by such Holders in connection with the Exchange Offer.

     “Lien” means, with respect to any asset, any mortgage, lien, pledge, charge, security interest
or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise
perfected under applicable law, including any conditional sale or other title retention agreement,
any lease in the nature thereof, any option or other agreement to sell or give a security interest
in and any filing of or
agreement to give any financing statement under the Uniform Commercial Code (or equivalent
statutes) of any jurisdiction.

     “Limited Originator Recourse” means a reimbursement obligation of the Company in connection
with a drawing on a letter of credit, revolving loan commitment, cash collateral account or other
such credit enhancement issued to support Indebtedness of a Securitization Subsidiary that the
Company’s board of directors (or a duly authorized committee thereof) determines is necessary to
effectuate a Qualified Securitization Transaction; provided, that the available amount of any such
form of credit enhancement at any time shall not exceed 10% of the principal amount of such
Indebtedness at such time; and provided, further, that such reimbursement obligation is permitted
to be Incurred by the Company pursuant to Section 4.07 hereof.

     “Net Income” means, with respect to any specified Person, the net income (loss) of such
Person, determined in accordance with GAAP and before any reduction in respect of preferred stock
dividends, excluding, however:

     (1) any gain or loss, together with any related provision for taxes on such gain or
loss, realized in connection with: (a) any Asset Sale (without regard to the dollar
limitation in the definition thereof); (b) the disposition of any securities by such Person
or any of its Restricted Subsidiaries or the extinguishment of any Indebtedness of such
Person or any of its Restricted Subsidiaries; or (c) any acquisition, recapitalization or
Permitted Investment of such Person or any of its Restricted Subsidiaries;

     (2) any extraordinary, unusual or non-recurring gain, charge, expense or loss (together
with any related provision for taxes on such extraordinary, unusual or non-recurring gain,
charge, expense or loss), including, without limitation, (a) restructuring charges, reserves
or other related expenses, (b) fees, expenses or charges relating to facility shutdowns and
discontinued operations, (c) acquisition integration costs, (d) severance or other employee
termination or relocation costs, expenses or charges, (e) non-cash compensation charges
recorded from grants of stock options, restricted stock, stock appreciation rights and other
equity equivalents to officers, directors and employees and (f) litigation and investigation
settlement costs and related expenses; and

     (3) the net income (or loss) from disposed or discontinued operations for the four
fiscal quarters preceding the date of determining Net Income.

15

 

     “Net Proceeds” means the aggregate cash proceeds and Cash Equivalents received by the Company
or its Restricted Subsidiaries in respect of any Asset Sale (including, without limitation, any
cash received upon the sale or other disposition of any non-cash consideration received in any
Asset Sale), net of the direct costs relating to such Asset Sale, including, without limitation,
legal, accounting and investment banking fees, sales commissions, any relocation expenses incurred
as a result of the Asset Sale, any taxes paid or payable as a result of the Asset Sale, in each
case, after taking into account any available tax credits or deductions and any tax sharing
arrangements, amounts required to be applied to the repayment of Indebtedness, all distributions
and other payments required to be made to non-majority interest holders in subsidiaries or joint
ventures as a result of such Asset Sale and appropriate amounts to be provided by the Company or
any Restricted Subsidiary, as the case may be, as a reserve required in accordance with GAAP
against any liabilities associated with such Asset Sale and retained by the Company or any
Restricted Subsidiary, as the case may be, after such Asset Sale, including, without limitation,
pension and other post-employment benefit liabilities, liabilities related to environmental matters and liabilities
under any indemnification obligations associated with such Asset Sale.

     “Non-U.S. Person” means a person who is not a U.S. Person, as defined in Regulation S.

     “Notes” has the meaning assigned to it in the preamble to this Indenture. The Initial Notes,
any Additional Notes and any Exchange Notes shall be treated as a single class for all purposes
under this Indenture, and unless the context otherwise requires, all references to the Notes shall
include the Initial Notes, any Additional Notes and any Exchange Notes.

     “Obligations” means any principal, interest, penalties, fees, indemnifications,
reimbursements, damages and other liabilities payable under the documentation governing any
Indebtedness.

     “Officer” means, with respect to any Person, the Chairman of the Board, the Chief Executive
Officer, the President, the Chief Operating Officer, the Chief Financial Officer, the Treasurer,
any Assistant Treasurer, the Controller, the Secretary or any Vice-President of such Person. With
respect to any partnership, the term “Officer” shall include the Chairman of the Board, the Chief
Executive Officer, the President, the Chief Operating Officer, the Chief Financial Officer, the
Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Vice-President of the
general partners of such partnership. With respect to a limited liability company, the term
“Officer” shall include the Chairman of the Board, the Chief Executive Officer, the President, the
Chief Operating Officer, the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the
Controller, the Secretary or any Vice-President of such limited liability company, or such officers
of the manager or managing member of such limited liability company, as the case may be (or, if
such manager or managing member is an individual, such individual).

     “Officers’ Certificate” means a certificate signed on behalf of the Company or, if applicable,
a Guarantor, by two Officers of the Company or of a Guarantor, as the case may be, one of whom,
solely for the purposes of Section 4.04 hereof, must be the principal executive officer, the
principal financial officer or the principal accounting officer of the Company, that meets the
requirements of Section 12.05 hereof, if applicable.

     “Opinion of Counsel” means, as to the Company or, if applicable, a Guarantor, an opinion from
legal counsel who is reasonably acceptable to the Trustee, that meets the requirements of Section
12.05 hereof, if applicable. The counsel may be an employee of or counsel to the Company, any
Subsidiary of the Company or the Trustee.

     “Participant” means, with respect to the Depositary, Euroclear or Clearstream, a Person who
has an account with the Depositary, Euroclear or Clearstream, respectively (and, with respect to
DTC, shall include Euroclear or Clearstream).

16

 

     “Permitted Business” means the business or businesses conducted by the Company and its
Restricted Subsidiaries, or any of them, as of the Issue Date and any business ancillary or
complementary thereto.

     “Permitted Investments” means:

     (1) any Investment in the Company or in a Restricted Subsidiary;

     (2) any Investment in Cash Equivalents;

     (3) any Investment by the Company or any Restricted Subsidiary in a Person, if as a
result of such Investment:

     (a) such Person becomes a Restricted Subsidiary; or

     (b) such Person is merged, consolidated or amalgamated with or into, or
transfers or conveys substantially all of its assets to, or is liquidated into, the
Company or a Restricted Subsidiary;

     (4) any Investment made as a result of the receipt of non-cash consideration from an
Asset Sale (including any Asset Swap) that was made pursuant to and in compliance with the
provisions of Section 4.08 hereof;

     (5) any Investment received to the extent the consideration therefor was the issuance
of Equity Interests (other than Disqualified Stock) of the Company;

     (6) Hedging Obligations;

     (7) intercompany Indebtedness to the extent permitted under Section 4.07 hereof;

     (8) Investments in prepaid expenses, negotiable instruments held for collection and
lease, utility and workers’ compensation, performance and other similar deposits made in the
ordinary course of business and Investments to secure participation in government
reimbursement programs;

     (9) loans and advances to officers, directors and employees made in the ordinary course
of business;

     (10) Investments represented by accounts and notes receivable created or acquired in
the ordinary course of business;

     (11) Investments existing on the Issue Date and any renewal or replacement thereof on
terms and conditions not materially less favorable than that being renewed or replaced;

     (12) Investments by any qualified or nonqualified benefit plan established by the
Company or its Restricted Subsidiaries made in accordance with the terms of such plan, or
any Investments made by the Company or any Restricted Subsidiary in connection with the
funding thereof;

     (13) Investments received in settlement of debts or judgments owed to the Company or
any Restricted Subsidiary, including, without limitation, as a result of foreclosure,
perfection

17

 

or enforcement of any Lien or indebtedness or in connection with any bankruptcy,
liquidation, receivership or insolvency proceeding;

     (14) Investments in any Subsidiary that constitutes a special purpose entity formed for
the primary purpose of issuing trust preferred or similar securities in a transaction
permitted by Section 4.07 hereof;

     (15) Investments deemed to have been made as a result of the acquisition of a Person
permitted under clause (3) of this definition to the extent that the aggregate fair market
value of such Investments does not exceed 25% of the fair market value of the total
consideration paid to acquire such Person;

     (16) Investments by the Company or a Restricted Subsidiary in a Securitization
Subsidiary in connection with a Qualified Securitization Transaction, which investment
consists of a retained interest in transferred Receivables and Related Assets;

     (17) Investments made within 90 days after the date of the commitment to make the
Investment, that when such commitment was made would have complied with the terms of this
Indenture;

     (18) Guarantees issued in accordance with Section 4.07 hereof;

     (19) payroll, travel and similar advances to cover matters that are expected at the
time of such advances ultimately to be treated as expenses for accounting purposes and that
are made in the ordinary course of business;

     (20) Investments in a Permitted Joint Venture, together with all other Investments made
by the Company or any Restricted Subsidiary pursuant to this clause (20) in an aggregate
amount at the time of such Investment not to exceed $35 million outstanding at any one time;

     (21) Investments in any Insurance Subsidiary in an amount which does not at the time
made exceed 125% of the minimum amount of capital required under the laws of the
jurisdiction in which the Insurance Subsidiary is formed (other than any excess capital that
would result in any unfavorable tax or reimbursement impact if distributed), in any
self-insurance trust in an amount not to exceed 125% of the aggregate amount of the risk
retained by the Insurance Subsidiary, the Company or any of its Subsidiaries on an annual
basis and any Investment by such Insurance Subsidiary or self-insurance trust which is a
legal investment for an insurance company under the laws of the jurisdiction in which the
Insurance Subsidiary is formed or for a self-insurance trust under the applicable laws;

     (22) Investments consisting of Physician Support Obligations made by the Company or any
Restricted Subsidiary; and

     (23) other Investments in any Person having an aggregate fair market value (measured on
the date each such Investment was made and without giving effect to subsequent changes in
value), when taken together with all other outstanding Investments made pursuant to this
clause
(23), not to exceed the greater of $250 million and 5% of Total Assets in the aggregate
at any one time outstanding.

     “Permitted Joint Venture” means, with respect to any Person, (1) any corporation, association,
or other business entity (other than a partnership) of which 50% or less of the total voting power
of shares of

18

 

Capital Stock entitled (without regard to the occurrence of any contingency) to vote
in the election of directors, managers or trustees thereof is at the time of determination owned or
controlled, directly or indirectly, by such Person or one or more of the Restricted Subsidiaries of
that Person or a combination thereof and (2) any partnership, joint venture, limited liability
company or similar entity of which 50% or less of the capital accounts, distribution rights, total
equity and voting interests or general or limited partnership interests, as applicable, are owned
or controlled, directly or indirectly, by such Person or one or more of the other Restricted
Subsidiaries of that Person or a combination thereof whether in the form of membership, general,
special or limited partnership interests or otherwise.

     “Permitted Liens” means:

     (1) Liens in favor of the Company or its Restricted Subsidiaries;

     (2) Liens on property of a Person existing at the time such Person is merged with or
into or consolidated with the Company or any Restricted Subsidiary; provided that such Liens
were in existence prior to the contemplation of such merger or consolidation and do not
extend to any assets other than those of the Person merged into or consolidated with the
Company or the Restricted Subsidiary;

     (3) Liens on property existing at the time of acquisition of the property by the
Company or any Restricted Subsidiary, provided that such Liens were in existence prior to
the contemplation of such acquisition;

     (4) Liens to secure Indebtedness (including, without limitation, Capital Lease
Obligations) permitted by clause (d) of the second paragraph of Section 4.07 hereof covering
only the assets acquired with such Indebtedness;

     (5) Liens existing on the Issue Date;

     (6) Liens for taxes, assessments or governmental charges or claims that are not yet
delinquent or that are being contested in good faith by appropriate proceedings promptly
instituted and diligently concluded, provided that any reserve or other appropriate
provision as is required in conformity with GAAP has been made therefor;

     (7) Liens securing any Hedging Obligations of the Company or any Restricted Subsidiary;

     (8) Liens securing any Indebtedness otherwise permitted to be incurred under this
Indenture, the proceeds of which are used to refinance Indebtedness of the Company or any
Restricted Subsidiary, provided that such Liens extend to or cover only the assets secured
by the Indebtedness being refinanced;

     (9) Liens on property of a Person existing at the time such Person becomes a Restricted
Subsidiary, provided that such Liens were not incurred in connection with, or in
contemplation of, such Person becoming a Restricted Subsidiary;

     (10) statutory Liens and other Liens imposed by law incurred in the ordinary course of
business for sums not yet delinquent or being contested in good faith, if the Company or any
applicable Restricted Subsidiaries shall have made any reserves or other appropriate
provision required by GAAP;

19

 

     (11) Liens incurred or deposits made in the ordinary course of business in connection
with workers’ compensation, unemployment insurance and other types of social security, or to
secure the performance of tenders, statutory obligations, surety and appeal bonds, bids,
leases, government contracts, performance, return-of-money bonds, participation in
government reimbursement programs and other similar obligations;

     (12) judgment Liens not giving rise to an Event of Default, so long as any appropriate
legal proceedings which may have been duly initiated for the review of such judgment shall
not have been finally terminated or the period within which such proceedings may be
initiated shall not have expired;

     (13) easements, rights-of-way, zoning restrictions and other similar charges or
encumbrances in respect of real property not interfering in any material respect with the
conduct of the business of the Company or any of its Restricted Subsidiaries;

     (14) any interest or title of a lessor in assets or property subject to Capital Lease
Obligations or an operating lease of the Company or any Restricted Subsidiary;

     (15) Liens incurred in connection with a financing involving the sale or other
disposition of accounts receivable and related assets (including, without limitation, in
connection with a securitization or similar financing);

     (16) leases or subleases granted to others not interfering with the ordinary conduct of
the business of the Company or any of the Restricted Subsidiaries;

     (17) bankers’ liens with respect to the right of set-off arising in the ordinary course
of business against amounts maintained in bank accounts or certificates of deposit in the
name of the Company or any Restricted Subsidiary;

     (18) the interest of any issuer of a letter of credit in any cash or Cash Equivalents
deposited with or for the benefit of such issuer as collateral for such letter of credit;
provided that the Indebtedness so collateralized is permitted to be incurred by the terms of
this Indenture;

     (19) any Lien consisting of a right of first refusal or option to purchase an ownership
interest in any Restricted Subsidiary or to purchase assets of the Company or any Restricted
Subsidiary, which right of first refusal or option is entered into in the ordinary course of
business or is otherwise permitted under this Indenture;

     (20) any Lien granted to the Trustee pursuant to the terms of this Indenture and any
substantially equivalent Lien granted to the respective trustees under the indentures for
other debt securities of the Company;

     (21) statutory, contractual or common law Liens of landlords and mortgagees of
landlords and Liens of carriers, warehousemen, mechanics, suppliers, materialmen, repairmen
or workmen in the ordinary course of business;

     (22) licenses and sublicenses of intellectual property granted to third parties in the
ordinary course of business;

     (23) Liens upon specific items of inventory or other goods and proceeds of any Person
securing such Person’s Obligations in respect of bankers’ acceptances issued or created for
the

20

 

account of such Person to facilitate the purchase, shipment or storage of such inventory
or other goods;

     (24) Liens securing Indebtedness of any Restricted Subsidiary (other than a Guarantor)
that was permitted by the terms of this Indenture to be incurred, and related Obligations,
which Liens encumber only assets of such Restricted Subsidiary;

     (25) Liens securing Indebtedness incurred pursuant to clause (a) or (v) of the second
paragraph of Section 4.07 hereof;

     (26) Liens securing any Indebtedness incurred pursuant to the first paragraph of
Section 4.07 hereof so long as, after giving effect to such incurrence, the Consolidated
Secured Debt Ratio shall be equal to or less than 3.0 to 1 as of the date on which such Lien
is incurred;

     (27) Liens with respect to obligations that do not at any one time outstanding exceed
the greater of $200 million and 5% of Total Assets; and

     (28) Liens on assets transferred to a Securitization Subsidiary or on assets of a
Securitization Subsidiary, in either case, incurred in connection with a Qualified
Securitization Transaction.

     “Permitted Refinancing Indebtedness” means any Indebtedness of the Company or any Restricted
Subsidiary issued in exchange for, or the net proceeds of which are used to extend, refinance,
renew, replace, defease or refund other Indebtedness of the Company or any of its Restricted
Subsidiaries (other than intercompany Indebtedness); provided that:

     (1) the principal amount of such Permitted Refinancing Indebtedness does not exceed the
principal amount of the Indebtedness extended, refinanced, renewed, replaced, defeased or
refunded (plus all accrued interest on the Indebtedness and the amount of all fees, expenses
and premiums incurred in connection therewith);

     (2) such Permitted Refinancing Indebtedness has a final maturity date not earlier than
the final maturity date of, and has a Weighted Average Life to Maturity equal to or greater
than, the Weighted Average Life to Maturity of, the Indebtedness being extended, refinanced,
renewed, replaced, defeased or refunded, except that, notwithstanding the foregoing, in the
case of a refinancing, replacement, defeasance or refunding of the 3.25% Convertible Senior
Subordinated
Debentures due 2025, such Permitted Refinancing Indebtedness may have a final maturity
date and a Weighted Average Life to Maturity of no earlier than one year after the final
maturity date and Weighted Average Life to Maturity of the Notes;

     (3) if the Indebtedness being extended, refinanced, renewed, replaced, defeased or
refunded is subordinated in right of payment to the Notes, such Permitted Refinancing
Indebtedness is subordinated in right of payment to the Notes on terms not materially less
favorable to the Holders of Notes as those contained in the documentation governing the
Indebtedness being extended, refinanced, renewed, replaced, defeased or refunded, except, in
the case of the 3.25% Convertible Senior Subordinated Debentures due 2025 and the 3.5%
Convertible Senior Subordinated Notes due 2014, as may be permitted under Section 4.05
hereof; and

     (4) if the Indebtedness being extended, refinanced, renewed, replaced, defeased or
refunded was incurred by the Company or a Guarantor, the obligor on the Permitted
Refinancing Indebtedness may not be a Restricted Subsidiary that is not a Guarantor.

21

 

     “Person” means any individual, corporation, partnership, joint venture, association,
joint-stock company, trust, unincorporated organization, limited liability company or government or
other entity.

     “Physician Support Obligation” means:

     (1) a loan to or on behalf of, or a Guarantee of Indebtedness of or income of, (x) a
physician or healthcare professional providing service to patients in the service area of a
Hospital operated by the Company or any of its Restricted Subsidiaries or (y) any
independent practice association or other entity that is majority owned by any Person or
group of Persons described in clause (x), in either case made or given by the Company or any
Restricted Subsidiary of the Company:

     (a) in the ordinary course of its business; and

     (b) pursuant to a written agreement having a period not to exceed five years;
or

     (2) Guarantees by the Company or any Restricted Subsidiary of leases and loans to
acquire property (real or personal) for or on behalf of a physician, healthcare professional
or any independent practice association or other entity that is majority owned by any Person
or group of Persons described in clause (x) above providing service to patients in the
service area of a Hospital operated by the Company or any of its Restricted Subsidiaries.

     “Principal Property” means each Hospital (excluding personal property, office fixtures and
equipment (including data processing equipment, vehicles and equipment used on, or useful with,
vehicles)) owned solely by the Company and/or one or more of its Subsidiaries and located in the
United States of America unless the Board of Directors of the Company determines that any such
hospital is not material to the Company and its Subsidiaries taken as a whole.

     “Private Placement Legend” means the legend set forth in Section 2.06(g)(1) hereof to be
placed on all Notes issued under this Indenture except where otherwise permitted by the provisions
of this Indenture.

     “QIB” means a “qualified institutional buyer” as defined in Rule 144A.

     “Qualified Securitization Transaction” means any transaction or series of transactions that
may be entered into by the Company or any Restricted Subsidiary pursuant to which (a) the Company
or any Restricted Subsidiary may sell, convey or otherwise transfer to a Securitization Subsidiary
its interests in Receivables and Related Assets and (b) such Securitization Subsidiary transfers to
any other person, or grants a security interest in, such Receivables and Related Assets, pursuant
to a transaction which is customarily used to achieve a transfer of financial assets under GAAP.

     “Receivables and Related Assets” means any account receivable (whether now existing or arising
thereafter) of the Company or any Restricted Subsidiary, and any assets related thereto including
all collateral securing such accounts receivable, all contracts and contract rights and all
Guarantees or other obligations in respect of such accounts receivable, proceeds of such accounts
receivable and other assets which are customarily transferred or in respect of which security
interest are customarily granted in connection with asset securitization transaction involving
accounts receivable.

     “Redemption Date,” when used with respect to any Note to be redeemed, shall mean the date
specified for redemption of such Note in accordance with the terms of such Note and this Indenture.

22

 

     “Redemption Price,” when used with respect to any Note to be redeemed, means the price at
which it is to be redeemed pursuant to this Indenture.

     “Registration Rights Agreement” means the Registration Rights Agreement dated September 23,
2010, among the Company, the Guarantors identified therein and Barclays Capital Inc., as
representative of the several Initial Purchasers.

     “Regular Record Date” for the interest payable on any Interest Payment Date on the Notes means
the date specified for that purpose.

     “Regulation S” means Regulation S promulgated under the Securities Act.

     “Regulation S Global Note” means a Global Note in the form of Exhibit A hereto bearing the
Global Note Legend, the Private Placement Legend and the Regulation S Legend and deposited with or
on behalf of and registered in the name of the Depositary or its nominee, issued in a denomination
equal to the outstanding principal amount of the Notes sold in reliance on Rule 903 of Regulation
S.

     “Regulation S Legend” means the legend set forth in Section 2.06(g)(3) hereof to be placed on
each Regulation S Global Note issued under this Indenture except where otherwise permitted by the
provisions of this Indenture.

     “Replacement Assets” mean properties or assets substantially similar to the assets disposed of
in a particular Asset Sale and acquired to replace the properties or assets that were the subject
of such Asset Sale or that are otherwise useful in a Permitted Business.

     “Responsible Officer,” when used with respect to the Trustee, means any officer within the
corporate trust department of the Trustee having direct responsibility for the administration of
this Indenture, or any other officer to whom any corporate trust matter is referred because of such
officer’s knowledge of and familiarity with the particular subject.

     “Restricted Definitive Note” means a Definitive Note bearing the Private Placement Legend.

     “Restricted Global Note” means a Global Note bearing the Private Placement Legend.

     “Restricted Investment” means an Investment other than a Permitted Investment.

     “Restricted Period” means the 40-day distribution compliance period as defined in Regulation
S, commencing on the Issue Date, in the case of the Initial Notes.

     “Restricted Subsidiary” means any direct or indirect Subsidiary of the Company other than an
Unrestricted Subsidiary.

     “Rule 144” means Rule 144 promulgated under the Securities Act.

     “Rule 144A” means Rule 144A promulgated under the Securities Act.

     “Rule 903” means Rule 903 promulgated under the Securities Act.

     “Rule 904” means Rule 904 promulgated under the Securities Act.

23

 

     “Sale and Leaseback Transaction” means, with respect to any Person, an arrangement whereby
such Person enters into a lease of property previously transferred by such Person to the lessor in
contemplation of such leasing.

     “SEC” means the Securities and Exchange Commission.

     “Securities Act” means the Securities Act of 1933, as amended.

     “Securitization Subsidiary” means a Subsidiary of the Company:

     (1) that is designated a “Securitization Subsidiary” by the Board of Directors of the
Company (or a duly authorized committee thereof);

     (2) that does not engage in any activities other than Qualified Securitization
Transactions and any activity necessary or incidental thereto;

     (3) no portion of the Indebtedness or any other obligation, contingent or otherwise, of
which

     (A) is Guaranteed by the Company or any Restricted Subsidiary in any way other
than pursuant to Standard Securitization Undertakings or Limited Originator
Recourse,

     (B) is recourse to or obligates the Company or any other Restricted Subsidiary
in any way other than pursuant to Standard Securitization Undertakings or Limited
Originator Recourse, or

     (C) subjects any property or asset of the Company or any other Restricted
Subsidiary, directly or indirectly, contingently or otherwise, to the satisfaction
thereof
other than pursuant to Standard Securitization Undertakings or Limited
Originator Recourse;

     (4) with respect to which neither the Company nor any other Restricted Subsidiary has
any obligation to maintain or preserve its financial condition or cause it to achieve
certain levels of operating results; and

     (5) with which neither the Company nor any Restricted Subsidiary has any material
contract, agreement, arrangement or understanding other than on terms no less favorable to
the Company or such Restricted Subsidiary than those that might be obtained at the time from
persons that are not Affiliates of the Company, other than Standard Securitization
Undertakings and fees payable in the ordinary course of business in connection with
servicing accounts receivable of such entity.

     Any designation of a Subsidiary as a Securitization Subsidiary shall be evidenced to the
Trustee by filing with the Trustee a Board Resolution of the Company giving effect to the
designation and an Officers’ Certificate certifying that the designation complied with the
preceding conditions.

     “Shelf Registration Statement” means the Shelf Registration Statement as defined in the
Registration Rights Agreement.

24

 

     “Significant Subsidiary” means any Subsidiary that would be a “significant subsidiary” as
defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as
such Regulation is in effect on the date hereof.

     “Special Interest” means any additional interest then owing in respect of the Notes pursuant
to the provisions of the Registration Rights Agreement.

     “Special Record Date” for the payment of any Defaulted Interest on the Notes means a date
fixed by the Trustee pursuant to Section 2.12 hereof.

     “Standard Securitization Undertakings” means representations, warranties, covenants and
indemnities entered into by the Company or any Restricted Subsidiary that are reasonably customary
in accounts receivable securitization transactions, as the case may be.

     “Stated Maturity” means, with respect to any installment of interest or principal on any
series of Indebtedness, the date on which the payment of interest or principal was scheduled to be
paid in the original documentation governing such Indebtedness, and will not include any contingent
obligations to repay, redeem or repurchase any such interest or principal prior to the date
originally scheduled for the payment thereof.

     “Subordinated Indebtedness” means any Indebtedness of the Company or any Guarantor which is
subordinated in right of payment to the Notes or any Subsidiary Guarantee, as applicable, pursuant
to a written agreement to that effect.

     “Subsidiary” means, with respect to any specified Person, (a) any corporation more than 50% of
the outstanding securities having ordinary voting power of which shall at the time be owned or
controlled, directly or indirectly, by such Person or by one or more of its Restricted Subsidiaries
or by such Person and one or more of its Restricted Subsidiaries, or (b) any partnership, limited
liability company, association, joint
venture or similar business organization more than 50% of the ownership interests having
ordinary voting power of which shall at the time be so owned or controlled.

     “Subsidiary Guarantee” means a Guarantee of Notes pursuant to this Indenture.

     “TIA” means the Trust Indenture Act of 1939 (15 U.S.C. §§77aaa-77bbbb) as in effect on the
date on which this Indenture is qualified under the TIA.

     “Total Assets” means, as of any date of determination, the total assets of the Company and its
Restricted Subsidiaries as shown on the balance sheet for the most recently completed quarter for
which internal financial statements are available determined in accordance with GAAP.

     “Treasury Rate” means, as of the date the redemption notice is given to Holders of the Notes,
the yield to maturity as of such date (as compiled by and published in the most recent Federal
Reserve Statistical Release H. 15(519), which has become publicly available at least two Business
Days prior to the date of the redemption notice for which such computation is being made (or if
such Statistical Release is no longer published, as reported in any publicly available source of
similar market data)), of United States Treasury securities with a constant maturity most nearly
equal to the period from the relevant Redemption Date to October 1, 2015; provided that, if such
period is not equal to the constant maturity of the United States Treasury security for which a
weekly average yield is given, the Treasury Rate shall be obtained by linear interpolation
(calculated to the nearest one-twelfth of a year) from the weekly average yields of United States
Treasury securities for which such yields are given, except that if such period is less than one

25

 

year, the weekly average yield on actually traded United States Treasury securities adjusted to a
constant maturity of one year shall be used.

     “Trustee” means the party named as such above until a successor replaces it in accordance with
the applicable provisions of this Indenture and thereafter means the successor serving hereunder.

     “U.S. Person” means a U.S. Person as defined in Rule 902(k) promulgated under the Securities
Act.

     “Unrestricted Definitive Note” means a Definitive Note that does not bear and is not required
to bear the Private Placement Legend.

     “Unrestricted Global Note” means a Global Note that does not bear and is not required to bear
the Private Placement Legend.

     “Unrestricted Subsidiary” means any Subsidiary of the Company that is designated by the Board
of Directors of the Company as an Unrestricted Subsidiary pursuant to a Board Resolution, but only
to the extent that such Subsidiary:

     (1) has no Indebtedness other than Indebtedness that is without recourse to the Company
or its Restricted Subsidiaries;

     (2) is not party to any agreement, contract, arrangement or understanding with the
Company or any Restricted Subsidiary unless the terms of any such agreement, contract,
arrangement or understanding are not materially less favorable to the Company or such
Restricted Subsidiary than those that might be obtained at the time from Persons who are not
Affiliates of the Company;

     (3) is a Person with respect to which neither the Company nor any of its Restricted
Subsidiaries has any (a) continuing direct or indirect obligation to subscribe for
additional Equity Interests or (b) direct or indirect obligation to maintain or preserve
such Person’s financial condition or to cause such Person to achieve any specified levels of
operating results; and

     (4) has not guaranteed or otherwise directly or indirectly provided credit support for
any Indebtedness of the Company or any of its Restricted Subsidiaries.

     In addition, any Subsidiary that constitutes a special purpose entity formed for the primary
purpose of financing receivables or for the primary purpose of issuing trust preferred or similar
securities in connection with a transaction permitted by Section 4.07 hereof shall be, and any
Insurance Subsidiary may be, an Unrestricted Subsidiary.

     Any designation of a Subsidiary of the Company as an Unrestricted Subsidiary after the Issue
Date shall be evidenced to the Trustee by filing with the Trustee a Board Resolution of the Company
giving effect to such designation and an Officers’ Certificate certifying that such designation
complied with the preceding conditions and was permitted by Section 4.05 hereof. If, at any time,
any Unrestricted Subsidiary would fail to meet the preceding requirements as an Unrestricted
Subsidiary, it will thereafter cease to be an Unrestricted Subsidiary for purposes of this
Indenture and any Indebtedness of such Subsidiary will be deemed to be incurred by a Restricted
Subsidiary of the Company as of such date and, if such Indebtedness is not permitted to be incurred
as of such date under Section 4.07 hereof, the Company will be in default of such covenant. The
Board of Directors of the Company may at any time designate any Unrestricted Subsidiary to be a
Restricted Subsidiary; provided that such designation will be deemed to be an incurrence

26

 

of
Indebtedness by a Restricted Subsidiary of any outstanding Indebtedness of such Unrestricted
Subsidiary and such designation will only be permitted if (1) such Indebtedness is permitted under
Section 4.07 hereof, calculated on a pro forma basis as if such designation had occurred at the
beginning of the four quarter reference period; and (2) no Default or Event of Default would be in
existence following such designation.

     “Voting Stock” of any Person as of any date means the Capital Stock of such Person that is at
the time entitled to vote in the election of the Board of Directors of such Person.

     “Weighted Average Life to Maturity” means, when applied to any Indebtedness at any date, the
number of years obtained by dividing:

     (1) the sum of the products obtained by multiplying (a) the amount of each then
remaining installment, sinking fund, serial maturity or other required payments of
principal, including payment at final maturity, in respect of the Indebtedness, by (b) the
number of years (calculated to the nearest one-twelfth) that will elapse between such date
and the making of such payment; by

     (2) the then outstanding principal amount of such Indebtedness.

Section 1.02. Other Definitions.

	 	 	 	 	 
	 	 	Defined in	 
	Term	 	Section	 
	“Affiliate Transaction” 
	 	 	4.09	 
	“Asset Sale Offer” 
	 	 	4.08	 
	“Change of Control Offer” 
	 	 	4.11	 
	“Change of Control Payment” 
	 	 	4.11	 
	“Change of Control Payment Date” 
	 	 	4.11	 
	“Covenant Defeasance” 
	 	 	8.03	 
	“Covenant Suspension Event” 
	 	 	4.15	 
	“Defaulted Interest” 
	 	 	2.12	 
	“Defeased Securities” 
	 	 	8.01	 
	“DTC” 
	 	 	2.03	 
	“Event of Default” 
	 	 	6.01	 
	“Excess Proceeds” 
	 	 	4.08	 
	“Legal Defeasance” 
	 	 	8.02	 
	“Moody’s” 
	 	 	4.15	 
	“Offer Amount” 
	 	 	3.09	 
	“Offer Period” 
	 	 	3.09	 
	“Paying Agent” 
	 	 	2.03	 
	“Payment Default” 
	 	 	6.01	 
	“Permitted Debt” 
	 	 	4.07	 
	“Purchase Date” 
	 	 	3.09	 
	“Rating Agencies” 
	 	 	4.15	 
	“Registrar” 
	 	 	2.03	 
	“Restricted Payments” 
	 	 	4.05	 
	“Reversion Date” 
	 	 	4.15	 
	“S&P” 
	 	 	4.15	 
	“Suspended Covenants” 
	 	 	4.15	 
	“Suspension Date” 
	 	 	4.15	 
	“Suspension Period” 
	 	 	4.15	 

27

 

Section 1.03. Incorporation by Reference of Trust Indenture Act.

     Whenever this Indenture refers to a provision of the TIA, the provision is incorporated by
reference in and made a part of this Indenture.

     The following TIA terms used in this Indenture have the following meanings:

     “indenture securities” means the Notes;

     “indenture security Holder” means a Holder of a Note;

     “indenture to be qualified” means this Indenture;

     “indenture trustee” or “institutional trustee” means the Trustee; and

     “obligor” on the Notes and the Guarantees means the Company and the Guarantors,
respectively, and any successor obligor upon the Notes and the Guarantees, respectively.

     All other terms used in this Indenture that are defined by the TIA, defined by TIA reference
to another statute or defined by SEC rule under the TIA have the meanings so assigned to them.

Section 1.04. Rules of Construction.

     Unless the context otherwise requires:

          (a) a term has the meaning assigned to it;

          (b) an accounting term not otherwise defined has the meaning assigned to it in
accordance with GAAP;

          (c) “or” is not exclusive;

          (d) words in the singular include the plural, and in the plural include the singular;

          (e) provisions apply to successive events and transactions; and

          (f) references to sections of or rules under the Securities Act shall be deemed to
include substitute, replacement or successor sections or rules adopted by the SEC from time
to time.

ARTICLE 2.

THE NOTES

Section 2.01. Form and Dating.

     (a) General. The Notes and the Trustee’s certificate of authentication shall be
substantially in the form of Exhibit A hereto. The Notes may have notations, legends or
endorsements required by law, stock exchange rule or usage (provided that any such notation, legend
or endorsement required by usage is in a form reasonably acceptable to the Company). Each Note
shall be dated the date of its
authentication. The Notes shall be in denominations of $2,000 and integral multiples of $1,000
in excess thereof.

28

 

     The terms and provisions contained in the Notes shall constitute, and are hereby expressly
made, a part of this Indenture and the Company, the Guarantors and the Trustee, by their execution
and delivery of this Indenture, expressly agree to such terms and provisions and to be bound
thereby. However, to the extent any provision of any Note conflicts with the express provisions of
this Indenture, the provisions of this Indenture shall govern and be controlling.

     (b) Global Notes. Notes issued in global form shall be substantially in the form of
Exhibit A hereto (including the Global Note Legend thereon and the “Schedule of Exchanges of
Interests in the Global Note” attached thereto). Notes issued in definitive form shall be
substantially in the form of Exhibit A hereto (but without the Global Note Legend thereon and
without the “Schedule of Exchanges of Interests in the Global Note” attached thereto). Each Global
Note shall represent such of the outstanding Notes as shall be specified therein and each shall
provide that it represents the aggregate principal amount of outstanding Notes from time to time
endorsed thereon and that the aggregate principal amount of outstanding Notes represented thereby
may from time to time be reduced or increased, as appropriate, to reflect exchanges and
redemptions. Any endorsement of a Global Note to reflect the amount of any increase or decrease in
the aggregate principal amount of outstanding Notes represented thereby shall be made by the
Trustee or the custodian, at the direction of the Trustee, in accordance with instructions given by
the Holder thereof as required by Section 2.06 hereof and shall be made on the records of the
Trustee and the Depositary. Notes offered and sold to a QIB in reliance on Rule 144A shall be
issued initially in the form of one or more 144A Global Notes and numbered from 1 upward with the
prefix “RA”, Notes offered and sold in reliance on Regulation S shall be issued initially in the
form of one or more Regulation S Global Notes and numbered from 1 upward with the prefix “RS”, and
Unrestricted Global Notes shall be issued initially in the form of one or more permanent Global
Notes with the Global Legend and numbered from 1 upward with the prefix “R”, which in each case
shall be deposited with the Trustee, as custodian for the Depositary (or with such other custodian
as the Depositary may direct), and registered in the name of the Depositary or a nominee of the
Depositary, duly executed by the Company and authenticated by the Trustee as hereinafter provided.

     (c) Euroclear and Clearstream Procedures Applicable. The provisions of the “Operating
Procedures of the Euroclear System” and “Terms and Conditions Governing Use of Euroclear” and the
“General Terms and Conditions of Clearstream Banking” and “Customer Handbook” of Clearstream shall
be applicable to transfers of beneficial interests in the Regulation S Global Note that are held by
Participants through Euroclear or Clearstream.

Section 2.02. Execution and Authentication.

     At least one Officer must sign the Notes for the Company by manual or facsimile signature.

     If an Officer whose signature is on a Note no longer holds that office at the time a Note is
authenticated, the Note shall nevertheless be valid.

     A Note shall not be valid until authenticated by the manual signature of an authorized
signatory of the Trustee. The signature shall be conclusive evidence that the Note has been
authenticated under this Indenture.

     The Trustee shall, upon receipt of a Company Order, authenticate Notes for original issue that
may be validly issued under this Indenture, including any Additional Notes and any Exchange Notes.
The aggregate principal amount of Notes outstanding at any time may not exceed the aggregate
principal amount of Notes authorized for issuance by the Company pursuant to one or more Company
Orders, except as provided in Section 2.07 hereof.

29

 

     The Trustee may appoint an authenticating agent acceptable to the Company to authenticate
Notes. An authenticating agent may authenticate Notes whenever the Trustee may do so. Each
reference in this Indenture to authentication by the Trustee includes authentication by such agent.
An authenticating agent has the same rights as an Agent to deal with Holders or an Affiliate of the
Company.

Section 2.03. Registrar and Paying Agent.

     The Company shall maintain an office or agency where Notes may be presented for registration
of transfer or for exchange (“Registrar”) and an office or agency where Notes may be presented for
payment (“Paying Agent”). The Registrar shall keep a register of the Notes and of their transfer
and exchange. The Company may appoint one or more co-registrars and one or more additional paying
agents. The term “Registrar” includes any co-registrar and the term “Paying Agent” includes any
additional paying agent. The Company may change any Paying Agent or Registrar without notice to any
Holder. The Company shall notify the Trustee in writing of the name and address of any Agent not a
party to this Indenture. If the Company fails to appoint or maintain another entity as Registrar or
Paying Agent, the Trustee shall act as such. The Company or any of its Subsidiaries may act as
Paying Agent or Registrar.

     The Company initially appoints The Depository Trust Company (“DTC”) to act as Depositary with
respect to the Global Notes.

     The Company initially appoints the Trustee to act as the Registrar and Paying Agent and to act
as custodian with respect to the Global Notes.

Section 2.04. Paying Agent to Hold Money in Trust.

     The Company shall require each Paying Agent other than the Trustee to agree in writing that
the Paying Agent will hold in trust for the benefit of Holders or the Trustee all money held by the
Paying Agent for the payment of principal, premium or Special Interest, if any, or interest on the
Notes, and will notify the Trustee of any default by the Company in making any such payment. While
any such default continues, the Trustee may require a Paying Agent to pay all money held by it to
the Trustee. The Company at any time may require a Paying Agent to pay all money held by it to the
Trustee. Upon payment over to the Trustee, the Paying Agent (if other than the Company or a
Subsidiary) shall have no further liability for the money. If the Company or a Subsidiary acts as
Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of the Holders
all money held by it as Paying Agent. Upon any bankruptcy or reorganization proceedings relating to
the Company, the Trustee shall serve as Paying Agent for the Notes.

Section 2.05. Holder Lists.

     The Trustee shall preserve in as current a form as is reasonably practicable the most recent
list available to it of the names and addresses of all Holders and shall otherwise comply with TIA
§312(a). If the Trustee is not the Registrar, the Company shall furnish to the Trustee at least
seven Business Days before each interest payment date and at such other times as the Trustee may
request in writing, a list in such form and as of such date as the Trustee may reasonably require
of the names and addresses of the Holders of Notes and the Company shall otherwise comply with
TIA §312(a).

Section 2.06. Transfer and Exchange.

     (a) Transfer and Exchange of Global Notes. A Global Note may not be transferred
except as a whole by the Depositary to a nominee of the Depositary, by a nominee of the Depositary
to the Depositary or to another nominee of the Depositary, or by the Depositary or any such nominee
to a successor Depositary or a nominee of such successor Depositary. All Global Notes shall be
exchanged by the Company for Definitive Notes if:

30

 

     (1) the Company delivers in writing to the Trustee notice that the Depositary is
unwilling or unable to continue to act as Depositary or that it is no longer a clearing
agency registered under the Exchange Act and, in either case, a successor Depositary is not
appointed by the Company within 90 days after the date of such notice or cessation; or

     (2) there has occurred and is continuing an Event of Default and the Registrar has
received a request from the Depositary to issue the certificated Notes.

     Upon the occurrence of either of the preceding events in (1) or (2) above, Definitive Notes
shall be issued in such names as the Depositary shall instruct the Trustee. Global Notes also may
be exchanged or replaced, in whole or in part, as provided in Sections 2.07 and 2.10 hereof. Except
as aforesaid, every Note authenticated and delivered in exchange for, or in lieu of, a Global Note
or any portion thereof, pursuant to this Section 2.06 or Section 2.07 or 2.10 hereof, shall be
authenticated and delivered in the form of, and shall be, a Global Note. A Global Note may not be
exchanged for another Note other than as provided in this Section 2.06(a), however, beneficial
interests in a Global Note may be transferred and exchanged as provided in Section 2.06(b), (c) or
(f) hereof.

     (b) Transfer and Exchange of Beneficial Interests in the Global Notes. The transfer
and exchange of beneficial interests in the Global Notes shall be effected through the Depositary,
in accordance with the provisions of this Indenture and the Applicable Procedures. Beneficial
interests in the Restricted Global Notes shall be subject to restrictions on transfer comparable to
those set forth herein to the extent required by the Securities Act. Transfers of beneficial
interests in the Global Notes also shall require compliance with either subparagraph (1) or (2)
below, as applicable, as well as one or more of the other following subparagraphs, as applicable:

     (1) Transfer of Beneficial Interests in the Same Global Note. Beneficial
interests in any Restricted Global Note may be transferred to Persons who take delivery
thereof in the form of a beneficial interest in the same Restricted Global Note in
accordance with the transfer restrictions set forth in the Private Placement Legend;
provided, however, that prior to the expiration of the Restricted Period, transfers of
beneficial interests in the Regulation S Global Note may not be made to a U.S. Person or for
the account or benefit of a U.S. Person (other than an Initial Purchaser). Beneficial
interests in any Unrestricted Global Note may be transferred to Persons who take delivery
thereof in the form of a beneficial interest in an Unrestricted Global Note. No written
orders or instructions shall be required to be delivered to the Registrar to effect the
transfers described in this Section 2.06(b)(1).

     (2) All other Transfers and Exchanges of Beneficial Interests in Global Notes.
In connection with all transfers and exchanges of beneficial interests that are not subject
to Section 2.06(b)(1) above, the transferor of such beneficial interest must deliver to the
Registrar either:

(A) both:

     (a) a written order from a Participant or an Indirect Participant given
to the Depositary in accordance with the Applicable Procedures directing the
Depositary to credit or cause to be credited a beneficial interest in
another Global Note in an amount equal to the beneficial interest to be
transferred or exchanged; and

     (b) instructions given in accordance with the Applicable Procedures
containing information regarding the Participant account to be credited with
such increase; or

31

 

(B) both:

     (a) a written order from a Participant or an Indirect Participant given
to the Depositary in accordance with the Applicable Procedures directing the
Depositary to cause to be issued a Definitive Note in an amount equal to the
beneficial interest to be transferred or exchanged; and

     (b) instructions given by the Depositary to the Registrar containing
information regarding the Person in whose name such Definitive Note shall be
registered to effect the transfer or exchange referred to in (B)(a) above.

Upon consummation of an Exchange Offer by the Company in accordance with Section 2.06(f) hereof,
the requirements of this Section 2.06(b)(2) shall be deemed to have been satisfied upon receipt by
the Registrar of the instructions contained in the Letter of Transmittal delivered by the Holder of
such beneficial interests in the Restricted Global Notes. Upon satisfaction of all of the
requirements for transfer or exchange of beneficial interests in Global Notes contained in this
Indenture and the Notes or otherwise applicable under the Securities Act, the Trustee shall adjust
the principal amount of the relevant Global Note(s) pursuant to Section 2.06(h) hereof.

     (3) Transfer of Beneficial Interests to Another Restricted Global Note. A
beneficial interest in any Restricted Global Note may be transferred to a Person who takes
delivery thereof in the form of a beneficial interest in another Restricted Global Note if
the transfer complies with the requirements of Section 2.06(b)(2) above and the Registrar
receives the following:

     (A) if the transferee shall take delivery in the form of a beneficial interest
in the 144A Global Note, then the transferor must deliver a certificate in the form
of Exhibit B hereto, including the certifications in item (1) thereof; and

     (B) if the transferee shall take delivery in the form of a beneficial interest
in the Regulation S Global Note, then the transferor must deliver a certificate in
the form of Exhibit B hereto, including the certifications in item (2) thereof.

     (4) Transfer and Exchange of Beneficial Interests in a Restricted Global Note for
Beneficial Interests in an Unrestricted Global Note. A beneficial interest in any
Restricted Global Note may be exchanged by any holder thereof for a beneficial interest in
an Unrestricted Global Note or transferred to a Person who takes delivery thereof in the
form of a beneficial interest in an Unrestricted Global Note if the exchange or transfer
complies with the requirements of Section 2.06(b)(2) above and:

     (A) such exchange or transfer is effected pursuant to the Exchange Offer in
accordance with the Registration Rights Agreement and the holder of the beneficial
interest to be transferred, in the case of an exchange, or the transferee, in the
case of a transfer, certifies in the applicable Letter of Transmittal that it is not
(i) a Broker-Dealer, (ii) a Person participating in the distribution of the Exchange
Notes or (iii) a Person who is an affiliate (as defined in Rule 144) of the Company;

     (B) such transfer is effected pursuant to the Shelf Registration Statement in
accordance with the Registration Rights Agreement;

     (C) such transfer is effected by a Broker-Dealer pursuant to the Exchange Offer
Registration statement in accordance with the Registration Rights Agreement; or

32

 

(D) the Registrar receives the following:

     (a) if the holder of such beneficial interest in a Restricted Global
Note proposes to exchange such beneficial interest for a beneficial interest
in an Unrestricted Global Note, a certificate from such holder in the form
of Exhibit C hereto, including the certifications in item (1)(a) thereof; or

     (b) if the holder of such beneficial interest in a Restricted Global
Note proposes to transfer such beneficial interest to a Person who shall
take delivery thereof in the form of a beneficial interest in an
Unrestricted Global Note, a certificate from such holder in the form of
Exhibit B hereto, including the certifications in item (4) thereof;

and, in each such case set forth in subparagraph (D) above, if the Company so requests or if the
Applicable Procedures so require, an Opinion of Counsel in form reasonably acceptable to the
Company to the effect that such exchange or transfer is in compliance with the Securities Act and
that the restrictions on transfer contained herein and in the Private Placement Legend are no
longer required in order to maintain compliance with the Securities Act.

     If any such transfer is effected pursuant to subparagraph (4) above at a time when an
Unrestricted Global Note has not yet been issued, the Company shall issue and, upon receipt of an
Company Order in accordance with Section 2.02 hereof, the Trustee shall authenticate one or more
Unrestricted Global Notes in an aggregate principal amount equal to the aggregate principal amount
of beneficial interests transferred pursuant to subparagraph (4) above.

     Beneficial interests in an Unrestricted Global Note cannot be exchanged for, or transferred to
Persons who take delivery thereof in the form of, a beneficial interest in a Restricted Global
Note.

     (c) Transfer or Exchange of Beneficial Interests for Definitive Notes.

     (1) Beneficial Interests in Restricted Global Notes to Restricted Definitive
Notes. If any holder of a beneficial interest in a Restricted Global Note proposes to
exchange such beneficial interest for a Restricted Definitive Note or to transfer such
beneficial interest to a Person who takes delivery thereof in the form of a Restricted
Definitive Note, then, upon receipt by the Registrar of the following documentation:

     (A) if the holder of such beneficial interest in a Restricted Global Note
proposes to exchange such beneficial interest for a Restricted Definitive Note, a
certificate from such holder in the form of Exhibit C hereto, including the
certifications in item (2)(a) thereof;

     (B) if such beneficial interest is being transferred to a QIB in accordance
with Rule 144A, a certificate to the effect set forth in Exhibit B hereto, including
the certifications in item (1) thereof;

     (C) if such beneficial interest is being transferred to a Non-U.S. Person in an
offshore transaction in accordance with Rule 903 or Rule 904, a certificate to the
effect set forth in Exhibit B hereto, including the certifications in item (2)
thereof;

     (D) if such beneficial interest is being transferred pursuant to an exemption
from the registration requirements of the Securities Act in accordance with Rule
144, a

33

 

certificate to the effect set forth in Exhibit B hereto, including the
certifications in item (3)(a) thereof;

     (E) if such beneficial interest is being transferred to the Company or any of
its Subsidiaries, a certificate to the effect set forth in Exhibit B hereto,
including the certifications in item (3)(b) thereof; or

     (F) if such beneficial interest is being transferred pursuant to an effective
registration statement under the Securities Act, a certificate to the effect set
forth in Exhibit B hereto, including the certifications in item (3)(c) thereof,

the Trustee shall cause the aggregate principal amount of the applicable Global Note to be reduced
accordingly pursuant to Section 2.06(h) hereof, and the Company shall execute and the Trustee shall
authenticate and deliver to the Person designated in the instructions a Definitive Note in the
appropriate principal amount. Any Definitive Note issued in exchange for a beneficial interest in a
Restricted Global Note pursuant to this Section 2.06(c) shall be registered in such name or names
and in such authorized denomination or denominations as the holder of such beneficial interest
shall instruct the Registrar through instructions from the Depositary and the Participant or
Indirect Participant. The Trustee shall deliver such Definitive Notes to the Persons in whose names
such Notes are so registered. Any Definitive Note issued in exchange for a beneficial interest in a
Restricted Global Note pursuant to this Section 2.06(c)(1) shall bear the Private Placement Legend
and shall be subject to all restrictions on transfer contained therein.

     (2) Beneficial Interests in Restricted Global Notes to Unrestricted Definitive
Notes. A holder of a beneficial interest in a Restricted Global Note may exchange such
beneficial interest for an Unrestricted Definitive Note or may transfer such beneficial
interest to a Person who takes delivery thereof in the form of an Unrestricted Definitive
Note only if:

     (A) such exchange or transfer is effected pursuant to the Exchange Offer in
accordance with the Registration Rights Agreement and the holder of such beneficial
interest, in the case of an exchange, or the transferee, in the case of a transfer,
certifies in the applicable Letter of Transmittal that it is not (i) a
Broker-Dealer, (ii) a Person participating in the distribution of the Exchange Notes
or (iii) a Person who is an affiliate (as defined in Rule 144) of the Company;

     (B) such transfer is effected pursuant to the Shelf Registration Statement in
accordance with the Registration Rights Agreement;

     (C) such transfer is effected by a Broker-Dealer pursuant to the Exchange Offer
Registration Statement in accordance with the Registration Rights Agreement; or

     (D) the Registrar receives the following:

     (a) if the holder of such beneficial interest in a Restricted Global
Note proposes to exchange such beneficial interest for an Unrestricted
Definitive Note, a certificate from such holder in the form of Exhibit C
hereto, including the certifications in item (1)(b) thereof; or

     (b) if the holder of such beneficial interest in a Restricted Global
Note proposes to transfer such beneficial interest to a Person who shall
take delivery thereof in the form of an Unrestricted Definitive Note, a
certificate from

34

 

such holder in the form of Exhibit B hereto, including the
certifications in item (4) thereof;

and, in each such case set forth in this subparagraph (D), if the Company so requests or if the
Applicable Procedures so require, an Opinion of Counsel in form reasonably acceptable to the
Company to the effect that such exchange or transfer is in compliance with the Securities Act and
that the restrictions on transfer contained herein and in the Private Placement Legend are no
longer required in order to maintain compliance with the Securities Act.

     (3) Beneficial Interests in Unrestricted Global Notes to Unrestricted Definitive
Notes. If any holder of a beneficial interest in an Unrestricted Global Note proposes
to exchange such beneficial interest for a Definitive Note or to transfer such beneficial
interest to a Person who takes delivery thereof in the form of a Definitive Note, then, upon
satisfaction of the conditions set forth in Section 2.06(b)(2) hereof, the Trustee shall
cause the aggregate principal amount of the applicable Global Note to be reduced accordingly
pursuant to Section 2.06(h) hereof, and the Company shall execute and the Trustee shall
authenticate and deliver to the Person designated in the instructions a Definitive Note in
the appropriate principal amount. Any Definitive Note issued in exchange for a beneficial
interest pursuant to this Section 2.06(c)(3) shall be registered in such name or names and
in such authorized denomination or denominations as the holder of such beneficial interest
requests through instructions to the Registrar from or through the Depositary and the
Participant or Indirect Participant. The Trustee shall deliver such Definitive Notes to the
Persons in whose names such Notes are so registered. Any Definitive Note issued in exchange
for a beneficial interest pursuant to this Section 2.06(c)(3) shall not bear the Private
Placement Legend.

     (d) Transfer and Exchange of Definitive Notes for Beneficial Interests.

     (1) Restricted Definitive Notes to Beneficial Interests in Restricted Global
Notes. If any Holder of a Restricted Definitive Note proposes to exchange such Note for
a beneficial interest in a Restricted Global Note or to transfer such Restricted Definitive
Notes to a Person who takes delivery thereof in the form of a beneficial interest in a
Restricted Global Note, then, upon receipt by the Registrar of the following documentation:

     (A) if the Holder of such Restricted Definitive Note proposes to exchange such
note for a beneficial interest in a Restricted Global Note, a certificate from such
Holder in the form of Exhibit C hereto, including the certifications in item (2)(b)
thereof;

     (B) if such Restricted Definitive Note is being transferred to a QIB in
accordance with Rule 144A, a certificate to the effect set forth in Exhibit B
hereto, including the certifications in item (1) thereof;

     (C) if such Restricted Definitive Note is being transferred to a Non-U.S.
Person in an offshore transaction in accordance with Rule 903 or Rule 904, a
certificate to the effect set forth in Exhibit B hereto, including the
certifications in item (2) thereof;

     (D) if such Restricted Definitive Note is being transferred pursuant to an
exemption from the registration requirements of the Securities Act in accordance
with Rule 144, a certificate to the effect set forth in Exhibit B hereto, including
the certifications in item (3)(a) thereof;

35

 

     (E) if such Restricted Definitive Note is being transferred to the Company or
any of its Subsidiaries, a certificate to the effect set forth in Exhibit B hereto,
including the certifications in item (3)(b) thereof; or

     (F) if such Restricted Definitive Note is being transferred pursuant to an
effective registration statement under the Securities Act, a certificate to the
effect set forth in Exhibit B hereto, including the certifications in item (3)(c)
thereof,

the Trustee shall cancel the Restricted Definitive Note, increase or cause to be increased the
aggregate principal amount of, in the case of clause (A) above, the appropriate Restricted Global
Note, in the case of clause (B) above, the 144A Global Note, in the case of clause (C) above, the
Regulation S Global Note.

     (2) Restricted Definitive Notes to Beneficial Interests in Unrestricted Global
Notes. A Holder of a Restricted Definitive Note may exchange such Note for a beneficial
interest in an Unrestricted Global Note or transfer such Restricted Definitive Note to a
Person who takes delivery thereof in the form of a beneficial interest in an Unrestricted
Global Note only if:

     (A) such exchange or transfer is effected pursuant to the Exchange Offer in
accordance with the Registration Rights Agreement and the Holder, in the case of an
exchange, or the transferee, in the case of a transfer, certifies in the applicable
Letter of Transmittal that it is not (i) a Broker-Dealer, (ii) a Person
participating in the distribution of the Exchange Notes or (iii) a Person who is an
affiliate (as defined in Rule 144) of the Company;

     (B) such transfer is effected pursuant to the Shelf Registration Statement in
accordance with the Registration Rights Agreement;

     (C) such transfer is effected by a Broker-Dealer pursuant to the Exchange Offer
Registration statement in accordance with the Registration Rights Agreement; or

     (D) the Registrar receives the following:

     (a) if the Holder of such Definitive Notes proposes to exchange such
notes for a beneficial interest in the Unrestricted Global Note, a
certificate from such Holder in the form of Exhibit C hereto, including the
certifications in item (1)(c) thereof; or

     (b) if the Holder of such Definitive Notes proposes to transfer such
notes to a Person who shall take delivery thereof in the form of a
beneficial interest in the Unrestricted Global Note, a certificate from such
Holder in the form of Exhibit B hereto, including the certifications in item
(4) thereof;

and, in each such case set forth in this subparagraph (D), if the Company so requests or if the
Applicable Procedures so require, an Opinion of Counsel in form reasonably acceptable to the
Company to the effect that such exchange or transfer is in compliance with the Securities Act and
that the restrictions on transfer contained herein and in the Private Placement Legend are no
longer required in order to maintain compliance with the Securities Act.

     Upon satisfaction of the conditions of any of the subparagraphs in this Section 2.06(d)(2),
the Trustee shall cancel the Definitive Notes and increase or cause to be increased the aggregate
principal amount of the Unrestricted Global Note.

36

 

     (3) Unrestricted Definitive Notes to Beneficial Interests in Unrestricted Global
Notes. A Holder of an Unrestricted Definitive Note may exchange such note for a
beneficial interest in an Unrestricted Global Note or transfer such Definitive Notes to a
Person who takes delivery thereof in the form of a beneficial interest in an Unrestricted
Global Note at any time. Upon receipt of a request for such an exchange or transfer, the
Trustee shall cancel the applicable Unrestricted Definitive Note and increase or cause to be
increased the aggregate principal amount of one of the Unrestricted Global Notes.

     If any such exchange or transfer from a Definitive Note to a beneficial interest is effected
pursuant to subparagraphs 2(A), (2)(B), 2(C), (2)(D) or (3) above at a time when an Unrestricted
Global Note has not yet been issued, the Company shall issue and, upon receipt of a Company Order
in accordance with Section 2.02 hereof, the Trustee shall authenticate one or more Unrestricted
Global Notes in an aggregate principal amount equal to the principal amount of Definitive Notes so
transferred.

     (e) Transfer and Exchange of Definitive Notes for Definitive Notes. Upon request by a
Holder of Definitive Notes and such Holder’s compliance with the provisions of this Section
2.06(e), the Registrar shall register the transfer or exchange of Definitive Notes. Prior to such
registration of transfer or exchange, the requesting Holder must present or surrender to the
Registrar the Definitive Notes duly endorsed or accompanied by a written instrument of transfer in
form satisfactory to the Registrar duly executed by such Holder or by its attorney, duly authorized
in writing. In addition, the requesting Holder must provide any additional certifications,
documents and information, as applicable, required pursuant to the following provisions of this
Section 2.06(e).

     (1) Restricted Definitive Notes to Restricted Definitive Notes. Any Restricted
Definitive Note may be transferred to and registered in the name of Persons who take
delivery thereof in the form of a Restricted Definitive Note if the Registrar receives the
following:

     (A) if the transfer shall be made pursuant to Rule 144A, then the transferor
must deliver a certificate in the form of Exhibit B hereto, including the
certifications in item (1) thereof;

     (B) if the transfer shall be made pursuant to Rule 903 or Rule 904, then the
transferor must deliver a certificate in the form of Exhibit B hereto, including the
certifications in item (2) thereof; and

     (C) if the transfer shall be made pursuant to any other exemption from the
registration requirements of the Securities Act, then the transferor must deliver a
certificate in the form of Exhibit B hereto, including the certifications,
certificates and Opinion of Counsel required by item (3) thereof, if applicable.

     (2) Restricted Definitive Notes to Unrestricted Definitive Notes. Any
Restricted Definitive Note may be exchanged by the Holder thereof for an Unrestricted
Definitive Note or transferred to a Person or Persons who take delivery thereof in the form
of an Unrestricted Definitive Note if:

     (A) such exchange or transfer is effected pursuant to the Exchange Offer in
accordance with the Registration Rights Agreement and the Holder, in the case of an
exchange, or the transferee, in the case of a transfer, certifies in the applicable
Letter of Transmittal that it is not (i) a Broker-Dealer, (ii) a Person
participating in the distribution of the Exchange Notes or (iii) a Person who is an
affiliate (as defined in Rule 144) of the Company;

37

 

     (B) any such transfer is effected pursuant to the Shelf Registration Statement
in accordance with the Registration Rights Agreement;

     (C) any such transfer is effected by a Broker-Dealer pursuant to the Exchange
Offer Registration Statement in accordance with the Registration Rights Agreement;
or

     (D) the Registrar receives the following:

     (a) if the Holder of such Restricted Definitive Notes proposes to
exchange such notes for an Unrestricted Definitive Note, a certificate from
such Holder in the form of Exhibit C hereto, including the certifications in
item (1)(d) thereof; or

     (b) if the Holder of such Restricted Definitive Notes proposes to
transfer such notes to a Person who shall take delivery thereof in the form
of an Unrestricted Definitive Note, a certificate from such Holder in the
form of Exhibit B hereto, including the certifications in item (4) thereof;

and, in each such case set forth in this subparagraph (D), if the Company so requests, an Opinion
of Counsel in form reasonably acceptable to the Company to the effect that such exchange or
transfer is in compliance with the Securities Act and that the restrictions on transfer contained
herein and in the Private Placement Legend are no longer required in order to maintain compliance
with the Securities Act.

     (3) Unrestricted Definitive Notes to Unrestricted Definitive Notes. A Holder
of Unrestricted Definitive Notes may transfer such Notes to a Person who takes delivery
thereof in the form of an Unrestricted Definitive Note. Upon receipt of a request to
register such a transfer, the Registrar shall register the Unrestricted Definitive Notes
pursuant to the instructions from the Holder thereof.

     (f) Exchange Offer. Upon the occurrence of the Exchange Offer in accordance with the
Registration Rights Agreement, the Company shall issue and, upon receipt of a Company Order in
accordance with Section 2.02 hereof, the Trustee shall authenticate:

     (1) one or more Unrestricted Global Notes in an aggregate principal amount equal to the
principal amount of the beneficial interests in the Restricted Global Notes accepted for
exchange in the Exchange Offer by Persons that certify in the applicable Letters of
Transmittal that (A) they are not Broker-Dealers, (B) they are not participating in a
distribution of the Exchange Notes and (C) they are not affiliates (as defined in Rule 144)
of the Company; and

     (2) Unrestricted Definitive Notes in an aggregate principal amount equal to the
principal amount of the Restricted Definitive Notes accepted for exchange in the Exchange
Offer by Persons that certify in the applicable Letters of Transmittal that (A) they are not
Broker-Dealers, (B) they are not participating in a distribution of the Exchange Notes and
(C) they are not affiliates (as defined in Rule 144) of the Company.

     Concurrently with the issuance of such Notes, the Trustee shall cause the aggregate principal
amount of the applicable Restricted Global Notes to be reduced accordingly, and the Company shall
execute and the Trustee shall authenticate and deliver to the Persons designated by the Holders of
Definitive Notes so accepted Unrestricted Definitive Notes in the appropriate principal amount.

38

 

     (g) Legends. The following legends shall appear on the face of all Global Notes and
Definitive Notes issued under this Indenture unless specifically stated otherwise in the applicable
provisions of this Indenture.

          (1) Private Placement Legend.

     (A) Except as permitted by subparagraph (B) below, each Global Note and each
Definitive Note (and all Notes issued in exchange therefor or substitution thereof)
shall bear a legend in substantially the following form:

“THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OR
OTHER JURISDICTION. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION
HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED
OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS
SUCH TRANSACTION IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION. THE
HOLDER OF THIS SECURITY, BY ITS ACCEPTANCE HEREOF, AGREES ON ITS OWN BEHALF
AND ON BEHALF OF ANY INVESTOR ACCOUNT FOR WHICH IT HAS PURCHASED
SECURITIES, TO OFFER, SELL OR OTHERWISE TRANSFER SUCH SECURITY, ONLY (A) TO
THE ISSUER, (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BECOME OR
BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT, (C) FOR SO LONG AS THE
SECURITIES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE
SECURITIES ACT, TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED
INSTITUTIONAL BUYER” AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT THAT
PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED
INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING
MADE IN RELIANCE ON RULE 144A, (D) PURSUANT TO OFFERS AND SALES THAT
OCCUR OUTSIDE THE UNITED STATES IN ACCORDANCE WITH REGULATION S UNDER
THE SECURITIES ACT, (E) PURSUANT TO THE EXEMPTION FROM REGISTRATION
PROVIDED BY RULE 144 UNDER THE SECURITIES ACT (IF AVAILABLE) OR (F) PURSUANT
TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT, SUBJECT TO THE ISSUER’S AND THE TRUSTEE’S RIGHT PRIOR TO
ANY SUCH OFFER, SALE OR TRANSFER PURSUANT TO CLAUSES (D), (E) OR (F) TO
REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION AND/ OR OTHER
INFORMATION SATISFACTORY TO EACH OF THEM.”

     (B) Notwithstanding the foregoing, any Global Note or Definitive Note issued
pursuant to subparagraphs (b)(4), (c)(2), (c)(3), (d)(2), (d) (3), (e)(2), (e) (3)
or (f) of this Section 2.06 (and all Notes issued in exchange therefor or
substitution thereof) shall not bear the Private Placement Legend.

     (2) Global Note Legend. Each Global Note shall bear a legend in substantially
the following form:

“THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS NOTE) OR
ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO
ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (1) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS
MAY BE REQUIRED PURSUANT TO SECTION 2.01 AND SECTION 2.06 OF THE INDENTURE, (2) THIS GLOBAL NOTE
MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.06(a) OF THE INDENTURE, (3) THIS
GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.11 OF THE

39

 

INDENTURE AND (4) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR
WRITTEN CONSENT OF THE ISSUER.

UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY
NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A
NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE
DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.
UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST
COMPANY (55 WATER STREET, NEW YORK, NEW YORK) (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION
OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &
CO. OR SUCH OTHER NAME AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT
IS MADE TO CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF
DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.”

     (3) Regulation S Legend. Each Regulation S Global Note shall bear a legend in
substantially the following form:

“THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE
OFFERED, SOLD OR DELIVERED IN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, ANY U.S.
PERSON, UNLESS SUCH NOTES ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE
REGISTRATION REQUIREMENTS THEREOF IS AVAILABLE. THIS LEGEND WILL BE REMOVED AFTER THE EXPIRATION OF
FORTY DAYS FROM THE LATER OF (i) THE DATE ON WHICH THESE NOTES WERE FIRST OFFERED AND (ii) THE DATE
OF ISSUE OF THESE NOTES.”

     (h) Cancellation and/or Adjustment of Global Notes. At such time as all beneficial
interests in a particular Global Note have been exchanged for Definitive Notes or a particular
Global Note has been redeemed, repurchased or canceled in whole and not in part, each such Global
Note shall be returned to or retained and canceled by the Trustee in accordance with Section 2.11
hereof. At any time prior to such cancellation, if any beneficial interest in a Global Note is
exchanged for or transferred to a Person who shall take delivery thereof in the form of a
beneficial interest in another Global Note or for Definitive Notes, the principal amount of Notes
represented by such Global Note shall be reduced accordingly and an endorsement shall be made on
such Global Note by the Trustee or by the Depositary at the direction of the Trustee to reflect
such reduction; and if the beneficial interest is being exchanged for or transferred to a Person
who shall take delivery thereof in the form of a beneficial interest in another Global Note, such
other Global Note shall be increased accordingly and an endorsement shall be made on such Global
Note by the Trustee or by the Depositary at the direction of the Trustee to reflect such increase.

     (i) General Provisions Relating to Transfers and Exchanges and Global Notes.

     (1) To permit registrations of transfers and exchanges, the Company shall execute and
the Trustee shall authenticate Global Notes and Definitive Notes upon receipt of a Company
Order in accordance with Section 2.02 hereof or at the Registrar’s request.

     (2) No service charge shall be made to a Holder of a beneficial interest in a Global
Note or to a Holder of a Definitive Note for any registration of transfer or exchange, but
the Company may require payment of a sum sufficient to cover any transfer tax or similar

40

 

governmental charge payable in connection therewith (other than any such transfer taxes or
similar governmental charge payable upon exchange or transfer pursuant to Sections 2.10,
3.06, 3.09, 4.08, 4.11 and 9.05 hereof).

     (3)

    The Registrar shall not be required to register the transfer of or exchange of any
Note selected for redemption in whole or in part, except the unredeemed portion of any Note
being redeemed in part.

     (4)

    All Global Notes and Definitive Notes issued upon any registration of transfer or
exchange of Global Notes or Definitive Notes shall be the valid obligations of the Company,
evidencing the same debt, and entitled to the same benefits under this Indenture, as the
Global Notes or Definitive Notes surrendered upon such registration of transfer or exchange.

     (5)

    The Company shall not be required:

     (A) to issue, to register the transfer of or to exchange any Notes during a
period beginning at the opening of business 15 days before the day of any selection
of
Notes for redemption under Section 3.02 hereof and ending at the close of
business on the day of selection; or

     (B) to register the transfer of or to exchange any Note selected for redemption
in whole or in part, except the unredeemed portion of any Note being redeemed in
part.

     (6) Prior to due presentment for the registration of a transfer of any Note, the
Trustee, any Agent and the Company may deem and treat the Person in whose name any Note is
registered as the absolute owner of such Note for the purpose of receiving payment of
principal of, premium, if any, and (subject to Section 2.12) interest on such Notes and for
all other purposes, and none of the Trustee, any Agent or the Company shall be affected by
notice to the contrary.

     (7) The Trustee shall authenticate Global Notes and Definitive Notes in accordance with
the provisions of Section 2.02 hereof.

     (8) All certifications, certificates and opinions of counsel required to be submitted
to the Registrar pursuant to this Section 2.06 to effect a registration of transfer or
exchange may be submitted by facsimile.

     (9) The Trustee shall have no responsibility or obligation to any beneficial owner of a
Global Note, any Participant in the Depositary or other Person with respect to the accuracy
of the records of the Depositary or its nominee or of any Participant or member thereof,
with respect to any ownership interest in Global Notes or with respect to the delivery to
any Participant, member, beneficial owner or other Person (other than the Depositary) of any
notice (including any notice of redemption) or the payment of any amount, under or with
respect to such Global Notes. All notices and communications to be given to the Holders and
all payments to be made to Holders under the Global Notes shall be given or made only to or
upon the order of the registered Holders (which shall be the Depositary or its nominee in
the case of a Global Note). The rights of beneficial owners in any Global Note shall be
exercised only through the Depositary subject to the applicable rules and procedures of the
Depositary. The Trustee may rely conclusively and shall be fully protected in relying upon
information furnished by the Depositary with respect to its members, Participants and any
beneficial owners. The Trustee shall have no obligation or duty to

41

 

monitor, determine or
inquire as to compliance with any restrictions on transfer imposed under the Indenture or
under applicable law with respect to any transfer of any interest in any Global Note
(including any transfers between or among Depositary Participants, members or beneficial
owners in any Global Note) other than to require delivery of such certificates and other
documentation or evidence as are expressly required by, and to do so if and when expressly
required by, the terms of this Indenture, and to examine the same to determine substantial
compliance as to form with the express requirements hereof.

Section 2.07. Replacement Notes.

     If any mutilated Note is surrendered to the Trustee or the Company and the Trustee receives
evidence to its satisfaction of the destruction, loss or theft of any Note, the Company shall issue
and the Trustee, upon receipt of a Company Order, shall authenticate a replacement Note if the
Trustee’s requirements are met. If required by the Trustee or the Company, an indemnity bond must
be supplied by the Holder that is sufficient in the judgment of the Trustee and the Company to
protect the Company, the
Trustee, any Agent and any authenticating agent from any loss that any of them may suffer if a
Note is replaced. The Company may charge for its expenses in replacing a Note.

     Every replacement Note is an additional obligation of the Company and shall be entitled to all
of the benefits of this Indenture equally and proportionately with all other Notes duly issued
hereunder.

     Notwithstanding the foregoing provisions of this Section 2.07, in case any mutilated,
destroyed, lost or stolen Note has become or is about to become due and payable, the Company in its
discretion may, instead of issuing a new Note, pay such Note.

     The provisions of this Section 2.07 shall be exclusive and shall preclude (to the extent
lawful) all other rights and remedies with respect to the replacement or payment of mutilated,
destroyed, lost or stolen Notes.

Section 2.08. Outstanding Notes.

     The Notes outstanding at any time are all the Notes authenticated by the Trustee except for
those canceled by it, those delivered to it for cancellation, those reductions in the interest in a
Global Note effected by the Trustee in accordance with the provisions hereof, and those described
in this Section as not outstanding. Except as set forth in Section 2.09 hereof, a Note does not
cease to be outstanding because the Company or an Affiliate of the Company holds the Note. Subject
to the foregoing, only Notes outstanding at the time of such determination shall be considered in
any such determination (including, without limitation, determinations pursuant to Articles 6 and 9
hereof).

     If a Note is replaced pursuant to Section 2.07 hereof, it ceases to be outstanding unless the
Trustee receives proof satisfactory to it that the replaced Note is held by a bona fide purchaser.

     If the principal amount of any Note is considered paid under Section 4.01 hereof, it ceases to
be outstanding and interest on it ceases to accrue.

     If the Paying Agent (other than the Company, a Subsidiary or an Affiliate of any thereof)
holds, on a Redemption Date or maturity date, money sufficient to pay Notes payable on that date,
then on and after that date such Notes shall be deemed to be no longer outstanding and shall cease
to accrue interest.

42

 

Section 2.09. Treasury Notes.

     In determining whether the Holders of the required principal amount of Notes have concurred in
any direction, waiver or consent, Notes owned by the Company or any Guarantor, or by any Person
directly or indirectly controlling or controlled by or under direct or indirect common control with
the Company or any Guarantor, shall be considered as though not outstanding, except that for the
purposes of determining whether the Trustee shall be protected in relying on any such direction,
waiver or consent, only Notes that the Trustee knows are so owned shall be so disregarded.

Section 2.10. Temporary Notes.

     Until certificates representing Notes are ready for delivery, the Company may prepare and the
Trustee, upon receipt of a Company Order, shall authenticate temporary Notes. Temporary Notes shall
be substantially in the form of certificated Notes but may have variations that the Company
considers appropriate for temporary Notes as shall be reasonably acceptable to the Trustee. Without
unreasonable delay, the Company shall prepare and the Trustee shall authenticate definitive Notes in
exchange for temporary Notes.

   Holders of temporary Notes shall be entitled to all of the benefits of this Indenture.

Section 2.11. Cancellation.

     The Company at any time may deliver Notes to the Trustee for cancellation. The Registrar and
Paying Agent shall forward to the Trustee any Notes surrendered to them for registration of
transfer, exchange or payment. The Trustee and no one else shall cancel all Notes surrendered for
registration of transfer, exchange, payment, replacement or cancellation and shall dispose of
canceled Notes in accordance with its customary procedures (subject to the record retention
requirement of the Exchange Act). Certification of the disposition of all canceled Notes shall be
delivered to the Company. The Company may not issue new Notes to replace Notes that it has paid or
that have been delivered to the Trustee for cancellation.

Section 2.12. Payment of Interest.

     Interest on any Note which is payable, and is punctually paid or duly provided for, on any
Interest Payment Date shall be paid to the Person in whose name that Note (or one or more
predecessor Notes) is registered at the close of business on the Regular Record Date for such
interest.

     If the Company defaults in a payment of interest on the Notes which is payable (“Defaulted
Interest”), it shall pay the Defaulted Interest in any lawful manner plus, to the extent lawful,
interest payable on the Defaulted Interest, to the Persons who are Holders on a subsequent Special
Record Date, in each case at the rate provided in the Notes and in Section 4.01 hereof. The Company
shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each
Note and the date of the proposed payment. The Company shall fix or cause to be fixed each such
Special Record Date and payment date, provided that no such Special Record Date shall be less than
10 days prior to the related payment date for such Defaulted Interest. At least 15 days before the
Special Record Date, the Company (or, upon the written request of the Company, the Trustee in the
name and at the expense of the Company) shall mail or cause to be mailed to Holders of the Notes a
notice that states the Special Record Date, the related payment date and the amount of such
interest to be paid.

43

 

     Subject to the foregoing provisions of this Section 2.12 and Section 2.06 hereof, each Note
delivered under this Indenture upon registration of transfer of or in exchange for or in lieu of
any other Note shall carry the rights to interest accrued and unpaid, and to accrue, which were
carried by such other Note.

Section 2.13. Persons Deemed Owners.

     Prior to due presentment of a Note for registration of transfer, the Company, the Trustee and
any agent of the Company or the Trustee may treat the person in whose name such Note is registered
as the owner of such Note for the purpose of receiving payment of principal of and (subject to
Sections 2.06 and 2.12 hereof) interest on such Note and for all other purposes whatsoever, whether
or not such Note be overdue, and neither the Company, the Trustee nor any agent of the Company or
the Trustee shall be affected by notice to the contrary.

     None of the Company, the Trustee, any Paying Agent or the Registrar will have any
responsibility or liability for any aspect of the records relating to or payments made on account
of beneficial ownership
interests of a Note in global form or for maintaining, supervising or reviewing any records
relating to such beneficial ownership interests.

Section 2.14. Computation of Interest.

     Interest on the Notes shall be computed on the basis of a 360-day year comprised of twelve
30-day months.

Section 2.15. CUSIP or ISIN Numbers.

     The Company, in issuing the Notes, may use “CUSIP” or “ISIN” numbers (if then generally in
use) and, if so, the Trustee shall use “CUSIP” or “ISIN” numbers in notices of redemption as a
convenience to Holders; provided that any such notice may state that no representation is made as
to the correctness of such numbers either as printed on the Notes or as contained in any notice of
a redemption and that reliance may be placed only on the other identification numbers printed on
the Notes, and any such redemption shall not be affected by any defect in or omission of such
numbers. The Company will promptly notify the Trustee of any change in the “CUSIP” or “ISIN”
numbers.

Section 2.16. Issuance of Additional Notes.

     The Company shall be entitled, from time to time, subject to its compliance with Section 4.07
and Sections 12.04 and 12.05 hereof, without consent of the Holders, to issue Additional Notes
under this Indenture with identical terms as the Initial Notes issued on the Issue Date other than
with respect to (a) the date of issuance, (b) the issue price, (c) the amount of interest payable
on the first Interest Payment Date, (d) if applicable, the initial Interest Payment Date and the
initial interest accrual date and (e) any adjustments in order to conform to and ensure compliance
with the Securities Act (or other applicable securities laws) and any required legends. The Initial
Notes issued on the Issue Date, any Additional Notes and all Exchange Notes issued in exchange
therefor shall be treated as a single class for all purposes under this Indenture.

     With respect to any Additional Notes, the Company shall set forth in an Officers’ Certificate
pursuant to a Board Resolution of the Company, copies of which shall be delivered to the Trustee,
the following information:

     (1) the aggregate principal amount of such Additional Notes to be authenticated and
delivered pursuant to this Indenture;

44

 

     (2) the issue price, the issue date and the CUSIP number of such Additional Notes; and

     (3) whether such Additional Notes shall be subject to transfer restrictions or shall be
issued in the form of Exchange Notes.

ARTICLE 3.

REDEMPTION AND PREPAYMENT

Section 3.01. Notices to Trustee.

     If the Company elects to redeem Notes pursuant to the optional redemption provisions of
Section 3.07 hereof, it shall furnish to the Trustee, at least 40 days (or such shorter period as
may be acceptable to
the Trustee) but not more than 75 days before a Redemption Date, an Officers’ Certificate
setting forth (i) the clause of this Indenture pursuant to which the redemption shall occur, (ii)
the Redemption Date, (iii) the principal amount of Notes to be redeemed, (iv) any other information
necessary to identify the Notes to be redeemed and (v) the Redemption Price and stating that the
conditions, if any, to any such redemption have been complied with.

Section 3.02. Selection of Notes to Be Redeemed.

     If less than all of the Notes are to be redeemed at any time, the Trustee will select the
Notes to be redeemed among the Holders of the Notes on a pro rata basis, by lot or in accordance
with any other method the Trustee considers fair and appropriate. In the event of partial
redemption by lot, the particular Notes to be redeemed shall be selected, unless otherwise provided
herein, not less than 30 nor more than 60 days prior to the Redemption Date by the Trustee from the
outstanding Notes not previously called for redemption.

     The Trustee shall promptly notify the Company in writing of the Notes selected for redemption
and, in the case of any Note selected for partial redemption, the principal amount thereof to be
redeemed. Notes and portions of Notes selected will be in amounts of $1,000 and integral multiples
of $1,000 in excess thereof; provided that no Notes of $2,000 or less shall be redeemed in part.
Except as provided in the preceding sentence, provisions of this Indenture that apply to Notes
called for redemption also apply to portions of Notes called for redemption.

Section 3.03. Notice of Redemption to Holders.

     At least 30 days but not more than 60 days before a Redemption Date, the Company shall mail or
cause to be mailed, by first class mail, a notice of redemption to each Holder whose Notes are to
be redeemed at its registered address.

     The notice shall identify the Notes to be redeemed and shall state:

     (a) the Redemption Date;

     (b) the Redemption Price;

     (c) if less than all the outstanding Notes are to be redeemed, the identification (and
in the case of partial redemption, the principal amount) of the particular Note to be
redeemed;

45

 

     (d) that, after the Redemption Date upon surrender of such Note, a new Note or Notes in
principal amount equal to the unredeemed portion shall be issued upon cancellation of the
original Note;

     (e) the name and address of the Paying Agent;

     (f) that Notes called for redemption must be surrendered to the Paying Agent to collect
the Redemption Price;

     (g) that, unless the Company defaults in making such redemption payment, interest, if
any, on Notes called for redemption ceases to accrue on and after the Redemption Date;

     (h) the paragraph of the Notes and/or Section of this Indenture pursuant to which the
Notes called for redemption are being redeemed; and

     (i) that no representation is made as to the correctness or accuracy of the CUSIP or
ISIN number, if any, listed in such notice or printed on the Notes.

     At the Company’s request, the Trustee shall give the notice of redemption in the Company’s
name and at its expense; provided, however, that the Company shall have delivered to the Trustee,
at least 45 days prior to the Redemption Date (or such shorter period as may be acceptable to the
Trustee), an Officers’ Certificate requesting that the Trustee give such notice and setting forth
the information to be stated in such notice as provided in the preceding paragraph.

     Notwithstanding the foregoing, a redemption notice may be mailed more than 60 days prior to
the Redemption Date if the notice is issued in connection with a defeasance of the Notes or
satisfaction and discharge of this Indenture.

Section 3.04. Effect of Notice of Redemption.

     Once notice of redemption is mailed in accordance with Section 3.03 hereof, Notes called for
redemption become irrevocably due and payable on the Redemption Date at the Redemption Price. A
notice of redemption may be conditional upon the occurrence of certain events, including equity
offerings.

Section 3.05. Deposit of Redemption or Purchase Price.

     Prior to 12:00 noon (New York Time) on the Redemption Date or purchase date, the Company shall
deposit with the Trustee or with the Paying Agent money sufficient to pay the Redemption Price or
purchase price of and accrued interest and Special Interest, if any, on all Notes to be redeemed on
that date. The Trustee or the Paying Agent shall promptly return to the Company any money deposited
with the Trustee or the Paying Agent by the Company in excess of the amounts necessary to pay the
Redemption Price or purchase price of, and accrued interest on, all Notes to be redeemed.

     If the Company complies with the provisions of the preceding paragraph, on and after the
Redemption Date or purchase date, interest shall cease to accrue on the Notes or the portions of
Notes called for redemption or purchase. If a Note is redeemed or purchased on or after a Regular
Record Date but on or prior to the related Interest Payment Date, then any accrued and unpaid
interest shall be paid to the Person in whose name such Notes was registered at the close of
business on such Regular Record Date. If any Note called for redemption or subject to purchase
shall not be so paid upon surrender for redemption or purchase because of the failure of the
Company to comply with the preceding paragraph, interest shall be paid on the unpaid principal from
the Redemption Date or the purchase date until such principal is paid, and to the

46

 

extent lawful on any interest not paid on such unpaid principal, in each case at the rate
provided in the Notes and in Section 4.01 hereof.

Section 3.06. Notes Redeemed or Purchased in Part.

     Upon surrender of a Note that is redeemed or purchased in part, the Company shall issue and,
upon the Company’s written request, the Trustee shall authenticate for the Holder at the expense of
the Company a new Note equal in principal amount to the unredeemed portion of the Note surrendered.

Section 3.07. Optional Redemption.

     (a) At any time prior to October 1, 2013, the Company may on any one or more occasions redeem
up to 35% of the aggregate principal amount of the Notes (including any Additional Notes) issued
under this Indenture at a Redemption Price of 106.625% of the principal amount, plus accrued and
unpaid interest and Special Interest, if any, to (but not including) the Redemption Date, with the
net cash proceeds of one or more Equity Offerings; provided that:

     (1) at least 65% of the aggregate principal amount of Notes issued under this Indenture
remains outstanding immediately after the occurrence of such redemption (excluding Notes
held by the Company and its Subsidiaries); and

     (2) the redemption occurs within 180 days of the date of the closing of such Equity
Offering.

     (b) At any time prior to October 1, 2015, the Company may redeem all or a part of the Notes,
upon not less than 30 nor more than 60 days’ notice, at a Redemption Price equal to 100% of the
principal amount thereof, plus the Applicable Redemption Premium and accrued and unpaid interest
and Special Interest, if any, to (but not including) the Redemption Date. The Company shall be
responsible for determining the Applicable Redemption Premium.

     (c) Except pursuant to the preceding two paragraphs, the Notes will not be redeemable at the
Company’s option prior to October 1, 2015. On or after October 1, 2015, the Company may redeem all
or a part of the Notes upon not less than 30 nor more than 60 days’ notice, at the Redemption
Prices (expressed as percentages of principal amount) set forth below plus accrued and unpaid
interest and Special Interest, if any, on the Notes redeemed, to (but not including) the applicable
Redemption Date, if redeemed during the twelve-month period beginning on October 1 of the years
indicated below:

	 	 	 	 	 
	Year	 	Percentage	 
	2015
	 	 	103.313	%
	2016
	 	 	102.208	%
	2017
	 	 	101.104	%
	2018 and thereafter
	 	 	100.000	%

     (d) Any redemption pursuant to this Section 3.07 shall be made pursuant to the provisions of
Sections 3.01 through 3.06 hereof.

Section 3.08. Mandatory Redemption.

     Except as set forth in Sections 3.09, 4.08 and 4.11, the Company is not required to make
mandatory redemption or sinking fund payments with respect to the Notes.

47

 

Section 3.09. Offer to Purchase by Application of Excess Proceeds.

     In the event that pursuant to Section 4.08 hereof, the Company shall be required to commence
an Asset Sale Offer, it shall follow the procedures specified below.

     The Asset Sale Offer shall remain open for a period of 20 Business Days following its
commencement, except to the extent that a longer period is required by applicable law (the “Offer
Period”). No later than five Business Days after the termination of the Offer Period (the
“Purchase Date”), the Company shall purchase the principal amount of Notes required to be purchased
pursuant to Section 4.08 hereof (the “Offer Amount”) or, if less than the Offer Amount has been
tendered, all Notes tendered in response to the Asset Sale Offer.

     If the Purchase Date is on or after an Regular Record Date and on or before the related
Interest Payment Date, any accrued and unpaid interest shall be paid to the Person in whose name a
Note is registered at the close of business on such record date, and no additional interest shall
be payable to Holders who tender Notes pursuant to the Asset Sale Offer.

     Upon commencement of an Asset Sale Offer, the Company shall send, by first class mail, a
notice to the Trustee and each of the Holders. The notice shall contain all instructions and
materials necessary to enable such Holders to tender Notes pursuant to the Asset Sale Offer. The
Asset Sale Offer shall be made to all Holders. The notice, which shall govern the terms of the
Asset Sale Offer, shall state:

     (a) that the Asset Sale Offer is being made pursuant to this Section 3.09 and Section 4.08
hereof and the length of time the Asset Sale Offer shall remain open;

     (b) the Offer Amount, the purchase price and the Purchase Date;

     (c) that any Note not tendered or accepted for payment shall continue to accrue interest;

     (d) that, unless the Company defaults in making such payment, any Note accepted for payment
pursuant to the Asset Sale Offer shall cease to accrue interest after the Purchase Date;

     (e) that Holders electing to have a Note purchased pursuant to an Asset Sale Offer may elect
to have Notes purchased only in minimum denominations of $1,000 and in integral multiples of $1,000
in excess thereof, provided that the unrepurchased portion of a Note must be in a minimum
denomination of $2,000;

     (f) that Holders electing to have a Note purchased pursuant to any Asset Sale Offer shall be
required to surrender the Note, with the form entitled “Option of Holder to Elect Purchase” on the
reverse of the Note completed, or transfer by book-entry transfer, to the Company, a depositary, if
appointed by the Company, or a Paying Agent at the address specified in the notice at least three
days before the Purchase Date;

     (g) that Holders shall be entitled to withdraw their election if the Company, the Depositary
or the Paying Agent, as the case may be, receives, no later than the close of business on the last
day of the Offer Period, a telegram, telex, facsimile transmission or letter setting forth the name
of the Holder, the principal amount of the Note the Holder delivered for purchase and a statement
that such Holder is withdrawing his election to have such Note purchased;

     (h) that, if the aggregate principal amount of Notes surrendered by Holders exceeds the Offer
Amount, the Trustee shall select the Notes to be purchased on a pro rata basis (with such
adjustments as

48

 

may be deemed appropriate by the Trustee so that only Notes in minimum denominations
of $1,000, or integral multiples of $1,000 in excess thereof, shall be purchased); and

     (i) that Holders whose Notes were purchased only in part shall be issued new Notes equal in
principal amount, in minimum amounts of $2,000 and integral multiples of $1,000 in excess thereof,
to the unpurchased portion of the Notes surrendered (or transferred by book-entry transfer) upon
cancellation of the original Notes.

     On or before the Purchase Date, the Company shall, to the extent lawful, accept for payment,
on a pro rata basis to the extent necessary, the Offer Amount of Notes or portions thereof tendered
pursuant to the Asset Sale Offer, or if less than the Offer Amount has been tendered, all Notes
tendered, deposit with the Paying Agent an amount equal to the Offer Amount in respect of all Notes
or portions of Notes properly tendered and shall deliver to the Trustee an Officers’ Certificate
stating that such Notes or portions thereof were accepted for payment by the Company in accordance
with the terms of this Section 3.09. The Paying Agent shall promptly (but in any case not later
than five Business Days after the Purchase Date) mail or deliver to each tendering Holder an amount
equal to the purchase price of the Notes tendered by such Holder and accepted by the Company for
purchase, and the Company shall promptly issue a new Note, and the Trustee, upon written request
from the Company shall authenticate and mail or deliver such new Note to such Holder, in a
principal amount equal to any unpurchased portion of the Note surrendered upon cancellation of the
original Note. Any Note not so accepted shall be promptly mailed or delivered by the Company to the
Holder thereof. The Company shall publicly announce the results of the Asset Sale Offer on the
Purchase Date.

     Other than as specifically provided in this Section 3.09, any purchase pursuant to this
Section 3.09 shall be made pursuant to the provisions of Sections 3.01 through 3.06 hereof.

ARTICLE 4.

COVENANTS

Section 4.01. Payment of Notes.

     The Company shall pay or cause to be paid the principal of, premium, if any, and interest and
Special Interest, if any, on the Notes on the dates and in the manner provided in the Notes.
Principal, premium, if any, and interest and Special Interest, if any, shall be considered paid on
the date due if the Paying Agent, if other than the Company or a Subsidiary thereof, holds as of
10:00 a.m. New York Time on the due date money deposited by the Company in immediately available
funds and designated for and sufficient to pay all principal, premium, if any, and interest and
Special Interest, if any, then due. The Company shall pay all Special Interest, if any, in the same
manner and on the same dates and to the same Persons as ordinary interest and in the amounts set
forth in the Registration Rights Agreement.

Section 4.02. Maintenance of Office or Agency.

     The Company shall maintain in the Borough of Manhattan, the City of New York an office or
agency (which may be an office of the Trustee or an affiliate of the Trustee, Registrar or
co-registrar) where Notes may be surrendered for registration of transfer or for exchange and where
notices and demands to or upon the Company in respect of the Notes and this Indenture may be
served. The Company shall give prompt written notice to the Trustee of the location, and any change
in the location, of such office or agency. If at any time the Company shall fail to maintain any
such required office or agency or shall fail to furnish the Trustee with the address thereof, such
presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office
of the Trustee.

49

 

     The Company also may from time to time designate one or more other offices or agencies where
the Notes may be presented or surrendered for any or all such purposes and may from time to time
rescind such designations; provided, however, that no such designation or rescission shall in any
manner relieve the Company of its obligation to maintain an office or agency in the Borough of
Manhattan, the City of New York for such purposes. The Company shall give prompt written notice to
the Trustee of any such designation or rescission and of any change in the location of any such
other office or agency.

     The Company hereby designates the Trustee, acting through its affiliate, The Bank of New York
Mellon, as one such office or agency of the Company in accordance with Section 2.03 hereof.

Section 4.03. Reports.

     Whether or not required by the SEC, so long as any Notes are outstanding, the Company will
furnish to the Holders of Notes and file with the SEC (unless the SEC will not accept such filing),
within the time periods specified in the SEC’s rules and regulations:

     (a) all quarterly and annual financial information that would be required to be
contained in a filing with the SEC on Forms 10-Q and 10-K if the Company were required to
file such Forms, including a “Management’s Discussion and Analysis of Financial Condition
and Results of Operations” and, with respect to the annual information only, a report on the
annual financial statements by the Company’s certified independent accountants; and

     (b) all current reports that would be required to be filed with the SEC on Form 8-K if
the Company were required to file such reports;

provided, that any information accepted for filing with the SEC shall be deemed to have been
furnished to Holders of the Notes.

     The Company shall at all times comply with TIA § 314(a). Delivery of reports, information and
documents to the Trustee pursuant to TIA § 314(a) is for informational purposes only and the
Trustee’s receipt of such shall not constitute constructive notice of any information contained
therein or determinable from information contained therein, including the Company’s compliance with
any of its covenants hereunder.

Section 4.04. Compliance Certificate.

     The Company and each Guarantor (to the extent that such Guarantor is so required under the
TIA) shall deliver to the Trustee, within 120 days after the end of each fiscal year, an Officers’
Certificate stating
that a review of the activities of the Company and its Subsidiaries during the preceding
fiscal year has been made under the supervision of the signing Officers with a view to determining
whether the Company has kept, observed, performed and fulfilled its obligations under this
Indenture, and further stating, as to each such Officer signing such certificate, that to the best
of his or her knowledge the Company has kept, observed, performed and fulfilled each and every
covenant contained in this Indenture and is not in default in the performance or observance of any
of the terms, provisions and conditions of this Indenture (or, if a Default or Event of Default
shall have occurred, describing all such Defaults or Events of Default of which he or she may have
knowledge and what action the Company is taking or proposes to take with respect thereto).

50

 

Section 4.05. Restricted Payments.

     The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or
indirectly:

     (a) declare or pay any dividend or make any other payment or distribution on account of the
Company’s or any Restricted Subsidiary’s Equity Interests (including, without limitation, any
payment in connection with any merger or consolidation involving the Company or any of its
Restricted Subsidiaries) or to the direct or indirect holders of the Company’s or any of its
Restricted Subsidiaries’ Equity Interests in their capacity as such (other than dividends or
distributions payable in Equity Interests (other than Disqualified Stock) of the Company or to the
Company or a Restricted Subsidiary);

     (b) purchase, redeem or otherwise acquire or retire for value (including, without limitation,
in connection with any merger or consolidation involving the Company) any Equity Interests of the
Company;

     (c) make any voluntary or optional payment on or with respect to, or purchase, redeem, defease
or otherwise acquire or retire for value any Subordinated Indebtedness, except a payment of
interest or principal at the Stated Maturity thereof or the purchase, redemption, defeasance,
acquisition or retirement for value of any such Indebtedness within 365 days of the Stated Maturity
thereof; or

     (d) make any Restricted Investment

(all such payments and other actions set forth in these clauses (a) through (d) being collectively
referred to as “Restricted Payments”), unless, at the time of and after giving effect to such
Restricted Payment:

     (1) no Default or Event of Default has occurred and is continuing or would occur as a
consequence of such Restricted Payment;

     (2) the Company would, at the time of such Restricted Payment and after giving pro
forma effect thereto as if such Restricted Payment had been made at the beginning of the
applicable four-quarter period, have been permitted to incur at least $1.00 of additional
Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in the first
paragraph of Section 4.07 hereof; and

     (3) such Restricted Payment, together with the aggregate amount of all other Restricted
Payments made by the Company and its Restricted Subsidiaries after June 30, 2010 (excluding
Restricted Payments permitted by clauses (b), (c), (d), (f), (g), (h), (i), (j), (l), (m),
(n), and (o) of the next succeeding paragraph) is less than the sum, without duplication,
of:

     (A) 50% of the Consolidated Net Income of the Company for the period (taken as
one accounting period) from June 30, 2010 to the end of the Company’s most recently
ended fiscal quarter for which internal financial statements are available at the
time of such Restricted Payment (or, if such Consolidated Net Income for such period
is a deficit, less 100% of such deficit), plus

     (B) 100% of the aggregate net cash proceeds received by the Company since June
30, 2010 as a contribution to its common equity capital or from the issue or sale of
Equity Interests of the Company (other than Disqualified Stock) or from the issue or
sale of convertible or exchangeable Disqualified Stock or convertible or
exchangeable debt securities that have been converted into or exchanged for such
Equity Interests of the

51

 

Company (other than Equity Interests (or Disqualified Stock
or debt securities) sold to a Restricted Subsidiary), plus

     (C) to the extent that any Restricted Investment that was made after June 30,
2010 is sold for cash or Cash Equivalents (or a combination thereof) or otherwise
liquidated or repaid for cash or Cash Equivalents (or a combination thereof), the
lesser of (1) the return of capital with respect to such Restricted Investment (less
the cost of disposition, if any) and (2) the initial amount of such Restricted
Investment, plus

     (D) an amount equal to the sum of (1) the net reduction in Investments in
Unrestricted Subsidiaries resulting from cash dividends, repayments of loans or
advances or other transfers of assets, in each case to the Company or any Restricted
Subsidiary from Unrestricted Subsidiaries, plus (2) the portion (proportionate to
the Company’s equity interest in such Subsidiary) of the fair market value of the
net assets of an Unrestricted Subsidiary at the time such Unrestricted Subsidiary is
designated a Restricted Subsidiary, in each case since June 30, 2010 (provided,
however, that the foregoing sum shall not exceed, in the case of any Unrestricted
Subsidiary, the amount of Investments made since June 30, 2010 by the Company or any
Restricted Subsidiary that were treated as Restricted Payments, and provided,
further, that no amount will be included under this clause (D) to the extent it is
already included in clauses (A), (B) or (C) above).

     The preceding provisions shall not prohibit:

     (a) the payment of any dividend within 60 days after the date of declaration of the
dividend, if at the date of declaration the dividend payment would have complied with the
provisions of this Indenture;

     (b) the redemption, repurchase, retirement, defeasance or other acquisition of any
Subordinated Indebtedness of the Company or any Restricted Subsidiary or of any Equity
Interests of the Company in exchange for, or out of the net cash proceeds of the
substantially concurrent sale (other than to a Restricted Subsidiary) of, Equity Interests
of the Company (other than Disqualified Stock);

     (c) the defeasance, redemption, repurchase or other acquisition of Subordinated
Indebtedness of the Company or any Restricted Subsidiary with the net cash proceeds from an
incurrence of (1) Permitted Refinancing Indebtedness or (2) any other Indebtedness to the
extent that the Consolidated Senior Leverage Ratio for the Company’s most recently ended
four full fiscal
quarters for which internal financial statements are available immediately preceding
the date on which such Indebtedness other than Subordinated Indebtedness is incurred is less
than 4.5 to 1, determined on a pro forma basis (including a pro forma application of the net
proceeds therefrom), as if such Indebtedness had been incurred at the beginning of such
four-quarter period;

     (d) the payment of any dividend or similar distribution by a Restricted Subsidiary to
the holders of its Equity Interests on a pro rata basis;

     (e) the repurchase, redemption or other acquisition or retirement for value of any
Equity Interests of the Company or any Restricted Subsidiary held by any officer, director
or employee of the Company or any Subsidiary of the Company in connection with any
management equity subscription agreement, any compensation, retirement, disability,
severance or benefit plan or agreement, any stock option or incentive plan or agreement, any
employment agreement or any

52

 

other similar plans or agreements; provided that the aggregate
price paid for all such repurchased, redeemed, acquired or retired Equity Interests may not
exceed $15.0 million in any calendar year (with unused amounts in any calendar year being
carried over to succeeding years);

     (f) the repurchase of Equity Interests deemed to occur upon the exercise of stock
options or stock appreciation rights or the lapsing of restrictions on restricted stock, to
the extent such Equity Interests represent a portion of the exercise price of those stock
options or stock appreciation rights or the withholding taxes payable in connection with
such stock options, stock appreciation rights or restricted stock;

     (g) the repurchase of any class of Capital Stock of a Restricted Subsidiary (other than
Disqualified Stock) if such repurchase is made pro rata among all holders of such class of
Capital Stock;

     (h) the payment of any scheduled dividend or similar distribution, and any scheduled
repayment of the stated amount, liquidation preference or any similar amount at final
maturity or on any scheduled redemption or repurchase date, in respect of any series of
preferred stock or similar securities of the Company or any Restricted Subsidiary (including
Disqualified Stock), provided that such series of preferred stock or similar securities was
issued in compliance with Section 4.07 hereof;

     (i) payments in lieu of fractional shares;

     (j) the purchase of any Indebtedness that is subordinate to the Notes at a purchase
price no greater than 101% of the principal amount thereof in the event of a Change of
Control in accordance with provisions similar to those described under Section 4.11 hereof;
provided that prior to such purchase the Company has made the Change of Control Offer as
provided in such section and has purchased all notes validly tendered for payment in
connection with such Change of Control Offer;

     (k) payments or distributions to dissenting stockholders pursuant to applicable law in
connection with any merger, consolidation or disposition in accordance with the terms of
this Indenture;

     (l) the purchase, redemption, cancellation or other retirement for a nominal value per
right of any rights granted to holders of the Company’s common stock pursuant to a
shareholder rights plan;

     (m) the repurchase, redemption or other acquisition of Disqualified Stock of the
Company or any of its Restricted Subsidiaries in exchange for or out of the proceeds of a
substantially concurrent offering of, Disqualified Stock of the Company;

     (n) the repurchase of Equity Interests of the Company in an aggregate amount not to
exceed $225 million; and

     (o) additional Restricted Payments pursuant to this clause (o) in an aggregate amount
not to exceed $300 million at the time of such Restricted Payment (with each such Restricted
Payment being valued as of the date made and without regard to subsequent changes in value);

provided, that at the time of, and after giving effect to, any Restricted Payment permitted under
subclause (2) of clause (c) and clause (o) above, no Default has occurred and is continuing or
would be caused thereby.

53

 

     The amount of all Restricted Payments (other than cash) will be the fair market value on the
date of the Restricted Payment of the asset(s) or securities proposed to be transferred or issued
by the Company or such Restricted Subsidiary, as the case may be, pursuant to the Restricted
Payment. The fair market value of any assets or securities that are required to be valued by this
Section 4.05 will be determined by the Board of Directors of the Company in good faith, whose
determination with respect thereto will be conclusive.

     For purposes of determining compliance with this Section 4.05, in the event that a Restricted
Payment meets the criteria of more than one of the categories of Restricted Payments described in
clauses (a) through (o) above, or is entitled to be incurred pursuant to the first paragraph of
this Section 4.05, the Company will be entitled to classify such Restricted Payment (or portion
thereof) on the date of its payment or later reclassify such Restricted Payment (or portion
thereof) in any manner that complies with this Section 4.05.

Section 4.06. Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries.

     The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or
indirectly, create or permit to exist or become effective any consensual encumbrance or restriction
on the ability of any Restricted Subsidiary to:

     (a) pay dividends or make any other distributions on its Capital Stock to the Company
or any of its Restricted Subsidiaries, or with respect to any other interest or
participation in, or measured by, its profits, or pay any indebtedness owed to the Company
or any of its Restricted Subsidiaries;

     (b) make loans or advances to the Company or any of its Restricted Subsidiaries; or

     (c) transfer any of its properties or assets to the Company or any of its Restricted
Subsidiaries.

     However, the preceding restrictions will not apply to encumbrances or restrictions existing
under or by reason of:

     (a) agreements governing Existing Indebtedness and Credit Facilities or other
agreements as in effect on the Issue Date and any amendments, modifications, restatements,
renewals, increases, supplements, refundings, replacements or refinancings of those
agreements, provided that the amendments, modifications, restatements, renewals, increases,
supplements, refundings, replacement or refinancings are not materially more restrictive,
taken as a whole, with respect to such dividend and other payment restrictions than those
contained in those agreements on the Issue Date;

     (b) the Indenture, the Notes, the Subsidiary Guarantees the Exchange Notes and the
Exchange Subsidiary Guarantees;

     (c) applicable law;

     (d) any instrument governing Indebtedness or Capital Stock of a Person, or such
encumbrances or restrictions with respect to other property or assets, in any case acquired
by the Company or any of its Restricted Subsidiaries as in effect at the time of such
acquisition (except to the extent such encumbrances or restrictions relate to Indebtedness
was incurred in connection with or in contemplation of such acquisition), which encumbrance
or restriction is not applicable to any Person, or the properties or assets of any Person,
other than the Person, the property or

54

 

assets of the Person, so acquired, provided that, in
the case of Indebtedness, such Indebtedness was permitted by the terms of this Indenture to
be incurred;

     (e) customary non-assignment provisions in leases, licenses and other agreements
entered into in the ordinary course of business;

     (f) purchase money obligations or Capital Lease Obligations for property acquired or
leased in the ordinary course of business that impose restrictions on that property or the
assets otherwise subject thereto of the nature described in clause (c) of the preceding
paragraph;

     (g) any agreement for the sale or other disposition of a Restricted Subsidiary or any
assets thereof that restricts distributions by that Restricted Subsidiary pending the sale
or other disposition;

     (h) Permitted Refinancing Indebtedness, provided that the restrictions contained in the
agreements governing such Permitted Refinancing Indebtedness are not materially more
restrictive, taken as a whole, than those contained in the agreements governing the
Indebtedness being refinanced;

     (i) Liens securing Indebtedness otherwise permitted to be incurred under Section 4.10
hereof;

     (j) provisions with respect to the disposition or distribution of assets or property in
joint venture agreements, assets sale agreements, stock sale agreements and other similar
agreements entered into in the ordinary course of business;

     (k) restrictions imposed in connection with a financing transaction involving a sale or
other disposition of accounts receivable and related assets (including, without limitation,
in connection with a securitization or similar financing) or in connection with a financing
involving a subsidiary trust or similar financing vehicle that is permitted by Section 4.07
hereof, provided,
that such restrictions do not materially adversely affect the Company’s ability to pay
interest and principal on the Notes when due;

     (l) restrictions on cash or other deposits or net worth imposed by customers under
contracts entered into in the ordinary course of business or imposed by governmental
agencies or authorities;

     (m) in the case of clause (c) of the preceding paragraph, encumbrances or restrictions
arising or agreed to in the ordinary course of business, not relating to Indebtedness and
that do not materially detract from the value of the property or assets of the Company and
its Restricted Subsidiaries;

     (n) encumbrances or restrictions contained in the terms of Indebtedness if the
encumbrance or restriction is not materially more disadvantageous to Holders than is
customary in comparable financings and will not materially affect the Company’s ability to
make principal or interest payments on the Notes (in each case determined by the Company in
good faith); and

     (o) agreements with respect to Insurance Subsidiaries or with respect to securities
thereof, in each case in connection with the operation of any Insurance Subsidiary.

55

 

Section 4.07. Incurrence of Indebtedness and Issuance of Preferred Stock.

     The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or
indirectly, create, incur, issue, assume, guarantee or otherwise become directly or indirectly
liable, contingently or otherwise, with respect to (collectively, “incur”) any Indebtedness
(including Acquired Debt), and the Company shall not issue any Disqualified Stock and shall not
permit any of its Restricted Subsidiaries to issue any shares of preferred stock; provided,
however, that the Company and any Restricted Subsidiary may incur Indebtedness (including Acquired
Debt) and the Company may issue Disqualified Stock and any Restricted Subsidiary may issue
preferred stock (including Disqualified Stock) if the Fixed Charge Coverage Ratio for the Company’s
most recently ended four full fiscal quarters for which internal financial statements are available
immediately preceding the date on which such additional Indebtedness is incurred or such
Disqualified Stock or preferred stock is issued would have been at least 2.0 to 1, determined on a
pro forma basis (including a pro forma application of the net proceeds therefrom), as if the
additional Indebtedness had been incurred or the Disqualified Stock or preferred stock had been
issued, as the case may be, at the beginning of such four-quarter period.

     The first paragraph of this Section 4.07 will not prohibit the following (collectively,
“Permitted Debt”):

     (a) the incurrence by the Company and its Restricted Subsidiaries of additional
Indebtedness and letters of credit under Credit Facilities in an aggregate principal amount
at any one time outstanding under this clause (a) (with letters of credit being deemed to
have a principal amount equal to the maximum potential liability of the Company and its
Restricted Subsidiaries thereunder) not to exceed $1,000 million (less the aggregate
principal amount of Indebtedness incurred by Securitization Subsidiaries and then
outstanding pursuant to clause (q) of this paragraph);

     (b) Existing Indebtedness;

     (c) the incurrence by the Company and the Guarantors of Indebtedness represented by (a)
the Notes and the related Subsidiary Guarantees to be issued on the Issue Date and (b) the
Exchange Notes and the Exchange Subsidiary Guarantees to be issued pursuant to this
Indenture in exchange for the Notes and the Subsidiary Guarantees in accordance with the
terms of the Registration Rights Agreement;

     (d) the incurrence by the Company or any of its Restricted Subsidiaries of Indebtedness
represented by Capital Lease Obligations, mortgage financings or purchase money obligations,
in each case, incurred for the purpose of financing all or any part of the purchase price or
cost of construction or improvement of property, plant or equipment used in the business of
the Company or such Subsidiary, in an aggregate principal amount, including all Permitted
Refinancing Indebtedness incurred to refund, refinance or replace any Indebtedness incurred
pursuant to this clause (d), not to exceed the greater of $100.0 million and 2.5% of Total
Assets at any time outstanding;

     (e) the incurrence by the Company or any of its Restricted Subsidiaries of Permitted
Refinancing Indebtedness in exchange for, or the net proceeds of which are used to extend,
refinance, renew, replace, defease, or refund Indebtedness (other than intercompany
Indebtedness) that was permitted by this Indenture to be incurred under the first paragraph
of this Section 4.07 or clauses (b), (c), (d), (l), (m), (o), (z) or this clause (e) of this
paragraph;

56

 

     (f) the incurrence by the Company or any of its Restricted Subsidiaries of intercompany
Indebtedness or the issuance of Disqualified Stock or Preferred Stock between or among the
Company and any of its Restricted Subsidiaries; provided, however, that (i) any subsequent
issuance or transfer of Equity Interests that results in any such Indebtedness, Disqualified
Stock or Preferred Stock being held by a Person other than the Company or a Restricted
Subsidiary and (ii) any sale or other transfer of any such Indebtedness, Disqualified Stock
or Preferred Stock to a Person that is not either the Company or a Restricted Subsidiary,
will be deemed, in each case, to constitute an incurrence of such Indebtedness, Disqualified
Stock or Preferred Stock by the Company or such Restricted Subsidiary, as the case may be,
that was not permitted by this clause (f);

     (g) the incurrence by the Company or any of its Restricted Subsidiaries of Hedging
Obligations that are incurred for the purpose of fixing or hedging (i) interest rate risk
with respect to any Indebtedness that is permitted by the terms of this Indenture to be
outstanding or (ii) exchange rate risk with respect to obligations under any agreement or
Indebtedness, or with respect to any asset, of such Person that is payable or denominated in
a currency other than U.S. Dollars;

     (h) the guarantee by the Company or any of the Restricted Subsidiaries of Indebtedness
of the Company or a Restricted Subsidiary that was permitted to be incurred by another
provision of this Section 4.07;

     (i) the accrual of interest, the accretion or amortization of original issue discount,
the payment of interest on any Indebtedness in the form of additional Indebtedness with the
same terms, and the payment of dividends on preferred stock (including Disqualified Stock)
in the form of additional shares of the same class of preferred stock (including
Disqualified Stock) will not be deemed to be an incurrence of Indebtedness or an issuance of
preferred stock (including
Disqualified Stock) for purposes of this Section 4.07; provided, in each such case,
that the amount thereof is included in Fixed Charges of the Company as accrued;

     (j) Indebtedness of the Company or any Restricted Subsidiary consisting of guarantees,
indemnities, hold backs or obligations in respect of purchase price adjustments in
connection with the acquisition or disposition of assets, including, without limitation,
            shares of Capital Stock of restricted Subsidiaries, or contingent payment obligations
incurred in connection with the acquisition or disposition of assets which are contingent on
the performance of the assets acquired or disposed of;

     (k) Indebtedness represented by (i) letters of credit for the account of the Company or
any Restricted Subsidiary or (ii) other obligations to reimburse third parties pursuant to
any surety bond or other similar arrangements, to the extent that such letters of credit and
other obligations, as the case may be, are intended to provide security for workers’
compensation claims, payment obligations in connection with self-insurance, in connection
with participation in government reimbursement or other programs or other similar
requirements in the ordinary course of business;

     (l) the incurrence by the Company or any Restricted Subsidiary of Indebtedness to the
extent the proceeds thereof are used to purchase Notes pursuant to a Change of Control Offer
or defease or discharge the Notes in accordance with the terms of this Indenture;

     (m) Indebtedness arising from the honoring by a bank or other financial institution of
a check, draft or similar instrument inadvertently (except in the case of daylight
overdrafts) drawn

57

 

against insufficient funds in the ordinary course of business; provided,
however, that such Indebtedness is extinguished within five Business Days of incurrence;

     (n) Indebtedness incurred in the ordinary course of business in connection with cash
pooling arrangements, cash management and other Indebtedness incurred in the ordinary course
of business in respect of netting services, overdraft protections and similar arrangements
in each case in connection with cash management and deposit accounts;

     (o) Indebtedness consisting of (i) the financing of insurance premiums or (ii) take or
pay obligations in supply agreements, in each case in the ordinary course of business;

     (p) Indebtedness of the Company and its Subsidiaries representing the obligation of
such Person to make payments with respect to the cancellation or repurchase of Capital Stock
of officers, employees or directors (or their estates) of the Company or such Subsidiaries
pursuant to the terms of employment, severance or termination agreements, benefit plans or
similar documents;

     (q) Indebtedness incurred by a Securitization Subsidiary in connection with a Qualified
Securitization Transaction that is non-recourse with respect to the Company and its
Restricted Subsidiaries; provided, however, that in the event such Securitization Subsidiary
ceases to qualify as a Securitization Subsidiary or such Indebtedness becomes recourse to
the Company or any of its Restricted Subsidiaries, such Indebtedness will, in each case, be
deemed to be, and must be classified by the Company as, incurred at such time (or at the
time initially incurred) under one more of the other provisions of this Section 4.07;

     (r) the disposition of accounts receivable in connection with receivables factoring
arrangements in the ordinary course of business;

     (s) unsecured Indebtedness in respect of obligations of the Company or any of its
Restricted Subsidiaries to pay the deferred purchase price of goods or services or progress
payments in connection with such goods and services; provided that such obligations are
incurred in connection with open accounts extended by suppliers on customary trade terms
(which require that all such payments be made within 60 days after the Incurrence of the
related obligations) in the ordinary course of business;

     (t) Indebtedness representing deferred compensation to employees of the Company or any
of its Restricted Subsidiaries Incurred in the ordinary course of business;

     (u) reimbursement obligations with respect to letters of credit, bank guarantees,
warehouse receipts or similar instruments issued in the ordinary course of business, and
Indebtedness of the Company in respect of letters of credit issued by the Company for its
own account or for the account of any of its Restricted Subsidiaries;

     (v) Indebtedness arising from any Sale and Leaseback Transaction, provided that the
principal amount of any Indebtedness incurred pursuant to this clause may not exceed (1) $35
million less (2) the aggregate amount of Permitted Refinancing Indebtedness incurred to
refinance Indebtedness incurred pursuant to this clause;

     (w) Physician Support Obligations incurred by the Company or any Restricted Subsidiary;

58

 

     (x) Indebtedness incurred on behalf of or representing Guarantees of Indebtedness of
Permitted Joint Ventures of the Company or any Restricted Subsidiary not in excess of $35
million at any one time outstanding;

     (y) the incurrence by the Company or any of its Restricted Subsidiaries of additional
Indebtedness (which may include, but is not limited to, Indebtedness of the types referred
to in the foregoing clauses (a) through (x) and clause (z)) in an aggregate principal amount
(or accreted value, as applicable) at any time outstanding, including all Permitted
Refinancing Indebtedness incurred to refund, refinance or replace any Indebtedness incurred
pursuant to this clause (y), not to exceed the greater of $200 million and 5.0% of Total
Assets; and

     (z) Indebtedness of a Restricted Subsidiary outstanding on the date on which such
Restricted Subsidiary was acquired by the Company or otherwise became a Restricted
Subsidiary (other than Indebtedness incurred as consideration in, or to provide all or any
portion of the funds or credit support utilized to consummate, the transaction or series of
transactions pursuant to which such Restricted Subsidiary became a Subsidiary of the Company
or was otherwise acquired by the Company), provided that after giving effect thereto, (a)
the Company would be permitted to incur at least $1 of additional Indebtedness pursuant to
the Fixed Charge Coverage Ratio test in the first paragraph of this Section 4.07, or (b) the
Fixed Charge Coverage Ratio would be no worse than immediately prior thereto.

     For purposes of determining compliance with this Section 4.07, in the event that an item of
proposed Indebtedness meets the criteria of more than one of the categories of Permitted Debt
described in
clauses (a) through (z) above, or is entitled to be incurred pursuant to the first paragraph
of this Section 4.07, the Company will be permitted to classify and reclassify such item of
Indebtedness in any manner that complies with this Section 4.07. Indebtedness under Credit
Facilities outstanding on the date on which Notes are first issued and authenticated hereunder will
be deemed to have been incurred on such date in reliance on the exception provided by clause (a) of
the definition of Permitted Debt.

     Notwithstanding any other provision of this Section 4.07, the maximum amount of Indebtedness
that may be Incurred pursuant to this covenant will not be deemed to be exceeded with respect to
any Indebtedness solely as a result of fluctuations in exchange rates or currency values.

     Guarantees of, or obligations in respect of letters of credit relating to, Indebtedness that
is otherwise included in the determination of particular amount of Indebtedness shall not be
included in the determination of such amount of Indebtedness; provided that the incurrence of the
Indebtedness represented by such guarantee or letter of credit, as the case may be, was in
compliance with this Section 4.07.

Section 4.08. Asset Sales.

     The Company shall not, and shall not permit any of the Restricted Subsidiaries to, consummate
an Asset Sale unless:

     (a) the Company (or the Restricted Subsidiary, as the case may be) receives
consideration at the time of the Asset Sale at least equal to the fair market value of the
assets or Equity Interests issued or sold or otherwise disposed of;

     (b) the fair market value is determined by the Company’s Board of Directors and
evidenced by a Board Resolution; and

59

 

     (c) at least 75% of the consideration received in the Asset Sale by the Company or such
Restricted Subsidiary is in the form of cash, Cash Equivalents and/or Replacement Assets.
For purposes of this provision, each of the following will be deemed to be cash:

     (1) any liabilities, as shown on the Company’s or any Restricted Subsidiary’s
most recent balance sheet, of the Company or any Restricted Subsidiary (other than
contingent liabilities and liabilities that are by their terms subordinated to the
Notes or any Subsidiary Guarantee) that are assumed by the transferee of any such
assets and from which the Company or such Restricted Subsidiary is released from
further liability;

     (2) any securities, notes or other obligations received by the Company or any
such Restricted Subsidiary from such transferee that are converted by the Company or
such Restricted Subsidiary into cash within 180 days of receipt, to the extent of
the cash received in that conversion; and

     (3) any Designated Non-cash Consideration received by the Company or any of its
Restricted Subsidiaries in such Asset Sale having an aggregate fair market value,
taken together with all other Designated Non-cash Consideration received pursuant to
this clause (3) that is at that time outstanding, not to exceed $50 million at the
time of the receipt of such Designated Non-cash Consideration (with the fair market
value of each
item of Designated Non-cash Consideration being measured at the time received
and without giving effect to subsequent changes in value).

     Within 365 days after the receipt of any Net Proceeds from an Asset Sale, the Company or a
Restricted Subsidiary may apply those Net Proceeds at its option:

     (a) to repay, prepay, redeem or purchase (x) Indebtedness of the Company or any
Guarantor that is not Subordinated Indebtedness or (y) any Indebtedness of a Restricted
Subsidiary that is not a Guarantor;

     (b) to acquire all or substantially all of the assets of, or a majority of the Voting
Stock of, another Permitted Business;

     (c) to make a capital expenditure;

     (d) to acquire Replacement Assets; or

     (e) to acquire other long-term assets that are used or useful in a Permitted Business.

     The Company or the relevant Restricted Subsidiary will be deemed to have complied with the
immediately preceding sentence with respect to any such Net Proceeds if it enters into a binding
agreement to make an acquisition or capital expenditure permitted pursuant to clause (b), (c), (d)
or (e) of the immediately preceding sentence in an amount equal to such Net Proceeds within such
365 days; provided that, if the relevant acquisition or capital expenditure is not consummated or
completed, as the case may be, within the later of (x) 365 days after the receipt of the relevant
Net Proceeds and (y) 180 days after the date of such binding agreement, such Net Proceeds will
constitute “Excess Proceeds.” Pending the final application of any Net Proceeds, the Company or
the Restricted Subsidiary may temporarily invest the Net Proceeds in any manner that is not
prohibited by this Indenture.

60

 

     Any Net Proceeds from Asset Sales that are not applied or invested as provided in the
preceding paragraph will constitute Excess Proceeds. When the aggregate amount of Excess Proceeds
exceeds $50 million, the Company shall make an offer (an “Asset Sale Offer”) to all Holders of
Notes (and, at the option of the Company, to holders of any other Indebtedness of the Company or
any Guarantor that is not Subordinated Indebtedness and/or any Indebtedness of any Restricted
Subsidiary of the Company (collectively, “other indebtedness”)) to purchase the maximum principal
amount of Notes (and such other Indebtedness), in minimum denominations of $1,000 principal amount
and in integral multiples of $1,000 in excess thereof; provided, that the unrepurchased portion of
a Note must be in a minimum denomination of $2,000, out of the Excess Proceeds at a purchase price
of 100% of their principal amount (or, in the event such other Indebtedness was issued with
significant original issue discount, 100% of the accreted value thereof) without premium, plus
accrued but unpaid interest (or, in respect of such other Indebtedness, such lesser price, if any,
as may be provided for by the terms of such Indebtedness) in accordance with the procedures
(including prorating in the event of oversubscription) set forth in this Indenture. To the extent
that the aggregate amount of Notes (and such other Indebtedness) tendered pursuant to such an offer
is less than the Excess Proceeds, the Company may use any remaining Excess Proceeds for general
corporate purposes. If the aggregate principal amount of Notes (and such other Indebtedness)
surrendered by holders thereof exceeds the amount of Excess Proceeds, the Company shall allocate
the Excess Proceeds among the Notes and such other Indebtedness that have been surrendered for
purchase on a pro rata basis. Upon completion of each Asset Sale Offer, the amount of Excess
Proceeds will be reset at zero.

     The Company will comply with the requirements of Rule 14e-1 under the Exchange Act and any
other securities laws and regulations thereunder to the extent those laws and regulations are
applicable in connection with each repurchase of Notes pursuant to an Asset Sale Offer. To the
extent that the provisions of any securities laws or regulations conflict with Section 3.09 hereof
or this Section 4.08, the Company will comply with the applicable securities laws and regulations
and will not be deemed to have breached its obligations under Section 3.09 hereof or this Section
4.08, by virtue of such conflict.

Section 4.09. Transactions with Affiliates.

     The Company shall not, and shall not permit any of its Restricted Subsidiaries to, make any
payment to, or sell, lease, transfer or otherwise dispose of any of its properties or assets to, or
purchase any property or assets from, or enter into or make or amend any transaction, contract,
agreement, understanding, loan, advance or Guarantee with, or for the benefit of, any Affiliate
(each, an “Affiliate Transaction”), unless:

     (a) the Affiliate Transaction is on terms that are no less favorable to the Company or
the relevant Restricted Subsidiary than those that would have been obtained in a comparable
transaction by the Company or such Restricted Subsidiary with an unrelated Person; and

     (b) with respect to any Affiliate Transaction or series of related Affiliate
Transactions involving aggregate consideration in excess of $30.0 million, the Company
delivers to the Trustee a resolution of the Company’s Board of Directors set forth in an
Officers’ Certificate certifying that such Affiliate Transaction complies with this Section
4.09 and that such Affiliate Transaction has been approved by a majority of the
disinterested members of the Company’s Board of Directors, or an opinion as to the fairness
to the Holders of such Affiliate Transaction from a financial point of view issued by an
accounting, appraisal or investment banking firm of national standing in the United States.

     The following items will not be deemed to be Affiliate Transactions and, therefore, will not
be subject to the provisions of the prior paragraph:

61

 

     (a) directors’ fees, indemnification and similar arrangements, consulting fees,
employee salaries, bonuses or employment agreements, compensation, retirement, disability,
severance or employee benefit arrangements and incentive arrangements with, and loans and
advances to, any officer, director or employee in the ordinary course of business;

     (b) performance of all agreements in existence on the Issue Date and any modification
thereto or any transaction contemplated thereby in any replacement agreement therefor so
long as such modification or replacement is not materially more disadvantageous to the
Company or any of its Restricted Subsidiaries than the original agreement in effect on the
Issue Date;

     (c) transactions in connection with a financing transaction involving a sale or other
disposition of accounts receivable and related assets (including, without limitation, in
connection with a securitization or similar financing) or in connection with a financing
involving a subsidiary trust or similar financing vehicle that is permitted by Section 4.07
hereof;

     (d) transactions in the ordinary course of business with any joint venture that is
otherwise permitted by the Indenture; provided, that such joint venture is between or among
the
Company and/or any of its Subsidiaries on the one hand and third parties that are not
otherwise Affiliates of the Company on the other hand;

     (e) transactions between or among the Company and/or its Restricted Subsidiaries;

     (f) transactions with a Person (other than an Unrestricted Subsidiary) that is an
Affiliate of the Company solely because the Company or a Restricted Subsidiary owns an
Equity Interest in, or controls, such Person;

     (g) sales of Equity Interests (other than Disqualified Stock) to Affiliates of the
Company and the granting of registration and other customary rights in connection therewith;

     (h) Restricted Payments and Permitted Investments that are permitted by Section 4.05
hereof;

     (i) transactions complying with Section 5.01 hereof;

     (j) pledges of Equity Interests of Unrestricted Subsidiaries;

     (k) any transaction effected as part of a Qualified Securitization Financing; and

     (l) any transaction with an Insurance Subsidiary in the ordinary course of business.

Section 4.10. Liens.

     The Company will not, and will not permit any Restricted Subsidiary to, directly or
indirectly, issue, assume or guarantee any Indebtedness secured by any Lien (other than a Permitted
Lien) on any property or asset now owned or hereafter acquired by the Company or such Restricted
Subsidiary without making effective provision whereby any and all Notes then or thereafter
outstanding will be secured by a Lien equally and ratably with or prior to any and all other
obligations thereby secured for so long as any such obligations shall be so secured. Any Lien
created for the benefit of the Holders pursuant to the preceding sentence shall provide by its
terms that such Lien shall be automatically and unconditionally released and discharged upon the
release and discharge of the initial Lien.

62

 

Section 4.11. Offer to Repurchase Upon Change of Control.

     If a Change of Control occurs, unless the Company has exercised its right to redeem all of the
Notes pursuant to Section 3.07 hereof by giving notice of such redemption to the Holders, each
Holder of Notes will have the right to require the Company to repurchase all or any part (equal to
$1,000 or an integral multiple of $1,000 in excess thereof; provided, that the unrepurchased
portion of a Note must be in a minimum denomination of $2,000) of that Holder’s Notes (a “Change of
Control Offer”) on the terms set forth herein. In the Change of Control Offer, the Company will
offer an amount in cash equal to 101% of the aggregate principal amount of Notes repurchased plus
accrued and unpaid interest and Special Interest, if any, on the Notes repurchased, to (but not
including) the date of purchase (the “Change of Control Payment”). Within 30 days following any
Change of Control, the Company will mail a notice to each Holder stating the transaction or
transactions that constitute the Change of Control and offering to repurchase Notes on the date
specified in the notice (the “Change of Control Payment Date”), which date will be no earlier than
30 days and no later than 60 days from the date such notice is mailed, pursuant to the procedures
required hereby and described in such notice. The Company will comply with the requirements
of Rule 14e-1 under the Exchange Act, and any other securities laws and regulations thereunder
to the extent those laws and regulations are applicable in connection with the repurchase of the
Notes as a result of a Change of Control. To the extent that the provisions of any securities laws
or regulations conflict with the Change of Control provisions hereof, the Company will comply with
the applicable securities laws and regulations and will not be deemed to have breached its
obligations under this Section 4.11 by virtue of such conflict.

     On the Change of Control Payment Date, the Company will, to the extent lawful:

     (a) accept for payment all Notes or portions of Notes properly tendered pursuant to the
Change of Control Offer;

     (b) deposit with the Paying Agent an amount equal to the Change of Control Payment in
respect of all Notes or portions of Notes properly tendered; and

     (c) deliver or cause to be delivered to the Trustee the Notes properly accepted
together with an Officers’ Certificate stating the aggregate principal amount of Notes or
portions of Notes being purchased by the Company.

     The Paying Agent will promptly mail to each Holder of Notes properly tendered the Change of
Control Payment for such Notes, and the Trustee will promptly authenticate and mail (or cause to be
transferred by book-entry) to each Holder a new Note equal in principal amount to any unpurchased
portion of the Notes surrendered, if any; provided that each new Note will be in a principal amount
of $2,000 or an integral multiple of $1,000 in excess thereof.

     The Company will publicly announce the results of the Change of Control Offer on or as soon as
practicable after the Change of Control Payment Date.

     Notwithstanding anything to the contrary in this Section 4.11, the Company will not be
required to make a Change of Control Offer upon a Change of Control if a third party makes the
Change of Control Offer in the manner, at the times and otherwise in compliance with the
requirements set forth in this Section 4.11 and all other provisions of the Indenture applicable to
a Change of Control Offer made by the Company and purchases all Notes properly tendered and not
withdrawn under the Change of Control Offer. Any Change of Control Offer may be made in advance of
a Change in Control, and conditioned upon such Change of Control, if a definitive agreement is in
place for the Change of Control at the time of making the Change of Control Offer.

63

 

Section 4.12. Additional Subsidiary Guarantees.

     If the Company or any of its Restricted Subsidiaries acquires or creates another Domestic
Subsidiary after the Issue Date, then that newly acquired or created Domestic Subsidiary (other
than an Excluded Subsidiary) will become a Guarantor and execute a supplemental indenture in
substantially the form of Exhibit D hereto as promptly as possible after the end of the fiscal
quarter in which it was acquired or created.

Section 4.13. Designation of Restricted and Unrestricted Subsidiaries.

     The Board of Directors of the Company may designate any Restricted Subsidiary to be an
Unrestricted Subsidiary if that designation would not cause a Default. If a Restricted Subsidiary
is designated as an Unrestricted Subsidiary, the aggregate fair market value of all outstanding
Investments owned by the Company and its Restricted Subsidiaries in the Subsidiary so designated
will be deemed to be an Investment made as of the time of the designation and will reduce the
amount available for Restricted Payments under the first paragraph of Section 4.05 or Permitted
Investments, as determined by the Company. That designation will only be permitted if the
Investment would be permitted at that time and if the Restricted Subsidiary otherwise meets the
definition of an Unrestricted Subsidiary. The Board of Directors of the Company may re-designate
any Unrestricted Subsidiary to be a Restricted Subsidiary if the redesignation would not cause a
Default. As of the Issue Date, the Company’s Subsidiary Point of Life Indemnity, LTD is an
Unrestricted Subsidiary.

Section 4.14. Limitation on Sale and Leaseback Transactions.

     The Company will not, and will not permit any Restricted Subsidiary to, enter into any Sale
and Leaseback Transaction with respect to any property or asset unless the Company or the
Restricted Subsidiary would be entitled to:

     (1) incur Indebtedness in an amount equal to the Attributable Debt with respect to such
Sale and Leaseback Transaction pursuant to the covenant contained in Section 4.07 hereof;
and

     (2) create a Lien on such property securing such Attributable Debt pursuant to the
covenant contained in Section 4.10 hereof,

in which case, the corresponding Indebtedness and Lien will be deemed incurred pursuant to those
provisions.

Section 4.15. Suspension of Covenants.

     From and after the first date on which both (a) the Notes are rated Investment Grade by each
of Moody’s Investor Service, Inc. (“Moody’s”) and Standard & Poor’s Ratings Group (“S&P” and
together with Moody’s the “Rating Agencies”) and (b) there shall not exist a Default or Event of
Default hereunder (the occurrence of the events described in the foregoing clauses (a) and (b)
being collectively referred to as a “Covenant Suspension Event”), the Company and the Restricted
Subsidiaries will no longer be subject to Sections 4.05, 4.06, 4.07, 4.08, 4.09, 4.10, 4.12, 4.14
and clause (d) of the first paragraph of Section 5.01 hereof (collectively, the “Suspended
Covenants”); provided that, during the Suspension Period (as defined below), the Company and its
Restricted Subsidiaries will be subject to Section 4.16 hereof. Upon the occurrence of a Covenant
Suspension Event (the “Suspension Date”), the Subsidiary Guarantees of each of the Guarantors will
be automatically released.

64

 

     In the event that the Company and the Restricted Subsidiaries are not subject to the Suspended
Covenants for any period of time as a result of the foregoing, and on any subsequent date (the
“Reversion Date”) one or both of the Rating Agencies withdraw their Investment Grade rating or
downgrade the rating assigned to the Notes to below an Investment Grade rating then, following the
Reversion Date, the Company and the Restricted Subsidiaries will again be subject to the Suspended
Covenants and all required Subsidiary Guarantees will be reinstated and issued. Following the
Reversion Date, the Company and its Restricted Subsidiaries will not be subject to Section 4.16.

     The period of time between the Suspension Date and the Reversion Date is referred to as the
“Suspension Period.” Additionally, upon the occurrence of a Covenant Suspension Event, the amount
of Excess Proceeds from Net Proceeds shall be reset at zero. In the event of any such
reinstatement, no action taken or omitted to be taken by the Company or any of its Restricted
Subsidiaries prior to such reinstatement will give rise to a Default or Event of Default hereunder
with respect to Notes. Calculations made after the Reversion Date of the amount available to be
made as Restricted Payments under Section 4.05 will be made as though such covenant had been in
effect since the Issue Date and during the Suspension Period. For purposes of Section 4.07, all
Indebtedness incurred, or Disqualified Stock or Preferred Stock issued, during the Suspension
Period will be classified to have been incurred or issued pursuant to clause (b) of the second
paragraph of Section 4.07. For purposes of Section 4.10, on the Reversion Date, any Lien securing
Indebtedness, which Lien was permitted by Section 4.16 and did not require that a Lien be created
for the benefit of Holders pursuant to the requirements of Section 4.16, shall be deemed to have
been outstanding on the Issue Date so that it is classified as permitted under clause (5) of the
definition of “Permitted Lien.” For purposes of Section 4.06, on the Reversion Date, any
encumbrance or restriction on the ability of any Restricted Subsidiary described under clauses (a),
(b) or (c) of the first paragraph thereof created, otherwise caused or permitted to exist or become
effective during the Suspension Period shall be deemed to have been outstanding on the Issue Date,
so that it is classified as permitted under clause (a) of the second paragraph of Section 4.06. For
purposes of Section 4.09 hereof, on the Reversion Date, any Affiliate Transaction entered into or
permitted to exist during the Suspension Period shall be deemed to have been outstanding on the
Issue Date, so that it is classified as permitted under clause (b) of the second paragraph of such
covenant.

     In the event Moody’s or S&P is no longer in existence or issuing ratings, such organization
may be replaced by a nationally recognized statistical rating organization (as defined in the
Securities Act) designated by the Company with notice to the Trustee and the foregoing provisions
will apply to the rating issued by the replacement rating agency.

Section 4.16. Limitation on Secured Indebtedness.

     During any Suspension Period, the Company will not, and will not permit any Subsidiary that is
not an Excluded Subsidiary to, incur any Indebtedness secured by a Lien (other than a Permitted
Lien) on any Principal Property or on any share of stock or Indebtedness of a Subsidiary without
making effective provisions whereby the Company or such Restricted Subsidiary, as the case may be,
will secure the Notes equally and ratably with (or, if the Indebtedness to be secured by such Lien
is subordinated in right of payment to the Notes, prior to) the Indebtedness so secured until such
time as such Indebtedness is no longer secured by a Lien, unless the aggregate amount of all
Indebtedness secured by all such Liens (excluding any Permitted Lien) would not exceed 5% of Total
Assets. Any Lien created for the benefit of the Holders pursuant to the preceding sentence shall
provide by its terms that such Lien shall be automatically and unconditionally released and
discharged upon the release and discharge of the initial Lien. For purposes of this Section 4.16,
“Excluded Subsidiary” shall include, in addition to any Subsidiary included within the meaning
thereof, any Subsidiary that is an Unrestricted Subsidiary on the Suspension Date.

65

 

Section 4.17. Corporate Existence.

     Subject to Article 5 hereof, the Company shall do or cause to be done all things necessary to
preserve and keep in full force and effect (i) its corporate existence in accordance with the
organizational documents (as the same may be amended from time to time) of the Company and (ii) the
rights (charter and statutory), licenses and franchises of the Company; provided, however, that the
Company shall not be required to preserve any such right, license or franchise if the Board of
Directors of the Company shall determine that the preservation thereof is no longer desirable in
the conduct of the business of the Company and its Restricted Subsidiaries, taken as a whole.

Section 4.18. Stay, Extension and Usury Laws.

     The Company and each of the Guarantors covenants (to the extent that it may lawfully do so)
that it shall not at any time insist upon, plead, or in any manner whatsoever claim or take the
benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time
hereafter in force, that may affect the covenants or the performance of this Indenture; and the
Company and each of the Guarantors (to the extent that it may lawfully do so) hereby expressly
waives all benefit or advantage of any such law, and covenants that it shall not, by resort to any
such law, hinder, delay or impede the execution of any power herein granted to the Trustee, but
shall suffer and permit the execution of every such power as though no such law has been enacted.

ARTICLE 5.

SUCCESSORS

Section 5.01. Merger, Consolidation or Sale of Assets.

     The Company shall not, directly or indirectly: (1) consolidate or merge with or into another
Person (whether or not the Company is the surviving corporation); or (2) sell, assign, transfer,
convey or otherwise dispose of all or substantially all of the properties or assets of the Company
and its Restricted Subsidiaries taken as a whole, in one or more related transactions, to another
Person; unless:

     (a) either: (i) the Company is the surviving corporation; or (ii) the Person formed by
or surviving any such consolidation or merger (if other than the Company) or to which such
sale, assignment, transfer, conveyance or other disposition has been made is a Person
organized or existing under the laws of the United States, any state of the United States or
the District of Columbia;

     (b) the Person formed by or surviving any such consolidation or merger (if other than
the Company) or the Person to which such sale, assignment, transfer, conveyance or other
disposition has been made assumes all the obligations of the Company under the Notes and the
Indenture pursuant to a supplemental indenture in form reasonably satisfactory to the
Trustee;

     (c) immediately after such transaction, on a pro forma basis giving effect to such
transaction or series of transactions (and treating any obligation of the Company or any
Restricted Subsidiary incurred in connection with or as a result of such transaction or
series of transactions as having been incurred at the time of such transaction), no Default
or Event of Default exists; and

     (d) except in the case of a transaction entered into to reincorporate the Company in
another jurisdiction, the Company or the Person formed by or surviving any such
consolidation or merger (if other than the Company), or to which such sale, assignment,
transfer, conveyance or

66

 

other disposition has been made, will, on the date of such
transaction after giving pro forma effect thereto and any related financing transactions as
if the same had occurred at the beginning of the applicable four-quarter period, (i) be
permitted to incur at least $1.00 of additional Indebtedness pursuant to the Fixed Charge
Coverage Ratio test set forth in the first paragraph of Section 4.07 hereof or (ii) have a
Fixed Charge Coverage Ratio that is no worse than the Fixed Charge Coverage Ratio of the
Company for such applicable four-quarter period without giving pro forma effect to such
transactions and the related financing transactions.

     In addition, the Company may not, directly or indirectly, lease all or substantially all of
the properties or assets of the Company and its Restricted Subsidiaries, taken as a whole, in one
or more related transactions, to any other Person. This Section 5.01 will not apply to a sale,
assignment, transfer, conveyance or other disposition of assets between or among the Company and
any of the Guarantors.

Section 5.02. Successor Corporation Substituted.

     Upon any consolidation or merger, or any sale, assignment, transfer, conveyance, transfer or
other disposition of all or substantially all of the properties or assets of the Company and its
Restricted Subsidiaries, taken as a whole, in accordance with the provisions of Section 5.01
hereof, the successor Person formed by such consolidation or into which the Company is merged or to
which such sale, assignment, transfer, conveyance or other disposition is made, shall succeed to,
and be substituted for, and may exercise every right and power of, the Company under this Indenture
with the same effect as if such successor had been named as the Company therein. When a successor
assumes all the obligations of its predecessor under this Indenture and the Notes following a
consolidation or merger, or any sale, assignment, transfer, conveyance or other disposition of all
or substantially all of the assets of the predecessor in accordance with the foregoing provisions,
the predecessor shall be released from those obligations.

ARTICLE 6.

DEFAULTS AND REMEDIES

Section 6.01. Events of Default.

     An “Event of Default” occurs if:

     (a) the Company defaults in the payment when due of interest on the Notes and such
default continues for a period of 30 days;

     (b) the Company defaults in the payment when due of principal of or premium, if any, on
the Notes (including the failure to repurchase Notes pursuant to a Change of Control Offer
or Asset Sale Offer) when the same becomes due and payable at maturity, upon redemption
(including in connection with an offer to purchase) or otherwise;

     (c) the Company or any of its Restricted Subsidiaries fails to comply with any of the
provisions of Section 5.01 hereof;

     (d) the Company or any of its Restricted Subsidiaries fails to observe or perform any
other covenant or other agreement in the Indenture or the Notes for 60 days after notice to
the Company by the Trustee or the Holders of at least 25% aggregate principal amount of the
Notes then outstanding voting as a single class;

     (e) the Company or any of its Restricted Subsidiaries defaults under any mortgage,
indenture or instrument under which there may be issued or by which there may be secured or

67

 

evidenced any Indebtedness for money borrowed by the Company or any of its Restricted
Subsidiaries (or the payment of which is guaranteed by the Company or any of its Restricted
Subsidiaries) whether such Indebtedness or guarantee exists as of the Issue Date, or is
created after the Issue Date, if that default:

     (1) is caused by a failure to pay principal of such Indebtedness at its final
stated maturity after giving effect to any grace period provided in such
Indebtedness on the date of such default (a “Payment Default”); or

     (2) results in the acceleration of such Indebtedness prior to its express
maturity,

and, in each case, the principal amount of any such Indebtedness, together with the
principal amount of any other such Indebtedness under which there has been a Payment Default
or the maturity of which has been so accelerated, aggregates $25.0 million or more;

     (f) the Company or any of its Restricted Subsidiaries fail to pay final, non-appealable
judgments aggregating in excess of $25.0 million that are not covered by insurance or as to
which an insurer has not acknowledged coverage in writing, which judgments are not paid,
discharged or stayed for a period of 60 days;

     (g) the Company or any of its Restricted Subsidiaries that is a Significant Subsidiary
pursuant to or within the meaning of Bankruptcy Law:

     (1) commences a voluntary case,

     (2) consents to the entry of an order for relief against it in an involuntary
case,

     (3) consents to the appointment of a custodian of it or for all or
substantially all of its property,

     (4) makes a general assignment of the benefit of its creditors, or

     (5) generally is not paying its debts as they become due;

     (h) a court of competent jurisdiction enters an order or decree under any Bankruptcy
Law that:

     (1) is for relief against the Company or any of its Restricted Subsidiaries
that is a Significant Subsidiary in an involuntary case;

     (2) appoints a custodian of the Company or any of its Restricted Subsidiaries
or for all or substantially all of the property of the Company or any of its
Restricted Subsidiaries that is a Significant Subsidiary; or

     (3) orders the liquidation of the Company or any of its Restricted Subsidiaries
that is a Significant Subsidiary;

and the order or decree remains unstayed and in effect for 60 consecutive days; or

68

 

     (i) except as permitted by this Indenture, any Subsidiary Guarantee of a Significant
Subsidiary shall be held in any final, non-appealable judicial proceeding to be
unenforceable or invalid or shall cease for any reason to be in full force and effect or any
Guarantor that is a Significant Subsidiary, or any Person acting on behalf of any such
Guarantor, shall deny or disaffirm its obligations under its Subsidiary Guarantee.

     A Default under clause (d) is not an Event of Default in respect of the Notes until the
Trustee or the Holders of at least 25% in principal amount of the Notes then outstanding notify the
Company and the Trustee (in the case of a notice given by Holders) of the Default and the Company
does not cure such default within the time specified after receipt of such notice. Such notice
must specify the Default, demand that it be remedied and state that such notice is a “Notice of
Default.”

Section 6.02. Acceleration.

     If any Event of Default (other than an Event of Default specified in clause (g) or (h) of
Section 6.01 with respect to the Company) occurs and is continuing, the Trustee or the Holders of
at least 25% in principal amount of the then outstanding Notes may declare all the Notes to be due
and payable immediately. Upon any such declaration, the Notes shall become due and payable
immediately. Notwithstanding the foregoing, if an Event of Default specified in clause (g) or (h)
of Section 6.01 occurs with respect to the Company, all outstanding Notes shall be due and payable
immediately without further action or notice. The Holders of a majority in aggregate principal
amount of the then outstanding Notes by written notice to the Trustee may on behalf of all of the
Holders rescind an acceleration and its consequences if all existing Events of Default (except
nonpayment of principal, interest or premium that has become due solely because of the
acceleration) have been cured or waived.

Section 6.03. Other Remedies.

     If an Event of Default occurs and is continuing, the Trustee may pursue any available remedy
to collect the payment of principal, premium, if any, and interest and Special Interest, if any, on
the Notes or to enforce the performance of any provision of the Notes or this Indenture.

     The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not
produce any of them in the proceeding. A delay or omission by the Trustee or any Holder of a Note
in exercising any right or remedy accruing upon an Event of Default shall not impair the right or
remedy or constitute a waiver of or acquiescence in the Event of Default. All remedies are
cumulative to the extent permitted by law.

Section 6.04. Waiver of Past Defaults.

     Holders of not less than a majority in aggregate principal amount of the then outstanding
Notes by notice to the Trustee may on behalf of the Holders of all of the Notes waive an existing
Default or Event of Default and its consequences hereunder, except a continuing Default or Event of
Default in the payment of the principal of, premium, if any, or interest on, the Notes (including
in connection with an offer to purchase) (provided, however, that the Holders of a majority in
aggregate principal amount of the then outstanding Notes may rescind an acceleration and its
consequences, including any related payment default that resulted from such acceleration). Upon any
such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be
deemed to have been cured for every purpose of this Indenture; but no such waiver shall extend to
any subsequent or other Default or impair any right consequent thereon.

69

 

Section 6.05. Control by Majority.

     Holders of a majority in principal amount of the then outstanding Notes may direct the time,
method and place of conducting any proceeding for exercising any remedy available to the Trustee or
exercising any trust or power conferred on it. However, the Trustee may refuse to follow any
direction that conflicts with law or this Indenture, that the Trustee determines may be unduly
prejudicial to the rights of other Holders of Notes or that may involve the Trustee in personal
liability.

Section 6.06. Limitation on Suits.

     A Holder may pursue a remedy with respect to this Indenture or the Notes only if:

     (a) the Holder gives to the Trustee written notice of a continuing Event of Default;

     (b) the Holders of at least 25% in principal amount of the then outstanding Notes make
a written request to the Trustee to pursue the remedy;

     (c) the Holder of a Note or Holders of Notes offer and, if requested, provide to the
Trustee indemnity satisfactory to the Trustee against any loss, liability or expense;

     (d) the Trustee does not comply with the request within 60 days after receipt of the
request and the offer and, if requested, the provision of indemnity; and

     (e) during such 60-day period the Holders of a majority in principal amount of the then
outstanding Notes do not give the Trustee a direction inconsistent with the request.

     A Holder of any Note may not use this Indenture to prejudice the rights of another Holder or
to obtain a preference or priority over another Holder.

Section 6.07. Rights of Holders of Notes to Receive Payment.

     Notwithstanding any other provision of this Indenture, the Holder of any Note shall have the
right to receive payment of principal of, premium, if any, and interest and Special Interest, if
any, on such Note, on or after the respective due dates expressed or provided in such Note
(including in connection with an offer to purchase), or to bring suit for the enforcement of any
such payment on or after such respective dates and such right shall not be impaired or affected
without the consent of such Holder.

Section 6.08. Collection Suit by Trustee.

     If an Event of Default specified in Section 6.01(a) or (b) hereof occurs and is continuing,
the Trustee is authorized to recover judgment in its own name and as trustee of an express trust
against the Company for the whole amount of principal of, premium, if any, and interest and Special
Interest, if any, remaining unpaid on the Notes and interest on overdue principal and, to the
extent lawful, interest and such further amount as shall be sufficient to cover the costs and
expenses of collection, including the reasonable compensation, expenses, disbursements and advances
of the Trustee, its agents and counsel.

Section 6.09. Trustee May File Proofs of Claim.

     The Trustee is authorized to file such proofs of claim and other papers or documents as may be
necessary or advisable in order to have the claims of the Trustee (including any claim for the
reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel) and the Holders

70

 

of the Notes allowed in any judicial proceedings relative to the Company
(or any other obligor upon the Notes), its creditors or its property and shall be entitled and
empowered to collect, receive and distribute any money or other property payable or deliverable on
any such claims and any custodian in any such judicial proceeding is hereby authorized by each
Holder to make such payments to the Trustee, and in the event that the Trustee shall consent to the
making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the
reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel, and any other amounts due the Trustee under Section 7.07 hereof. To the extent that the
payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents
and counsel, and any other amounts due the Trustee under Section 7.07 hereof out of the estate in
any such proceeding, shall be denied for any reason, payment of the same shall be secured by a Lien
on, and shall be paid out of, any and all distributions, dividends, money, securities and other
properties that the Holders may be entitled to receive in such proceeding whether in liquidation or
under any plan of reorganization or arrangement or otherwise. Nothing herein contained shall be
deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of any
Holder any plan of reorganization, arrangement, adjustment or composition affecting the Notes or
the rights of any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder
in any such proceeding.

Section 6.10. Priorities.

     If the Trustee collects any money pursuant to this Article 6, it shall pay out the money in
the following order:

     First: to the Trustee, its agents and attorneys for amounts due under Section 7.07 hereof,
including payment of all compensation, expense and liabilities incurred, and all advances made,
by the Trustee and the costs and expenses of collection;

     Second: to Holders of Notes for amounts due and unpaid on the Notes for principal,
premium, if any, and interest and Special Interest, if any, ratably, without preference or
priority of any kind, according to the amounts due and payable on the Notes for principal,
premium, if any and interest and Special Interest, if any, respectively; and

     Third: to the Company or to such party as a court of competent jurisdiction shall direct.

     The Trustee may fix a record date and payment date for any payment to Holders of Notes
pursuant to this Section 6.10.

Section 6.11. Undertaking for Costs.

     In any suit for the enforcement of any right or remedy under this Indenture or in any suit
against the Trustee for any action taken or omitted by it as a Trustee, a court in its discretion
may require the filing by any party litigant in the suit of an undertaking to pay the costs of the
suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’
fees, against any party litigant in the suit, having due regard to the merits and good faith of the
claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the
Trustee, a suit by a Holder of a Note pursuant to Section 6.07 hereof, or a suit by Holders of more
than 10% in principal amount of the then outstanding Notes.

71

 

ARTICLE 7.

TRUSTEE

Section 7.01. Duties of Trustee.

     (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such of
the rights and powers vested in it by this Indenture, and use the same degree of care and skill in
its exercise, as a prudent person would exercise or use under the circumstances in the conduct of
such person’s own affairs.

     (b) Except during the continuance of an Event of Default with respect to Notes:

     (i) the duties of the Trustee shall be determined solely by the express provisions of
this Indenture and the Trustee need perform only those duties that are specifically set
forth in this Indenture and no others, and no implied covenants or obligations shall be read
into this Indenture against the Trustee; and

     (ii) in the absence of bad faith on its part, the Trustee may conclusively rely, as to
the truth of the statements and the correctness of the opinions expressed therein, upon
certificates or opinions furnished to the Trustee and conforming to the requirements of this
Indenture. However, the Trustee shall examine the certificates and opinions to determine
whether or not they conform to the requirements of this Indenture (but need not confirm or
investigate the accuracy of any mathematical calculations or other facts, statements,
opinions or conclusions stated therein).

     (c) The Trustee may not be relieved from liabilities for its own negligent action, its own
negligent failure to act, or its own willful misconduct, except that:

     (i) this paragraph does not limit the effect of paragraph (b) of this Section 7.01;

     (ii) the Trustee shall not be liable for any error of judgment made in good faith by a
Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the
pertinent facts; and

     (iii) the Trustee shall not be liable with respect to any action it takes or omits to
take in good faith in accordance with a direction received by it pursuant to Section 6.05
hereof.

     (iv) No provision of this Indenture shall require the Trustee to expend or risk its own
funds or incur any liability. The Trustee shall be under no obligation to exercise any of
its rights and powers under this Indenture at the request of any Holders, unless such Holder
shall have offered to the Trustee security and indemnity satisfactory to it against any
loss, liability or expense.

     (d) Whether or not therein expressly so provided, every provision of this Indenture that in
any way relates to the Trustee is subject to paragraphs (a), (b), and (c) of this Section 7.01.

     (e) The Trustee shall not be liable for interest on any money received by it except as the
Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be
segregated from other funds except to the extent required by law.

72

 

Section 7.02. Rights of Trustee.

     (a) The Trustee may conclusively rely upon any document believed by it to be genuine and to
have been signed or presented by the proper Person. The Trustee need not investigate any fact or
matter stated in the document.

     (b) Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate
or an Opinion of Counsel or both. The Trustee shall not be liable for any action it takes or omits
to take in good faith in reliance on such Officers’ Certificate or Opinion of Counsel. The Trustee
may consult with counsel and the written advice of such counsel or any Opinion of Counsel shall be
full and complete authorization and protection from liability in respect of any action taken,
suffered or omitted by it hereunder in good faith and in reliance thereon.

     (c) The Trustee may act through its attorneys and agents and shall not be responsible for the
misconduct or negligence of any agent appointed with due care.

     (d) The Trustee shall not be liable for any action it takes or omits to take in good faith
that it believes to be authorized or within the rights or powers conferred upon it by this
Indenture.

     (e) Unless otherwise specifically provided in this Indenture, any demand, request, direction
or notice from the Company or any Guarantor, if applicable, shall be sufficient if signed by an
Officer of the Company or Guarantor, as applicable.

     (f) The Trustee shall be under no obligation to exercise any of the rights or powers vested in
it by this Indenture at the request or direction of any of the Holders unless such Holders shall
have offered to the Trustee reasonable security or indemnity against the costs, expenses and
liabilities that might be incurred by it in compliance with such request or direction.

     (g) the Trustee may request that the Company deliver an Officers’ Certificate setting forth
the names of individuals and/or titles of officers authorized at such time to take specified
actions pursuant to this Indenture, which Officers’ Certificate may be signed by any person
authorized to sign an Officers’ Certificate, including any person specified as so authorized in any
such certificate previously delivered and not superseded.

     (h) In no event shall the Trustee be responsible or liable for special, indirect, or
consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit)
irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and
regardless of the form of action.

     (i) the Trustee shall not be bound to make any investigation into the facts or matters stated
in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction,
consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document,
but the Trustee, in its discretion, may make such further inquiry or investigation into such facts
or matters as it may see fit, and, if
the Trustee shall determine to make such further inquiry or investigation, it shall (subject
to applicable legal requirements) be entitled to examine, during normal business hours, the books,
records and premises of the Company or any Guarantor, personally or by agent or attorney.

     (j) the Trustee shall not be charged with knowledge of any Default or any Event of Default
unless either (i) a Responsible Officer of the Trustee shall have actual knowledge of such Default
or Event of Default or (ii) written notice of such Default or Event of Default shall have been
given to the Trustee by the Company or any other obligor on the Notes, or by any Holder of the
Notes.

73

 

     (k) the rights, privileges, protections, immunities and benefits given to the Trustee,
including, without limitation, its right to be indemnified, are extended to, and shall be
enforceable by, the Trustee in each of its capacities hereunder.

Section 7.03. Individual Rights of Trustee.

     The Trustee in its individual or any other capacity may become the owner or pledgee of Notes
and may otherwise deal with the Company or any Affiliate of the Company with the same rights it
would have if it were not Trustee. However, in the event that the Trustee acquires any conflicting
interest, it must eliminate such conflict within 90 days, apply to the SEC for permission to
continue as Trustee or resign. Any Agent may do the same with like rights and duties. The Trustee
is also subject to Sections 7.10 and 7.11 hereof.

Section 7.04. Trustee’s Disclaimer.

     The Trustee shall not be responsible for and makes no representation as to the validity or
adequacy of this Indenture or the Notes, it shall not be accountable for the Company’s use of the
proceeds from the Notes or any money paid to the Company or upon the Company’s direction under any
provision of this Indenture, it shall not be responsible for the use or application of any money
received by any Paying Agent other than the Trustee, and it shall not be responsible for any
statement or recital herein or any statement in the Notes or any other document in connection with
the sale of the Notes or pursuant to this Indenture other than its certificate of authentication.

Section 7.05. Notice of Defaults.

     If a Default or Event of Default occurs and is continuing and if it is known to the Trustee,
the Trustee shall mail to Holders of Notes a notice of the Default or Event of Default within 90
days after it occurs. Except in the case of a Default or Event of Default in payment of principal
of, premium, if any, or interest or Special Interest, if any, on any Note, the Trustee may withhold
the notice if and so long as a committee of its Responsible Officers in good faith determines that
withholding the notice is in the interests of the Holders of the Notes.

Section 7.06. Reports by Trustee to Holders of the Notes.

     Within 60 days after each July 15 beginning with the July 15 following the date of this
Indenture, and for so long as Notes remain outstanding, the Trustee shall mail to the Holders of
the Notes a brief report dated as of such reporting date that complies with TIA §313(a) (but if no
event described in TIA §313(a) has occurred within the twelve months preceding the reporting date,
no report need be transmitted). The Trustee also shall comply with TIA §313(b)(2). The Trustee also
shall transmit by mail all reports as required by TIA § 313(c).

     A copy of each report at the time of its mailing to the Holders of Notes shall be mailed to
the Company and filed with the SEC and each stock exchange on which the Notes are listed in
accordance with TIA § 313(d). The Company shall promptly notify the Trustee when the Notes are
listed on any stock exchange.

Section 7.07. Compensation and Indemnity.

     The Company shall pay to the Trustee from time to time reasonable compensation for its
acceptance of this Indenture and services hereunder. The Trustee’s compensation shall not be
limited by any law on compensation of a trustee of an express trust. The Company shall reimburse
the Trustee promptly upon request for all reasonable disbursements, advances and expenses incurred
or made by it in addition to the

74

 

compensation for its services. Such expenses shall include the
reasonable compensation, disbursements and expenses of the Trustee’s agents and counsel.

     The Company shall indemnify the Trustee against any and all losses, liabilities or expenses
incurred by it arising out of or in connection with the acceptance or administration of its duties
under this Indenture, including the costs and expenses of enforcing this Indenture against the
Company (including this Section 7.07) and defending itself against any claim (whether asserted by
the Company or any Holder or any other person) or liability in connection with the exercise or
performance of any of its powers or duties hereunder, except to the extent any such loss, liability
or expense may be attributable to its negligence or willful misconduct. The Trustee shall notify
the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so
notify the Company shall not relieve the Company of its obligations hereunder. The Company shall
defend the claim and the Trustee shall cooperate in the defense. The Trustee may have separate
counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company
need not pay for any settlement made without its consent, which consent shall not be unreasonably
withheld.

     The obligations of the Company under this Section 7.07 shall survive the satisfaction and
discharge of this Indenture and the resignation or removal of the Trustee.

     To secure the Company’s payment obligations in this Section 7.07, the Trustee shall have a
Lien prior to the Notes on all money or property held or collected by the Trustee, except that held
in trust to pay principal and interest on particular Notes. Such Lien shall survive the
satisfaction and discharge of this Indenture.

     Without prejudice to any other rights available to the Trustee under applicable law, when the
Trustee incurs expenses or renders services after an Event of Default specified in Section 6.01(g)
or (h) hereof occurs, the expenses and the compensation for the services (including the fees and
expenses of its agents and counsel) are intended to constitute expenses of administration under any
Bankruptcy Law.

Section 7.08. Replacement of Trustee.

     A resignation or removal of the Trustee and appointment of a successor Trustee shall become
effective only upon the successor Trustee’s acceptance of appointment as provided in this Section
7.08.

     The Trustee may resign in writing at any time and be discharged from the trust hereby created
by so notifying the Company. The Holders of a majority in principal amount of the then outstanding
Notes may remove the Trustee by so notifying the Trustee and the Company in writing. The Company
may remove the Trustee if:

     (a) the Trustee fails to comply with Section 7.10 hereof;

     (b) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with
respect to the Trustee under any Bankruptcy Law;

     (c) a custodian or public officer takes charge of the Trustee or its property; or

     (d) the Trustee becomes incapable of acting.

     If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any
reason, the Company shall promptly appoint a successor Trustee.
Within one year after the successor Trustee takes

75

 

office, the Holders of a majority in principal amount of the then outstanding Notes
may appoint a successor Trustee to replace the successor Trustee appointed by the Company.

     If a successor Trustee does not take office within 60 days after the retiring Trustee resigns
or is removed, the retiring Trustee, the Company, or the Holders of at least 10% in principal
amount of the then outstanding Notes may petition any court of competent jurisdiction for the
appointment of a successor Trustee.

     If the Trustee, after written request by any Holder who has been a Holder for at least six
months, fails to comply with Section 7.10 hereof, such Holder may petition any court of competent
jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.

     A successor Trustee shall deliver a written acceptance of its appointment to the retiring
Trustee and to the Company. Thereupon, the resignation or removal of the retiring Trustee shall
become effective, and the successor Trustee shall have all the rights, powers and duties of the
Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to
Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the
successor Trustee, provided all sums owing to the Trustee hereunder have been paid and subject to
the Lien provided for in Section 7.07 hereof. Notwithstanding replacement of the Trustee pursuant
to this Section 7.08, the Company’s obligations under Section 7.07 hereof shall continue for the
benefit of the retiring Trustee.

Section 7.09. Successor Trustee by Merger, etc.

     If the Trustee consolidates, merges or converts into, or transfers all or substantially all of
its corporate trust business to, another corporation, the successor corporation without any further
act shall be the successor Trustee.

Section 7.10. Eligibility; Disqualification.

     There shall at all times be a Trustee hereunder that is a corporation organized and doing
business under the laws of the United States of America or of any state thereof that is authorized
under such laws to exercise corporate trustee power, that is subject to supervision or examination
by federal or state authorities and that has a combined capital and surplus of at least $100
million as set forth in its most recent published annual report of condition.

     This Indenture shall always have a Trustee who satisfies the requirements of TIA §310(a)(1),
(2) and (5). The Trustee is subject to TIA § 310(b).

Section 7.11. Preferential Collection of Claims Against Company.

     The Trustee is subject to TIA §311(a), excluding any creditor relationship listed in TIA
§311(b). A Trustee who has resigned or been removed shall be subject to TIA §311(a) to the extent
indicated therein.

ARTICLE 8.

LEGAL DEFEASANCE AND COVENANT DEFEASANCE

Section 8.01. Option to Effect Legal Defeasance or Covenant Defeasance.

     The Company may elect, at its option, at any time, to have either Section 8.02 or 8.03 hereof
be applied to all outstanding Notes and Subsidiary Guarantees (the “Defeased Securities”) upon
compliance

76

 

with the conditions set forth below in this Article 8. Any such election shall be
evidenced by a Board Resolution set forth in an Officers’ Certificate.

Section 8.02. Legal Defeasance and Discharge.

     Upon the Company’s exercise under Section 8.01 hereof of the option to have this Section 8.02
applied to the Notes, the Company and each of the Guarantors shall, subject to the satisfaction of
the conditions set forth in Section 8.04 hereof, be deemed to have been discharged from its
obligations with respect to all outstanding Defeased Securities on the date the conditions set
forth below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, Legal Defeasance
means that the Company and the Guarantors shall be deemed to have paid and discharged the entire
Indebtedness represented by the outstanding Defeased Securities, which shall thereafter be deemed
to be “outstanding” only for the purposes of Section 8.05 hereof and the other Sections of this
Indenture referred to in (a) and (b) below, and to have satisfied all its other obligations under
such Defeased Securities and this Indenture (and the Trustee, on demand of and at the expense of
the Company, shall execute proper instruments acknowledging the same), except for the following
provisions which shall survive until otherwise terminated or discharged hereunder: (a) the rights
of Holders of outstanding Defeased Securities to receive solely from the trust fund under Section
8.04 hereof, and as more fully set forth in such Section, payments in respect of the principal of,
premium, if any, and interest and Special Interest, if any, on such Defeased Securities when such
payments are due, (b) the Company’s obligations with respect to such Defeased Securities under
Article 2 and Section 4.02 hereof, (c) the rights, powers, trusts, duties and immunities of the
Trustee hereunder and the Company’s and the Guarantors’ obligations in connection therewith and (d)
this Article 8. Subject to compliance with this Article 8, the Company may exercise its option
under this Section 8.02 notwithstanding the prior exercise of its option under Section 8.03 hereof.

Section 8.03. Covenant Defeasance.

     Upon the Company’s exercise under Section 8.01 hereof of the option to have this Section 8.03
applied to the Notes, the Company and each Guarantor shall, subject to the satisfaction of the
conditions set forth in Section 8.04 hereof, be released from its obligations under Sections 3.09,
4.03 (other than pursuant to TIA §314(a)), 4.05, 4.06, 4.07, 4.08, 4.09, 4.10, 4.11, 4.12, 4.13,
4.14, 4.16, 4.18 and 5.01(d) hereof and Article 10 hereof with respect to the Notes and with
respect to the outstanding Defeased Securities on and after the date the conditions set forth in
Section 8.04 hereof are satisfied (hereinafter, “Covenant Defeasance”), and the Defeased Securities
shall thereafter be deemed not “outstanding” for the purposes of any direction, waiver, consent or
declaration or act of Holders of such Defeased Securities (and the consequences of any thereof) in
connection with such covenants, but shall continue to be deemed “outstanding” for all other
purposes hereunder (it being understood that such Defeased Securities shall not
be deemed outstanding for accounting purposes). For this purpose, Covenant Defeasance means
that, with respect to the outstanding Defeased Securities, the Company and each Guarantor may omit
to comply with and shall have no liability in respect of any term, condition or limitation set
forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere
herein to any such covenant or by reason of any reference in any such covenant to any other
provision herein or in any other document and such omission to comply shall not constitute a
Default or an Event of Default under Section 6.01 hereof, but, except as specified above, the
remainder of this Indenture and such Defeased Securities shall be unaffected thereby. In addition,
upon the Company’s exercise under Section 8.01 hereof of the option applicable to this Section 8.03
hereof, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, Sections
6.01(c), (d) (solely with respect to those covenants subject to Covenant Defeasance), (e), (f) and
(i) hereof shall not constitute Events of Default.

77

 

Section 8.04. Conditions to Legal or Covenant Defeasance.

     The following shall be the conditions to the application of either Section 8.02 or 8.03 hereof
to the Notes:

     In order to exercise either Legal Defeasance or Covenant Defeasance:

     (a) the Company must irrevocably deposit with the Trustee, in trust, for the benefit of
the Holders, cash in U.S. dollars sufficient, non-callable Government Securities, the
scheduled payments of principal of and interest on which will be sufficient, or a
combination of cash in U.S. dollars and non-callable Government Securities, the scheduled
payments of principal of and interest on which together with such cash be sufficient, in the
opinion of a nationally recognized firm of independent public accountants, without
consideration of any reinvestment of interest, to pay the principal of, premium, if any, and
interest and Special Interest, if any, on the outstanding Notes to the stated maturity or
the applicable redemption date, as the case may be, and the Company shall have specified
whether the Notes are being defeased to maturity or to a particular redemption date;

     (b) in the case of an election under Section 8.02 hereof, the Company shall have
delivered to the Trustee an Opinion of Counsel in form reasonably satisfactory to the
Trustee confirming that (A) the Company has received from, or there has been published by,
the Internal Revenue Service a ruling or (B) since the Issue Date, there has been a change
in the applicable federal income tax law, in either case to the effect that, and based
thereon such Opinion of Counsel shall confirm that, the Holders of the outstanding Notes
will not recognize income, gain or loss for federal income tax purposes as a result of such
Legal Defeasance and will be subject to federal income tax on the same amounts, in the same
manner and at the same times as would have been the case if such Legal Defeasance had not
occurred;

     (c) in the case of an election under Section 8.03 hereof, the Company shall have
delivered to the Trustee an Opinion of Counsel in form reasonably acceptable to the Trustee
confirming that the Holders of the outstanding Notes will not recognize income, gain or loss
for federal income tax purposes as a result of such Covenant Defeasance and will be subject
to federal income tax on the same amounts, in the same manner and at the same times as would
have been the case if such Covenant Defeasance had not occurred;

     (d) no Default or Event of Default has occurred and is continuing on the date of such
deposit (other than a Default or Event of Default resulting from the borrowing of funds to
be applied to such deposit and the grant of any Lien securing such borrowing);

     (e) such Legal Defeasance or Covenant Defeasance will not result in a breach or
violation of, or constitute a default under any material agreement or instrument (other than
the Indenture and the agreements governing any other Indebtedness being defeased, discharged
or replaced) to which the Company or any of its Subsidiaries is a party or by which the
Company or any of its Subsidiaries is bound;

     (f) the Company must deliver to the Trustee an Officers’ Certificate stating that the
deposit was not made by the Company with the intent of preferring the Holders of Notes over
the other creditors of the Company with the intent of defeating, hindering, delaying or
defrauding creditors of the Company or others; and

78

 

     (g) the Company must deliver to the Trustee an Officers’ Certificate and an Opinion of
Counsel, each stating that all conditions precedent relating to the Legal Defeasance or the
Covenant Defeasance have been complied with or waived.

     Notwithstanding the foregoing, the Opinion of Counsel with respect to a Legal Defeasance
required by clause (b) of this Section 8.04 need not be delivered if all Notes not theretofore
delivered to the Trustee for cancellation (i) have become due and payable or (ii) will become due
and payable on the maturity date or on a Redemption Date within one year (in the case of a
redemption) under arrangements satisfactory to the Trustee for the giving of notice of redemption
by the Trustee in the name, and at the expense, of the Company.

Section 8.05. Deposited Money and Government Securities to be Held in Trust; Other Miscellaneous
Provisions.

     Subject to Section 8.06 hereof, all money and non-callable Government Securities (including
the proceeds thereof) deposited with the Trustee pursuant to Section 8.04 hereof in respect of the
outstanding Defeased Securities shall be held in trust and applied by the Trustee, in accordance
with the provisions of such Defeased Securities and this Indenture, to the payment, either directly
or through any Paying Agent (including the Company acting as Paying Agent) as the Trustee may
determine, to the Holders of such Defeased Securities of all sums due and to become due thereon in
respect of principal, premium, if any, and interest, but such money need not be segregated from
other funds except to the extent required by law.

     The Company shall pay and indemnify the Trustee against any tax, fee or other charge imposed
on or assessed against the cash or non-callable Government Securities deposited pursuant to Section
8.04 hereof or the principal and interest received in respect thereof other than any such tax, fee
or other charge which by law is for the account of the Holders of the outstanding Defeased
Securities.

     Anything in this Article 8 to the contrary notwithstanding, the Trustee shall deliver or pay
to the Company from time to time upon the request of the Company any money or non-callable
Government Securities held by it as provided in Section 8.04 hereof which in the opinion of a
nationally recognized firm of independent public accountants expressed in a written certification
thereof delivered to the Trustee (in case Government Securities have been deposited) are in excess
of the amount thereof that would then be required to be deposited to effect an equivalent Legal
Defeasance or Covenant Defeasance.

Section 8.06. Repayment to Company.

     Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in
trust for the payment of the principal of, premium, if any, or interest or Special Interest, if
any, on any Note and
remaining unclaimed for two years after such principal, and premium, if any, or interest or
Special Interest, if any, has become due and payable shall be paid to the Company on its request or
(if then held by the Company) shall be discharged from such trust; and the Holder of such Note
shall thereafter look only to the Company for payment thereof, and all liability of the Trustee or
such Paying Agent with respect to such trust money, and all liability of the Company as trustee
thereof, shall thereupon cease; provided, however, that the Trustee or such Paying Agent, before
being required to make any such repayment, may at the expense of the Company cause to be published
once, in The New York Times and The Wall Street Journal (national edition), notice that such money
remains unclaimed and that, after a date specified therein, which shall not be less than 30 days
from the date of such notification or publication, any unclaimed balance of such money then
remaining will be repaid to the Company.

79

 

	Section 8.07. Reinstatement.

     If the Trustee or Paying Agent is unable to apply any cash or non-callable Government
Securities in accordance with Section 8.02 or 8.03 hereof, as the case may be, by reason of any
order or judgment of any court or governmental authority enjoining, restraining or otherwise
prohibiting such application, then the Company’s and the Guarantors’ obligations under this
Indenture and the Defeased Securities shall be revived and reinstated as though no deposit had
occurred pursuant to Section 8.02 or 8.03 hereof until such time as the Trustee or Paying Agent is
permitted to apply all such money in accordance with Section 8.02 or 8.03 hereof, as the case may
be; provided, however, that, if the Company makes any payment of principal of, premium, if any, or
interest or Special Interest, if any, on any Defeased Securities following the reinstatement of its
obligations, the Company shall be subrogated to the rights of the Holders of such Defeased
Securities to receive such payment from the money held by the Trustee or Paying Agent.

ARTICLE 9.

AMENDMENT, SUPPLEMENT AND WAIVER

	Section 9.01. Without Consent of Holders of Notes.

     Notwithstanding Section 9.02 hereof, the Company, the Guarantors, if applicable, and the
Trustee at any time and from time to time may amend this Indenture or the Notes or enter into one
or more indentures supplemental hereto without the consent of any Holder of a Note for any of the
following purposes:

     (a) to cure any ambiguity, defect or inconsistency;

     (b) to provide for uncertificated Notes in addition to or in place of certificated
notes;

     (c) to provide for the assumption of the Company’s or a Guarantor’s obligations to
Holders of Notes in the case of a merger or consolidation or sale of all or substantially
all of the Company’s or a Guarantor’s assets;

     (d) to make any change that would provide any additional rights or benefits to the
Holders of Notes or that does not adversely affect the legal rights under the Indenture of
any such Holder;

     (e) to comply with requirements of the SEC in order to effect or maintain the
qualification of the Indenture under the TIA;

     (f) to allow any Guarantor to execute a supplemental indenture and/or a Subsidiary
Guarantee with respect to the Notes under Section 4.12;

     (g) to evidence and provide the acceptance of the appointment of a successor trustee
under the Indenture;

     (h) to mortgage, pledge, hypothecate or grant a security interest in favor of the
Trustee for the benefit of the Holders of Notes as additional security for the payment and
performance of the Company’s or a Guarantor’s obligations;

     (i) to release a Guarantor from its Subsidiary Guarantee pursuant to the terms of the
Indenture when permitted or required pursuant to the terms of this Indenture; or

     (j) to conform the text of this Indenture, the Notes or the Subsidiary Guarantees to
any provision of the “Description of Notes” contained in the Offering Memorandum dated
September

80

 

20, 2010 to the extent that such provision in the “Description of Notes” was intended
to be a substantially verbatim recitation of a provision of this Indenture, the Notes or the
Subsidiary Guarantees.

Section 9.02. With Consent of Holders of Notes.

     Except as provided below in this Section 9.02, the Company, the Guarantors and the Trustee may
amend this Indenture (including Sections 3.09, 4.08 and 4.11 hereof) or the Notes with the consent
of the Holders of at least a majority in principal amount of the Notes then outstanding (including,
without limitation, consents obtained in connection with a purchase of, or tender offer or exchange
offer for, Notes), and, subject to Sections 6.04 and 6.07 hereof, any existing Default or Event of
Default (other than a Default or Event of Default in the payment of the principal of, premium, if
any, or interest or Special Interest, if any, on such Notes, except a payment default resulting
from an acceleration that has been rescinded) or compliance with any provision of this Indenture or
the Notes may be waived with the consent of the Holders of a majority in principal amount of the
then outstanding Notes voting as a single class (including, without limitation, consents obtained
in connection with a purchase of, or tender offer or exchange offer for, Notes).

     Upon the request of the Company accompanied by a Board Resolution authorizing the execution of
any such amended or supplemental indenture, and upon the filing with the Trustee of evidence
satisfactory to the Trustee of the consent of the Holders of Notes as aforesaid, and upon receipt
by the Trustee of the documents described in Sections 7.02, 12.04 and 12.05 hereof, the Trustee
shall join with the Company and the Guarantors in the execution of such amended or supplemental
indenture unless such amended or supplemental indenture adversely affects the Trustee’s own rights,
duties or immunities under this Indenture or otherwise, in which case the Trustee may in its
discretion, but shall not be obligated to, enter into such amended or supplemental Indenture.

     It shall not be necessary for the consent of the Holders of Notes under this Section 9.02 to
approve the particular form of any proposed amendment or waiver, but it shall be sufficient if such
consent approves the substance thereof.

     After an amendment, supplement or waiver under this Section 9.02 becomes effective, the
Company shall mail to the Holders of Notes affected thereby a notice briefly describing the
amendment, supplement or waiver. Any failure of the Company to mail such notice, or any defect
therein, shall not, however, in any way impair or affect the validity of any such amended or
supplemental indenture or waiver. Subject to Sections 6.04 and 6.07 hereof and except as otherwise
provided below in this Section 9.02, the Holders of a majority in aggregate principal amount of the
Notes then outstanding may waive compliance in a particular instance by the Company with any
provision of this Indenture or the Notes. However, without the consent of each Holder affected, an
amendment or waiver under this Section 9.02 may not (with respect to any Notes held by a
non-consenting Holder):

     (a) reduce the principal amount of Notes whose Holders must consent to an amendment,
supplement or waiver;

     (b) reduce the principal of or change the fixed maturity of any Note or alter any of
the provisions with respect to the redemption of the Notes except as provided above with
respect to Sections 3.09, 4.09 and 4.11 hereof and other than notice provisions with respect
to any optional redemption by the Company;

     (c) reduce the rate of or change the time for payment of interest on any Note;

81

 

     (d) waive a Default or Event of Default in the payment of principal of, or interest or
premium on the Notes (except a rescission of acceleration of the Notes by the Holders of at
least a majority in aggregate principal amount of the Notes and a waiver of the payment
default that resulted from such acceleration);

     (e) make any Note payable in money other than that stated in the Notes;

     (f) make any change in the provisions of this Indenture relating to waivers of past
Defaults or the rights of Holders of Notes to receive payments of principal of, or interest
or premium on, the Notes;

     (g) after the date of an event giving rise to a redemption, waive a redemption payment
with respect to any Note (other than a payment required by Sections 3.09, 4.08 or 4.11
hereof);

     (h) release any Guarantor from any of its obligations under its Subsidiary Guarantee or
this Indenture, except in accordance with the terms of this Indenture; or

     (i) make any change in the preceding amendment and waiver provisions.

Section 9.03. Compliance with Trust Indenture Act.

     Every amendment or supplement to this Indenture or the Notes shall be set forth in an amended
or supplemental indenture that complies with the TIA as then in effect.

Section 9.04. Revocation and Effect of Consents.

     Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a
Note is a continuing consent by the Holder of a Note and every subsequent Holder of a Note or
portion of a Note that evidences the same debt as the consenting Holder’s Note, even if notation of
the consent is not made on any Note. However, any such Holder of a Note or subsequent Holder of a
Note may revoke the consent as to its Notes if the Trustee receives written notice of revocation
before the date the waiver, supplement or amendment becomes effective. An amendment, supplement or
waiver becomes effective in accordance with its terms and thereafter binds every Holder.

Section 9.05. Notation on or Exchange of Notes.

     The Trustee may place an appropriate notation about an amendment, supplement or waiver on any
Note thereafter authenticated. The Company in exchange for all Notes may issue and the Trustee
shall, upon receipt of a Company Order, authenticate new Notes that reflect the amendment,
supplement or waiver. Failure to make the appropriate notation or issue a new Note shall not affect
the validity and effect of such amendment, supplement or waiver.

Section 9.06. Trustee to Sign Amendments, etc.

     The Trustee shall sign any amended or supplemental indenture authorized pursuant to this
Article 9 if the amendment or supplement does not adversely affect the rights, duties, liabilities
or immunities of the Trustee. The Company may not sign an amendment or supplemental Indenture until
the Board of Directors approves it. In executing any amended or supplemental indenture, the Trustee
shall be entitled to receive and (subject to Section 7.01 hereof) shall be fully protected in
relying upon, in addition to the documents

82

 

required by Sections 12.04 and 12.05 hereof, an Officers’ Certificate and an Opinion of
Counsel stating that the execution of such amended or supplemental indenture is authorized or
permitted by this Indenture.

Section 9.07. Effect of Supplemental Indentures.

     Upon the execution of any supplemental indenture under this Article 9, this Indenture shall be
modified in accordance therewith, and such supplemental indenture shall form a part of this
Indenture for all purposes; and every Holder of Notes theretofore or thereafter authenticated and
delivered hereunder shall be bound thereby, except to the extent otherwise set forth thereon.

ARTICLE 10.

GUARANTEES

Section 10.01. Guarantee.

     Subject to this Article 10, each of the Guarantors hereby, jointly and severally,
unconditionally guarantees to each Holder of Notes and to the Trustee and its successors and
assigns, irrespective of the validity and enforceability of this Indenture, the Notes or the
obligations of the Company hereunder or thereunder, that: (a) the principal of, premium, if any,
and interest on the Notes will be promptly paid in full when due, whether at maturity, by
acceleration, redemption or otherwise, and interest on the overdue principal of and premium, if
any, and interest on the Notes, if any, if lawful, and all other obligations of the Company to the
Holders or the Trustee hereunder or thereunder will be promptly paid in full or performed, all in
accordance with the terms hereof and thereof; and (b) in case of any extension of time of payment
or renewal of any Notes or any of such other obligations, that same will be promptly paid in full
when due or performed in accordance with the terms of the extension or renewal, whether at stated
maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any
performance so guaranteed for whatever reason, the Guarantors shall be jointly and severally
obligated to pay the same immediately. Each Guarantor agrees that this is a guarantee of payment
and not a guarantee of collection.

     Subject to this Article 10, the Guarantors hereby, jointly and severally, agree that their
obligations hereunder shall be unconditional, irrespective of the validity, regularity or
enforceability of the Notes or this Indenture, the absence of any action to enforce the same, any
waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the
recovery of any judgment against the Company, any action to enforce the same or any other
circumstance which might otherwise constitute a legal or equitable discharge or defense of a
guarantor. Each Guarantor hereby waives diligence, presentment, demand of payment, filing of claims
with a court in the event of insolvency or bankruptcy of the Company, any right to require a
proceeding first against the Company, protest, notice and all demands whatsoever and covenants that
this Subsidiary Guarantee shall not be discharged except by complete performance of the obligations
contained in the Notes and this Indenture.

     If any Holder or the Trustee is required by any court or otherwise to return to the Company,
the Guarantors or any custodian, trustee, liquidator or other similar official acting in relation
to either the Company or the Guarantors, any amount paid by either to the Trustee or such Holder,
this Subsidiary Guarantee, to the extent theretofore discharged, shall be reinstated in full force
and effect.

     Each Guarantor agrees that it shall not be entitled to any right of subrogation in relation to
the Holders in respect of any obligations guaranteed hereby until payment in full of all
obligations guaranteed hereby. Each Guarantor further agrees that, as between the Guarantors, on
the one hand, and the Holders and the Trustee, on the other hand, (x) the maturity of the
obligations guaranteed hereby may be accelerated as provided in Article 6 hereof for the purposes
of this Subsidiary Guarantee, notwithstanding any stay, injunction or other prohibition preventing
such acceleration in respect of the obligations guaranteed hereby,

83

 

and (y) in the event of any declaration of acceleration of such obligations as provided in
Article 6 hereof, such obligations (whether or not due and payable) shall forthwith become due and
payable by the Guarantors for the purpose of this Guarantee. The Guarantors shall have the right to
seek contribution from any non-paying Guarantor so long as the exercise of such right does not
impair the rights of the Holders under the Subsidiary Guarantee.

     Each Guarantor agrees that the Subsidiary Guarantees shall remain in full force and effect
notwithstanding any failure to endorse on each Note a notation of such Subsidiary Guarantee.

Section 10.02. Subsidiary Guarantors May Consolidate, etc. on Certain Terms.

     A Guarantor may not sell or otherwise dispose of all or substantially all of its assets to, or
consolidate with or merge with or into (whether or not such Guarantor is the surviving Person),
another Person, other than the Company or another Guarantor, unless:

     (a) immediately after giving effect to that transaction, no Default or Event of Default
exists; and

     (b) subject to the provisions of Section 10.04 hereof, the Person acquiring the
property in any such sale or disposition or the Person formed by or surviving any such
consolidation or merger assumes all the obligations of that Guarantor under the Indenture
and its Subsidiary Guarantee pursuant to a supplemental indenture in form satisfactory to
the Trustee.

     In case of any such consolidation, merger, sale or conveyance and, subject to the provisions
of Section 10.04 hereof, upon the assumption by the successor Person, by supplemental indenture,
executed and delivered to the Trustee and satisfactory in form to the Trustee, of the Subsidiary
Guarantee and the due and punctual performance of all of the covenants and conditions of the
Indenture to be performed by the Guarantor, such successor Person shall succeed to and be
substituted for the Guarantor with the same effect as if it had been named herein as a Guarantor.
All the Subsidiary Guarantees so issued shall in all respects have the same legal rank and benefit
under the Indenture as the Subsidiary Guarantees theretofore and thereafter issued in accordance
with the terms of this Indenture as though all of such Subsidiary Guarantees had been issued at the
date of the execution of this Indenture.

     Except as set forth in Articles 4 and 5 of this Indenture, and notwithstanding clauses (a) and
(b) above, nothing contained in the Indenture or in any of the Notes shall prevent any
consolidation or merger of a Guarantor with or into the Company or another Guarantor, or shall
prevent any sale or conveyance of the property of a Guarantor as an entirety or substantially as an
entirety to the Company or another Guarantor.

Section 10.03. Limitation on Guarantor Liability.

     Each Guarantor, and by its acceptance of Notes, each Holder, hereby confirms that it is the
intention of all such parties that the Subsidiary Guarantee of such Guarantor not constitute a
fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance
Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent
applicable to any Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and
the Guarantors hereby irrevocably agree that the obligations of such Guarantor shall be limited to
the maximum amount as will, after giving effect to all other contingent and fixed liabilities of
such Guarantor that are relevant under such laws, and after giving effect to any collections from,
rights to receive contribution from or payments made by or on behalf of any other Guarantor in
respect of the obligations of such other Guarantor under this Article 10, result in the

84

 

obligations of such Guarantor under its Subsidiary Guarantee not constituting a fraudulent
transfer or conveyance.

Section 10.04. Releases.

     The Subsidiary Guarantee of a Guarantor will be released, and any Person acquiring assets
(including by way of merger or consolidation) or Capital Stock of a Guarantor shall not be required
to assume the obligations of any such Guarantor:

          (a) in connection with any sale or other disposition of all or substantially all of the
assets of that Guarantor (including by way of merger or consolidation) to a Person that is
not (either before or after giving effect to such transaction) a Restricted Subsidiary, if
the sale or other disposition complies with Sections 3.09 and 4.08 hereof;

          (b) in connection with any sale of a majority of the Capital Stock of a Guarantor to a
Person that is not (either before or after giving effect to such transaction) a Restricted
Subsidiary, if as a result of such sale such Guarantor ceases to be a Subsidiary of the
Company and the sale complies with Sections 3.09 and 4.08 hereof;

          (c) if the Company designates any Restricted Subsidiary that is a Guarantor to be an
Unrestricted Subsidiary or an Excluded Subsidiary in accordance with the requirements of
this Indenture;

          (d) if any Guarantor is otherwise no longer obligated to provide a Subsidiary Guarantee
pursuant to this Indenture;

          (e) upon the Company’s exercise of its legal defeasance option or covenant defeasance
option as described under Article 8 hereof or if the Company’s obligations under the
Indenture and the Notes are discharged in accordance with the terms of the Indenture; or

          (f) pursuant to Section 4.15 hereof.

ARTICLE 11.

SATISFACTION AND DISCHARGE

Section 11.01. Satisfaction and Discharge.

     This Indenture will cease to be of further effect with respect to the Notes, and the Trustee,
at the expense of the Company, will execute proper instruments acknowledging satisfaction and
discharge of this Indenture as to the Notes when:

     (a) either:

     (i) all Notes that have been authenticated (except lost, stolen or destroyed Notes
that have been replaced or paid and Notes for whose payment money has theretofore been
deposited in trust and thereafter repaid to the Company) have been delivered to the
Trustee for cancellation; or

     (ii) all such Notes that have not been delivered to the Trustee for cancellation
have become due and payable by reason of the mailing of a notice of redemption or
otherwise or will become due and payable within one year and the Company or any Guarantor
has irrevocably deposited

85

 

or caused to be deposited with the Trustee as trust funds in trust solely for the
benefit of the Holders, cash in U.S. dollars sufficient, non-callable Government
Securities, the scheduled payments of principal of and interest on which will be
sufficient, or a combination of cash in U.S. dollars and non-callable Government
Securities, the scheduled payments of principal of and interest on which will, together
with such cash, be sufficient, in the opinion of a nationally recognized firm of
independent public accountants (which opinion need only be provided if non-callable
Government Securities have been deposited), without consideration of any reinvestment of
interest, to pay and discharge the entire indebtedness on such Notes not delivered to the
Trustee for cancellation of principal, premium and accrued interest to the date of
maturity or redemption;

     (b) the Company or any Guarantor has paid or caused to be paid all sums payable by it
under this Indenture;

     (c) the Company or any Guarantor has delivered an Officers’ Certificate and an Opinion
of Counsel to the Trustee stating that all conditions precedent to the satisfaction and
discharge of this Indenture have been satisfied or waived;

     (d) no Default or Event of Default has occurred and is continuing on the date of the
deposit (other than a Default or Event of Default resulting from the borrowing of funds to
be applied to such deposit and any similar deposit relating to other Indebtedness and, in
each case, the granting of Liens to secure such borrowing) and the deposit will not result
in a breach or violation of, or constitute a default under, any other instrument to which
the Company or any Guarantor is a party or by which the Company or any Guarantor is bound
(other than with respect to the borrowing of funds to make the deposit required to effect
such satisfaction and discharge and any similar deposit relating to other Indebtedness and
in each case the granting of Liens to secure such borrowings); and

     (e) the Company has delivered irrevocable instructions to the Trustee under the
Indenture to apply the deposited money toward the payment of the Notes at maturity or the
redemption date, as the case may be.

     Notwithstanding the satisfaction and discharge of this Indenture, if money shall have been
deposited with the Trustee pursuant to subclause (ii) of clause (a) of this Section 11.01, the
provisions of Sections 11.02 and 8.06 hereof shall survive.

Section 11.02. Application of Trust Money.

     Subject to the provisions of Section 8.06 hereof, all money deposited with the Trustee
pursuant to Section 11.01 hereof shall be held in trust and applied by it, in accordance with the
provisions of the Notes and this Indenture, to the payment, either directly or through any Paying
Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the
Persons entitled thereto, of the principal (and premium, if any) and interest for whose payment
such money has been deposited with the Trustee; but such money need not be segregated from other
funds except to the extent required by law.

     If the Trustee or Paying Agent is unable to apply any money or Government Securities in
accordance with Section 11.01 hereof by reason of any legal proceeding or by reason of any order or
judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting
such application, the Company’s obligations and, if applicable, any Guarantor’s obligations under
this Indenture and the Notes shall be revived and reinstated as though no deposit had occurred
pursuant to Section 11.01 hereof; provided that if the Company has made any payment of principal
of, premium, if any, or interest on

86

 

any Notes because of the reinstatement of its obligations, the Company shall be subrogated to
the rights of the Holders of Notes to receive such payment from the money or Government Securities
held by the Trustee or Paying Agent.

     The Company shall pay and indemnify the Trustee against any tax, fee or other charge imposed
on or assessed against the cash or non-callable Government Securities deposited pursuant to Section
11.01 hereof or the principal and interest received in respect thereof other than any such tax, fee
or other charge which by law is for the account of the Holders of the outstanding Notes.

     Anything in this Article 11 to the contrary notwithstanding, the Trustee shall deliver or pay
to the Company from time to time upon the request of the Company any money or non-callable
Government Securities held by it as provided in Section 11.01 hereof which in the opinion of a
nationally recognized firm of independent public accountants expressed in a written certification
thereof delivered to the Trustee (in case Government Securities have been deposited) are in excess
of the amount thereof that would then be required to be deposited to effect an equivalent
satisfaction and discharge of this Indenture.

ARTICLE 12.

MISCELLANEOUS

Section 12.01. Trust Indenture Act Controls.

     If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by
TIA §318(c), the imposed duties shall control. If any provision of this Indenture modifies or
excludes any provision of the TIA that may be so modified or excluded, the latter provision shall
be deemed to apply to this Indenture as so modified or excluded, as the case may be.

Section 12.02. Notices.

     Any notice or communication by the Company, any Guarantor or the Trustee to the others is duly
given if in writing and delivered in Person or mailed by first class mail (registered or certified,
return receipt requested), telex, telecopier or overnight air courier guaranteeing next day
delivery, to the others’ address:

If to the Company and/or any Guarantor:

LifePoint Hospitals, Inc.

103 Powell Court

Brentwood, Tennessee 37027

Telecopier No.: (615) 372-8575

Attention: Chief Financial Officer

With a copy to:

Dewey & LeBoeuf LLP

1301 Avenue of the Americas

New York, New York 10019

Telecopier No.: (212) 259-6333

Attention: Morton A. Pierce, Esq.

Frank R. Adams, Esq.

87

 

If to the Trustee:

The Bank of New York Mellon Trust Company, N.A.

900 Ashwood Parkway, Suite 425

Atlanta, Georgia 30338

Telecopier No.: (770) 698-5196

Attention: Corporate Finance

     The Company, any Guarantor or the Trustee, by notice to the others may designate additional or
different addresses for subsequent notices or communications.

     Any notice or communication to a Holder shall be mailed by first class mail, certified or
registered, return receipt requested, or by overnight air courier guaranteeing next day delivery to
its address shown on the register kept by the Registrar. Any notice or communication also shall be
so mailed to any Person described in TIA §313(c), to the extent required by the TIA. Failure to
mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency
with respect to other Holders.

     If the Company mails a notice or communication to Holders, it shall mail a copy to the Trustee
and each Agent at the same time.

     The Trustee agrees to accept and act upon instructions or directions pursuant to this
Indenture sent by unsecured e-mail, facsimile transmission or other similar unsecured electronic
methods; provided, however, that (a) the party providing such electronic instructions or
directions, subsequent to the transmission thereof, shall provide the originally executed
instructions or directions to the Trustee in a timely manner and (b) such originally executed
instructions or directions shall be signed by an authorized representative of the party providing
such instructions or directions. The Trustee shall not be liable for any losses, costs or expenses
arising directly or indirectly from the Trustee’s reliance upon and compliance with such
instructions or directions notwithstanding such instructions or directions conflict or are
inconsistent with a subsequent written instruction or direction or if the subsequent written
instruction or direction is never received. The party providing instructions or directions by
unsecured e-mail, facsimile transmission or other similar unsecured electronic methods, as
aforesaid, agrees to assume all risks arising out of the use of such electronic methods to submit
instructions and directions to the Trustee, including without limitation the risk of the Trustee
acting on unauthorized instructions, and the risk of interception and misuse by third parties.

Section 12.03. Communication by Holders of Notes with Other Holders of Notes.

     Holders may communicate pursuant to TIA §312(b) with other Holders with respect to their
rights under this Indenture or the Notes. The Company, the Trustee, the Registrar and anyone else
shall have the protection of TIA §312(c).

Section 12.04. Certificate and Opinion as to Conditions Precedent.

     Upon any request or application by the Company to the Trustee to take any action under this
Indenture, the Company shall furnish to the Trustee:

     (a) an Officers’ Certificate in form reasonably satisfactory to the Trustee (which
shall include the statements set forth in Section 12.05 hereof) stating that, in the opinion
of the signers, all conditions precedent and covenants, if any, provided for in this
Indenture relating to the proposed action have been satisfied or waived; and

88

 

     (b) an Opinion of Counsel in form reasonably satisfactory to the Trustee (which shall
include the statements set forth in Section 12.05 hereof) stating that, in the opinion of
such counsel, all such conditions precedent and covenants have been satisfied or waived.

Section 12.05. Statements Required in Certificate or Opinion.

     Each certificate or opinion with respect to compliance with a condition or covenant provided
for in this Indenture (other than a certificate provided pursuant to TIA §314(a)(4) and Section
4.04 hereof) shall comply with the provisions of TIA §314(e) and shall include:

     (a) a statement that the Person making such certificate or opinion has read such
covenant or condition;

     (b) a brief statement as to the nature and scope of the examination or investigation
upon which the statements or opinions contained in such certificate or opinion are based;

     (c) a statement that, in the opinion of such Person, he or she has made such
examination or investigation as is necessary to enable him to express an informed opinion as
to whether or not such covenant or condition has been satisfied or waived; and

     (d) a statement as to whether or not, in the opinion of such Person, such condition or
covenant has been satisfied or waived.

     In any case where several matters are required to be certified by, or covered by an opinion
of, any specified Person, it is not necessary that all such matters be certified by, or covered by
the opinion of, only one such Person, or that they be so certified or covered by only one document,
but one such Person may certify or give an opinion with respect to some matters and one or more
other such Persons as to other matters, and any such Person may certify or give an opinion as to
such matters in one or several documents.

     Any certificate or opinion of an Officer of the Company may be based insofar as it relates to
legal matters, upon a certificate or opinion of, or representations by, counsel, unless such
Officer knows, or in the exercise of reasonable care should know, that the certificate or opinion
or representations with respect to the matters upon which his certificate or opinion or
representations is based are erroneous. Any such certificate or opinion of counsel may be based,
insofar as it relates to factual matters, upon a certificate or opinion of, or representations by,
an officer or officers of the Company stating that the information with respect to such factual
matters is in the possession of the Company, unless such counsel knows, or in the exercise of
reasonable care should know, that the certificate or opinion or representations with respect to
such matters are erroneous.

     Where any Person is required to make, give or execute two or more applications, requests,
consents, certificates, statements, opinions or other instruments under this Indenture, they may,
but need not, be consolidated and form one instrument.

Section 12.06. Rules by Trustee and Agents.

     The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar
or Paying Agent may make reasonable rules and set reasonable requirements for its functions.

89

 

Section 12.07. No Personal Liability of Directors, Officers, Employees and Stockholders.

     No past, present or future director, officer, employee, incorporator or stockholder of the
Company or any Guarantor, as such, shall have any liability for any obligations of the Company or
such Guarantor under the Notes, the Subsidiary Guarantees, this Indenture or for any claim based
on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting a
Note waives and releases all such liability. The waiver and release are part of the consideration
for issuance of the Notes.

Section 12.08. Governing Law.

     THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS INDENTURE,
THE NOTES AND THE SUBSIDIARY GUARANTEES, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF
CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE
REQUIRED THEREBY.

Section 12.09. No Adverse Interpretation of Other Agreements.

     This Indenture may not be used to interpret any other indenture, loan or debt agreement of the
Company or its Subsidiaries or of any other Person. Any such indenture, loan or debt agreement may
not be used to interpret this Indenture.

Section 12.10. Successors.

     All agreements of the Company in this Indenture and the Notes shall bind its successors. All
agreements of the Trustee in this Indenture shall bind its successors. All agreements of each
applicable Guarantor in this Indenture shall bind its successors, except as otherwise provided
pursuant to Section 10.04 hereof.

Section 12.11. Severability.

     In case any provision in this Indenture or in the Notes shall be invalid, illegal or
unenforceable, the validity, legality and enforceability of the remaining provisions shall not in
any way be affected or impaired thereby.

Section 12.12. Waiver of Jury Trial.

     Each of the Company, the Guarantors, the Trustee and the Holders hereby irrevocably waive, to
the fullest extent permitted by applicable law, any and all right to trial by jury in any legal
proceeding arising out of or relating to this Indenture, the Subsidiary Guarantees or the Notes.

Section 12.13. Force Majeure.

     In no event shall the Trustee be responsible or liable for any failure or delay in the
performance of its obligations hereunder arising out of or caused by, directly or indirectly,
forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts
of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of
God, and interruptions, loss or malfunctions of utilities, communications or computer (software and
hardware) services; it being understood that the Trustee shall use reasonable efforts which are
consistent with accepted practices in the banking industry to resume performance as soon as
practicable under the circumstances.

90

 

Section 12.14. Counterpart Originals.

     The parties may sign any number of copies of this Indenture. Each signed copy shall be an
original, but all of them together represent the same agreement.

Section 12.15. Table of Contents, Headings, etc.

     The Table of Contents, Cross-Reference Table and Headings of the Articles and Sections of this
Indenture have been inserted for convenience of reference only, are not to be considered a part of
this Indenture and shall in no way modify or restrict any of the terms or provisions hereof.

[Signatures on following page]

91

 

SIGNATURES

Dated as of September 23, 2010

	 	 	 	 	 
	 	LIFEPOINT HOSPITALS, INC.

 	 
	 	By:  	/s/ Jeffrey S. Sherman
 	 
	 	 	Name:  	Jeffrey S. Sherman 	 
	 	 	Title:  	Executive Vice President and

Chief Financial Officer 	 
	 

					
	 	

Attest:

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and

Chief Accounting Officer 	 
	 

	 	 	 	 	 
	 	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.

 	 
	 	By:  	/s/ Lee Ann Willis
 	 
	 	 	Name:  	Lee Ann Willis 	 
	 	 	Title:  	Senior Associate 	 
	 

Attest:

/s/
Kristine Prall             

Authorized Signatory

Date: September 23, 2010

[GUARANTOR SIGNATURES BEGIN ON FOLLOWING PAGE]

92

 

ON BEHALF OF:

AMERICA MANAGEMENT COMPANIES, LLC

AMG-CROCKETT, LLC

AMG-HILCREST, LLC

AMG-HILLSIDE, LLC

AMG-LIVINGSTON, LLC

AMG-LOGAN, LLC

AMG-SOUTHERN TENNESSEE, LLC

AMG-TRINITY, LLC

ANDALUSIA PHYSICIAN PRACTICES, LLC

ASHLAND PHYSICIAN SERVICES, LLC

ASHLEY VALLEY MEDICAL CENTER, LLC

ASHLEY VALLEY PHYSICIAN PRACTICE, LLC

ATHENS PHYSICIANS PRACTICE, LLC

ATHENS REGIONAL MEDICAL CENTER, LLC

BARROW MEDICAL CENTER, LLC

BARTOW GENERAL PARTNER, LLC

BARTOW MEMORIAL LIMITED PARTNER, LLC

BOLIVAR PHYSICIAN PRACTICES, LLC

BOURBON COMMUNITY HOSPITAL, LLC

BOURBON PHYSICIAN PRACTICE, LLC

BRIM HOSPITALS, INC.

BUFFALO TRACE RADIATION ONCOLOGY ASSOCIATES, LLC

CARE HEALTH COMPANY, INC.

CASTLEVIEW HOSPITAL, LLC

CASTLEVIEW MEDICAL, LLC

CASTLEVIEW PHYSICIAN PRACTICE, LLC

CLINCH PROFESSIONAL PHYSICIAN SERVICES, LLC

CLINCH VALLEY ENDOCRINOLOGY, LLC

CLINCH VALLEY MEDICAL CENTER, INC.

CLINCH VALLEY PULMONOLOGY, LLC

CLINCH VALLEY UROLOGY, LLC

COLORADO PLAINS PHYSICIAN PRACTICES, LLC

COMMUNITY HOSPITAL OF ANDALUSIA, INC.

COMMUNITY MEDICAL, LLC

COMMUNITY-BASED SERVICES, LLC

CROCKETT HOSPITAL, LLC

CROCKETT PHO, LLC

DANVILLE DIAGNOSTIC IMAGING CENTER, LLC

DANVILLE PHYSICIAN PRACTICES, LLC

DANVILLE REGIONAL MEDICAL CENTER SCHOOL OF HEALTH PROFESSIONS, LLC

DANVILLE REGIONAL MEDICAL CENTER, LLC

DODGE CITY HEALTHCARE PARTNER, INC.

GEORGETOWN COMMUNITY HOSPITAL, LLC

GEORGETOWN REHABILITATION, LLC

GUYAN VALLEY HOSPITAL, LLC

HALSTEAD HOSPITAL, LLC

HCK LOGAN MEMORIAL, LLC

HDP ANDALUSIA, LLC

HDP GEORGETOWN, LLC

HILLSIDE HOSPITAL, LLC

S-1

 

HISTORIC LIFEPOINT HOSPITALS, INC.

HRMC, LLC

HST PHYSICIAN PRACTICE, LLC

HTI GEORGETOWN, LLC

HTI PINELAKE, LLC

HURRICANE HEALTHCARE PARTNER, LLC

INTEGRATED PHYSICIAN SERVICES, LLC

KANSAS HEALTHCARE MANAGEMENT COMPANY, INC.

KANSAS HEALTHCARE MANAGEMENT SERVICES, LLC

KENTUCKY HOSPITAL, LLC

KENTUCKY MEDSERV, LLC

KENTUCKY MSO, LLC

KENTUCKY PHYSICIAN SERVICES, INC.

LAKE CUMBERLAND CARDIOLOGY ASSOCIATES, LLC

LAKE CUMBERLAND PHYSICIAN PRACTICES, LLC

LAKE CUMBERLAND REGIONAL HOSPITAL, LLC

LAKE CUMBERLAND REGIONAL PHYSICIAN HOSPITAL ORGANIZATION, LLC

LAKELAND COMMUNITY HOSPITAL, LLC

LAKELAND PHYSICIAN PRACTICES, LLC

LANDER VALLEY AMBULATORY SURGERY CENTER, LLC

LANDER VALLEY MEDICAL CENTER, LLC

LANDER VALLEY PHYSICIAN PRACTICES, LLC

LAS CRUCES PHYSICIAN PRACTICES, LLC

LCMC MRI, LLC

LCMC PET, LLC

LHSC, LLC

LIFEPOINT ACQUISITION CORP.

LIFEPOINT BILLING SERVICES, LLC

LIFEPOINT CSGP, LLC

LIFEPOINT CSLP, LLC

LIFEPOINT HOLDINGS 2, LLC

LIFEPOINT HOLDINGS 3, INC.

LIFEPOINT HOSPITALS HOLDINGS, INC.

LIFEPOINT MEDICAL GROUP — HILLSIDE, INC

LIFEPOINT OF GAGP, LLC

LIFEPOINT OF KENTUCKY, LLC

LIFEPOINT OF LAKE CUMBERLAND, LLC

LIFEPOINT RC, INC.

LIFEPOINT VA HOLDINGS, INC.

LIFEPOINT WV HOLDINGS, INC.

LIVINGSTON REGIONAL HOSPITAL, LLC

LOGAN GENERAL HOSPITAL, LLC

LOGAN HEALTHCARE PARTNER, LLC

LOGAN MEDICAL, LLC

LOGAN MEMORIAL HOSPITAL, LLC

LOGAN PHYSICIAN PRACTICE, LLC

LOS ALAMOS PHYSICIAN PRACTICES, LLC

MARTINSVILLE PHYSICIAN PRACTICES, LLC

MEADOWVIEW PHYSICIAN PRACTICE, LLC

MEADOWVIEW REGIONAL MEDICAL CENTER, LLC

MEADOWVIEW RIGHTS, LLC

S-2

 

MEMORIAL HOSPITAL OF MARTINSVILLE & HENRY COUNTY AMBULATORY SURGERY CENTER, LLC

MEXIA-PRINCIPAL, INC.

MINDEN PHYSICIAN PRACTICES, LLC

NORTHEASTERN NEVADA PHYSICIAN PRACTICES, LLC

NORTHWEST MEDICAL CENTER-WINFIELD, LLC

NWMC-WINFIELD PHYSICIAN PRACTICES, LLC

OHIO HOSPITAL, LLC

OPELOUSAS IMAGING CENTER PARTNER, LLC

OPELOUSAS PET/CT IMAGING CENTER, LLC

ORTHOPEDICS OF SOUTHWEST VIRGINIA, LLC

PALESTINE-PRINCIPAL G.P., INC.

PHC HOSPITALS, LLC

PHC-AVIATION, INC.

PHC-BELLE GLADE, INC.

PHC-CLEVELAND, INC.

PHC-DOCTORS’ HOSPITAL, INC.

PHC-ELKO, INC.

PHC-FORT MOHAVE, INC.

PHC-FORT MORGAN, INC.

PHC-INDIANA, INC.

PHC-KNOX, INC.

PHC-LAKE HAVASU, INC.

PHC-LAKEWOOD, INC.

PHC-LAS CRUCES, INC.

PHC-LOS ALAMOS, INC.

PHC-LOUISIANA, INC.

PHC-MARTINSVILLE, INC.

PHC-MINDEN G.P., INC.

PHC-MORGAN LAKE, INC.

PHC-PALESTINE, INC.

PHC-SELMA, LLC

PHC-TENNESSEE, INC.

PINELAKE PHYSICIAN PRACTICE, LLC

PINELAKE REGIONAL HOSPITAL, LLC

POITRAS PRACTICE, LLC

PRHC-ALABAMA, LLC

PRHC-ENNIS G.P., INC.

PRINCIPAL HOSPITAL COMPANY OF NEVADA, INC.

PRINCIPAL KNOX, L.L.C.

PRINCIPAL-NEEDLES, INC.

PROVINCE HEALTHCARE COMPANY

PUTNAM AMBULATORY SURGERY CENTER, LLC

PUTNAM COMMUNITY MEDICAL CENTER, LLC

PUTNAM PHYSICIAN PRACTICES, LLC

R. KENDALL BROWN PRACTICE, LLC

RALEIGH GENERAL HOSPITAL, LLC

RIVER PARISHES HOLDINGS, LLC

RIVER PARISHES HOSPITAL, LLC

RIVER PARISHES PARTNER, LLC

RIVER PARISHES PHYSICIAN PRACTICES, LLC

S-3

 

RIVERTON AMBULATORY SURGERY CENTER, LLC

RIVERTON MEMORIAL HOSPITAL, LLC

RIVERTON ONCOLOGY PRACTICE, LLC

RIVERTON PHYSICIAN PRACTICES, LLC

RIVERVIEW MEDICAL CENTER, LLC

ROCKDALE HOSPITAL, LLC

ROCKDALE PHYSICIAN PRACTICES, LLC

RUSSELLVILLE HOSPITAL, LLC

RUSSELLVILLE PHYSICIAN PRACTICES, LLC

SELECT HEALTHCARE, LLC

SELMA DIAGNOSTIC IMAGING, LLC

SILETCHNIK PRACTICE, LLC

SMITH COUNTY MEMORIAL HOSPITAL, LLC

SOMERSET SURGERY PARTNER, LLC

SOUTHERN TENNESSEE EMS, LLC

SOUTHERN TENNESSEE MEDICAL CENTER, LLC

SOUTHERN TENNESSEE PHO, LLC

SPRING VIEW HOSPITAL, LLC

SPRING VIEW PHYSICIAN PRACTICES, LLC

SPRINGHILL MEDICAL CENTER, LLC

STARKE PHYSICIAN PRACTICES, LLC

SUMNER PHYSICIAN PRACTICES, LLC

SUMNER REAL ESTATE HOLDINGS, LLC

SUMNER REGIONAL MEDICAL CENTER, LLC

TEXAS SPECIALTY PHYSICIANS

THE MRI CENTER OF NORTHWEST ALABAMA, LLC

THM PHYSICIAN PRACTICE, LLC

TROUSDALE MEDICAL CENTER, LLC

VALLEY VIEW PHYSICIAN PRACTICES, LLC

VAUGHAN PHYSICIAN PRACTICES, LLC

VILLE PLATTE MEDICAL CENTER, LLC

VILLE PLATTE PHYSICIAN PRACTICES, LLC

WEST VIRGINIA MANAGEMENT SERVICES ORGANIZATION, INC.

WESTERN PLAINS PHYSICIAN PRACTICES, LLC

WESTERN PLAINS REGIONAL HOSPITAL, LLC

WOODFORD HOSPITAL, LLC

WYOMING HOLDINGS, LLC

WYTHE COUNTY COMMUNITY HOSPITAL, LLC

WYTHE COUNTY PHYSICIAN PRACTICES, LLC

ZONE, INCORPORATED

	 	 	 	 	 
	 	 	 
	 	                                                     /s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-4

 

	 	 	 	 	 

On Behalf of:

LIFEPOINT ASSET MANAGEMENT COMPANY, INC.

	 	 	 	 	 
	 	 	 
	 	                                  /s/ Christopher J. Monte
 	 
	 	Name:  	Christopher J. Monte 	 
	 	Title:  	Vice President 	 

S-5

 

	 	 	 	 	 

On Behalf of:

BARTOW HEALTHCARE SYSTEM, LTD.

	 	 	 	 	 
	 	Bartow General Partner, LLC, as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	Bartow Memorial Limited Partner, LLC, as limited

partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-6

 

	 	 	 	 	 

On Behalf of:

LAMAR SURGERY CENTER, LP

	 	 	 	 	 
	 	Northwest Medical Center-Winfield, LLC, as general

partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

S-7

 

On Behalf of:

LIFEPOINT CORPORATE SERVICES GENERAL PARTNERSHIP

	 	 	 	 	 
	 	LifePoint CSLP, LLC, as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	LifePoint CSGP, LLC, as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-8

 

	 	 	 	 	 

On Behalf of:

   LIFEPOINT OF GEORGIA, LIMITED PARTNERSHIP

	 	 	 	 	 
	 	

LifePoint Hospitals Holdings, Inc., as limited
partner
 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	LifePoint of GAGP, LLC, as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-9

 

	 	 	 	 	 

On Behalf of:

MEXIA PRINCIPAL HEALTHCARE LIMITED PARTNERSHIP

	 	 	 	 	 
	 	

Mexia-Principal, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	Principal Hospital Company of Nevada, Inc., as
limited
partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-10

 

	 	 	 	 	 

On Behalf of:

PALESTINE PRINCIPAL HEALTHCARE LIMITED PARTNERSHIP

	 	 	 	 	 
	 	

Palestine Principal G.P., Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	Principal Hospital Company of Nevada, Inc., as
limited
partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-11

 

	 	 	 	 	 

On Behalf of:

PHC-ASHLAND, L.P.

	 	 	 	 	 
	 	

PHC-Tennessee, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	Principal Hospital Company of Nevada, Inc., as
limited
partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-12

 

	 	 	 	 	 

On Behalf of:

PHC-CHARLESTOWN, L.P.

	 	 	 	 	 
	 	

PHC-Indiana, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	PHC Hospitals, LLC, as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-13

 

	 	 	 	 	 

On Behalf of:

PHC-MINDEN, L.P.

	 	 	 	 	 
	 	

PHC-Minden G.P., Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	PHC-Louisiana, Inc., as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-14

 

	 	 	 	 	 

On Behalf of:

PHC-MORGAN CITY, L.P.

	 	 	 	 	 
	 	

PHC-Lakewood, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	PHC-Morgan Lake, Inc, as limited partner.

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-15

 

	 	 	 	 	 

On Behalf of:

PHC-OPELOUSAS, L.P.

	 	 	 	 	 
	 	

PHC-Doctors’ Hospital, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	PHC-Louisiana, Inc., as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-16

 

	 	 	 	 	 

On Behalf of:

PRHC-ENNIS, L.P.

	 	 	 	 	 
	 	

PRHC-Ennis G.P., Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	Principal Hospital Company of Nevada, Inc., as
limited
partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-17

 

	 	 	 	 	 

On Behalf of:

PRINCIPAL KNOX, L.P.

	 	 	 	 	 
	 	

PHC-Knox, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 	Province Healthcare Company, as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-18

 

SCHEDULE I

America Management Companies, LLC

AMG-Crockett, LLC

AMG-Hilcrest, LLC

AMG-Hillside, LLC

AMG-Livingston, LLC

AMG-Logan, LLC

AMG-Southern Tennessee, LLC

AMG-Trinity, LLC

Andalusia Physician Practices, LLC

Ashland Physician Services, LLC

Ashley Valley Medical Center, LLC

Ashley Valley Physician Practice, LLC

Athens Physicians Practice, LLC

Athens Regional Medical Center, LLC

Barrow Medical Center, LLC

Bartow General Partner, LLC

Bartow Healthcare System, Ltd.

Bartow Memorial Limited Partner, LLC

Bolivar Physician Practices, LLC

Bourbon Community Hospital, LLC

Bourbon Physician Practice, LLC

Brim Hospitals, Inc.

Buffalo Trace Radiation Oncology Associates, LLC

Care Health Company, Inc.

Castleview Hospital, LLC

Castleview Medical, LLC

Castleview Physician Practice, LLC

Clinch Professional Physician Services, LLC

Clinch Valley Endocrinology, LLC

Clinch Valley Medical Center, Inc.

Clinch Valley Pulmonology, LLC

Clinch Valley Urology, LLC

Colorado Plains Physician Practices, LLC

Community Hospital of Andalusia, Inc.

Community Medical, LLC

Community-Based Services, LLC

Crockett Hospital, LLC

Crockett PHO, LLC

Danville Diagnostic Imaging Center, LLC

A-1

 

Danville Physician Practices, LLC

Danville Regional Medical Center School of Health Professions, LLC

Danville Regional Medical Center, LLC

Dodge City Healthcare Partner, Inc.

Georgetown Community Hospital, LLC

Georgetown Rehabilitation, LLC

Guyan Valley Hospital, LLC

Halstead Hospital, LLC

HCK Logan Memorial, LLC

HDP Andalusia, LLC

HDP Georgetown, LLC

Hillside Hospital, LLC

Historic LifePoint Hospitals, Inc.

HRMC, LLC

HST Physician Practice, LLC

HTI Georgetown, LLC

HTI PineLake, LLC

Hurricane Healthcare Partner, LLC

Integrated Physician Services, LLC

Kansas Healthcare Management Company, Inc.

Kansas Healthcare Management Services, LLC

Kentucky Hospital, LLC

Kentucky Medserv, LLC

Kentucky MSO, LLC

Kentucky Physician Services, Inc.

Lake Cumberland Cardiology Associates, LLC

Lake Cumberland Physician Practices, LLC

Lake Cumberland Regional Hospital, LLC

Lake Cumberland Regional Physician Hospital Organization, LLC

Lakeland Community Hospital, LLC

Lakeland Physician Practices, LLC

Lamar Surgery Center, LP

Lander Valley Ambulatory Surgery Center, LLC

Lander Valley Medical Center, LLC

Lander Valley Physician Practices, LLC

Las Cruces Physician Practices, LLC

LCMC MRI, LLC

LCMC PET, LLC

LHSC, LLC

LifePoint Acquisition Corp.

A-2

 

LifePoint Asset Management Company, Inc.

LifePoint Billing Services, LLC

LifePoint Corporate Services General Partnership

LifePoint CSGP, LLC

LifePoint CSLP, LLC

LifePoint Holdings 2, LLC

LifePoint Holdings 3, Inc.

LifePoint Hospitals Holdings, Inc.

LifePoint Medical Group — Hillside, Inc

LifePoint of GAGP, LLC

LifePoint of Georgia, Limited Partnership

LifePoint of Kentucky, LLC

LifePoint of Lake Cumberland, LLC

LifePoint RC, Inc.

LifePoint VA Holdings, Inc.

LifePoint WV Holdings, Inc.

Livingston Regional Hospital, LLC

Logan General Hospital, LLC

Logan Healthcare Partner, LLC

Logan Medical, LLC

Logan Memorial Hospital, LLC

Logan Physician Practice, LLC

Los Alamos Physician Practices, LLC

Martinsville Physician Practices, LLC

Meadowview Physician Practice, LLC

Meadowview Regional Medical Center, LLC

Meadowview Rights, LLC

Memorial Hospital of Martinsville & Henry County Ambulatory Surgery Center, LLC

Mexia Principal Healthcare Limited Partnership

Mexia-Principal, Inc.

Minden Physician Practices, LLC

Northeastern Nevada Physician Practices, LLC

Northwest Medical Center-Winfield, LLC

NWMC-Winfield Physician Practices, LLC

Ohio Hospital, LLC

Opelousas Imaging Center Partner, LLC

Opelousas PET/CT Imaging Center, LLC

Orthopedics of Southwest Virginia, LLC

Palestine Principal Healthcare Limited Partnership

Palestine-Principal G.P., Inc.

A-3

 

PHC Hospitals, LLC

PHC-Ashland, L.P.

PHC-Aviation, Inc.

PHC-Belle Glade, Inc.

PHC-Charlestown, L.P.

PHC-Cleveland, Inc.

PHC-Doctors’ Hospital, Inc.

PHC-Elko, Inc.

PHC-Fort Mohave, Inc.

PHC-Fort Morgan, Inc.

PHC-Indiana, Inc.

PHC-Knox, Inc.

PHC-Lake Havasu, Inc.

PHC-Lakewood, Inc.

PHC-Las Cruces, Inc.

PHC-Los Alamos, Inc.

PHC-Louisiana, Inc.

PHC-Martinsville, Inc.

PHC-Minden G.P., Inc.

PHC-Minden, L. P.

PHC-Morgan City, L.P.

PHC-Morgan Lake, Inc.

PHC-Opelousas, L.P.

PHC-Palestine, Inc.

PHC-Selma, LLC

PHC-Tennessee, Inc.

PineLake Physician Practice, LLC

PineLake Regional Hospital, LLC

Poitras Practice, LLC

PRHC-Alabama, LLC

PRHC-Ennis G.P., Inc.

PRHC-Ennis, L.P.

Principal Hospital Company of Nevada, Inc.

Principal Knox, L.L.C.

Principal Knox, L.P.

Principal-Needles, Inc.

Province Healthcare Company

Putnam Ambulatory Surgery Center, LLC

Putnam Community Medical Center, LLC

Putnam Physician Practices, LLC

A-4

 

R. Kendall Brown Practice, LLC

Raleigh General Hospital, LLC

River Parishes Holdings, LLC

River Parishes Hospital, LLC

River Parishes Partner, LLC

River Parishes Physician Practices, LLC

Riverton Ambulatory Surgery Center, LLC

Riverton Memorial Hospital, LLC

Riverton Oncology Practice, LLC

Riverton Physician Practices, LLC

Riverview Medical Center, LLC

Rockdale Hospital, LLC

Rockdale Physician Practices, LLC

Russellville Hospital, LLC

Russellville Physician Practices, LLC

Select Healthcare, LLC

Selma Diagnostic Imaging, LLC

Siletchnik Practice, LLC

Smith County Memorial Hospital, LLC

Somerset Surgery Partner, LLC

Southern Tennessee EMS, LLC

Southern Tennessee Medical Center, LLC

Southern Tennessee PHO, LLC

Spring View Hospital, LLC

Spring View Physician Practices, LLC

Springhill Medical Center, LLC

Starke Physician Practices, LLC

Sumner Physician Practices, LLC

Sumner Real Estate Holdings, LLC

Sumner Regional Medical Center, LLC

Texas Specialty Physicians

The MRI Center of Northwest Alabama, LLC

THM Physician Practice, LLC

Trousdale Medical Center, LLC

Valley View Physician Practices, LLC

Vaughan Physician Practices, LLC

Ville Platte Medical Center, LLC

Ville Platte Physician Practices, LLC

West Virginia Management Services Organization, Inc.

Western Plains Physician Practices, LLC

A-5

 

Western Plains Regional Hospital, LLC

Woodford Hospital, LLC

Wyoming Holdings, LLC

Wythe County Community Hospital, LLC

Wythe County Physician Practices, LLC

Zone, Incorporated

A-6

 

EXHIBIT A

[Face of Note]

[Insert the Global Note Legend if applicable pursuant to the provisions of the Indenture]

[Insert the Private Placement Legend if applicable pursuant to the provisions of the Indenture]

[Insert the Regulation S Legend if applicable pursuant to the provisions of the Indenture]

CUSIP _____

ISIN _____

6.625% Senior Note due 2020

(the “Notes”)

No. [RA- ] [RS- ] [R- ]

LIFEPOINT HOSPITALS, INC.

promises to pay to                                         , or registered assigns, the principal amount of $                    
[or such other principal amount as shall be set forth in the Schedule of Exchanges of Interests in
the Global Note attached hereto]* on October 1, 2020.

Interest Payment Dates: April 1 and October 1, commencing on April 1, 2011.

Regular Record Dates: March 15 and September 15.

Dated:

	 	 	 	 	 
	 	

LIFEPOINT HOSPITALS, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 

A-7

 

	 	 	 	 	 

CERTIFICATE OF AUTHENTICATION

This is one of the Notes referred to in the within-mentioned Indenture:

The Bank of New York Mellon Trust Company, N.A., as Trustee

	 	 	 	 	 
	 	 
	By:  	 	 
	 	Authorized Signatory 	 
	 	 	 
	 

 

*           Insert in Global Notes only

A-8

 

[Back of Note]

6.625% Senior Note due 2020

Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to
below unless otherwise indicated.

1. Interest.

LifePoint Hospitals, Inc., a Delaware corporation (herein the “Company” which term includes any
successor Person under the Indenture hereinafter referred to), for value received, hereby promises
to pay interest on the principal amount of this Note at the rate per annum shown above from
September 23, 2010 or from the most recent Interest Payment Date to which interest has been paid or
duly provided for semiannually on April 1 and October 1 in each year, commencing April 1, 2011, and
at the Stated Maturity thereof, until the principal hereof is paid or made available for payment
and on any Defaulted Interest to the extent permitted by law. Interest shall be computed on the
basis of a 360-day year of twelve 30-day months.

2. Method of Payment.

The Company will pay interest on the Notes on each April 1 and October 1 to the Persons who are
registered Holders of the relevant Notes at the close of business on the March 15 or September 15
(whether or not a Business Day) next preceding the Interest Payment Date, even if such Notes are
cancelled after such record date and on or before such Interest Payment Date, except as provided in
Section 2.12 of the Indenture with respect to Defaulted Interest. The Notes will be payable as to
principal, premium, if any, and interest at the office or agency of the Company maintained for such
purpose within or without the City and State of New York; provided, however, that at the option of
the Company payment of interest due on an Interest Payment Date may be made by check mailed to the
address of the Person entitled thereto as such address shall appear in the books of registry
maintained by the Registrar, and provided, further, that payment by wire transfer of immediately
available funds will be required with respect to principal of, premium if any and interest on all
Global Securities and all other Notes the Holders of which shall have provided wire transfer
instructions to the Company or the Paying Agent at least 15 days prior to the applicable Interest
Payment Date, subject to surrender of the Note at such office or agency in the case of payments of
principal or premium. Such payment shall be in such coin or currency of the United States of
America as at the time of payment is legal tender for payment of private debts.

3. Paying Agent and Registrar.

Initially, the Trustee under the Indenture will act as Paying agent and Registrar. The Company may
change any Paying Agent or Registrar without notice to any Holder. The Company or any of its
Subsidiaries may act in any such capacity.

4. Indenture.

This Note is one of a duly authorized issue of notes of the Company issued under an Indenture,
dated as of September 23, 2010 (the “Indenture”) among the Company, the Guarantors and The Bank of
New York Mellon Trust Company, N.A., as Trustee (herein called the “Trustee” which term includes
any successor Trustee under the Indenture), to which Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights,
duties and immunities thereunder of the Company, the Guarantors, the Trustee and the Holders of the
Notes and of the terms upon which the Notes are, and are to be, authenticated and delivered. All
Notes issued under the Indenture will be treated as a single class of securities under the
Indenture. The terms of the Notes
include those stated in this Indenture and those made a part of this Indenture by reference to the
Trust Indenture Act of 1939, as amended (15 U.S. Code §§ 77aaa-77bbbb). The Notes are subject to
all such

A-9

 

terms, and Holders are referred to this Indenture and such Act for a statement of such
terms. To the extent any provision of this security conflicts with the express provisions of this
Indenture, the provisions of this Indenture shall govern and be controlling.

5. Optional Redemption.

At any time prior to October 1, 2013, the Company may on any one or more occasions redeem up to 35%
of the aggregate principal amount of Notes issued under the Indenture at a redemption price of
106.625% of the principal amount, plus accrued interest and Special            Interest, if any, to
(but not including) the Redemption Date, with the net cash proceeds of one or more Equity
Offerings; provided that:

     (a) at least 65% of the aggregate principal amount of Notes issued under the Indenture
remains outstanding immediately after the occurrence of such redemption (excluding Notes held by
the Company and its Subsidiaries); and

     (b) the redemption occurs within 180 days of the date of the closing of such Equity
Offering.

At any time prior to October 1, 2015, the Company may redeem all or a part of the Notes, upon not
less than 30 nor more than 60 days’ notice, at a redemption price equal to 100% of the principal
amount thereof, plus the Applicable Redemption Premium and accrued and unpaid interest and Special
Interest, if any, to (but not including) the redemption date.

On or after October 1, 2015, the Company may redeem all or a part of the Notes upon not less than
30 nor more than 60 days’ notice, at the redemption prices (expressed as percentages of principal
amount) set forth below plus accrued and unpaid interest and Special Interest, if any, on the Notes
redeemed, to (but not including) the applicable redemption date, if redeemed during the
twelve-month period beginning on October 1 of the years indicated below:

	 	 	 	 	 
	Year	 	Percentage	 
	2015
	 	 	103.313	%
	2016
	 	 	102.208	%
	2017
	 	 	101.104	%
	2018 and thereafter
	 	 	100.000	%

6. Mandatory Redemption.

Except as set forth in paragraph 7 below, the Company shall not be required to make mandatory
redemption payments with respect to the Notes.

7. Repurchase at Option of Holder.

If there is a Change of Control, the Company shall be required to make an offer (a “Change of
Control Offer”) to repurchase all or any part (equal to $1,000 or an integral multiple of $1,000 in
excess thereof; provided that the unrepurchased portion of a Note must be in a minimum denomination
of $2,000) of each Holder’s Notes at a purchase price equal to 101% of the aggregate principal
amount thereof plus accrued and unpaid interest and Special Interest, if any, to (but not
including) the date of purchase (the “Change of Control Payment”). Within 30 days following any
Change of Control, the Company shall mail a notice to each Holder setting forth the procedures
governing the Change of Control Offer as required by the Indenture.

If the Company or a Subsidiary consummates any Asset Sales, when the aggregate amount of Excess
Proceeds exceeds $50 million, the Company shall commence an offer to all Holders of Notes (an
“Asset Sale Offer”) pursuant to Section 3.09 of the Indenture to purchase the maximum principal
amount of Notes that may be purchased out of the Excess Proceeds at an offer price in cash in an
amount equal to

A-10

 

100% of the principal amount thereof plus accrued and unpaid interest thereon to
the date fixed for the closing of such offer, in accordance with the procedures set forth in this
Indenture. To the extent that the aggregate amount of Notes tendered pursuant to an Asset Sale
Offer is less than the Excess Proceeds, the Company may use such deficiency for general corporate
purposes. If the aggregate principal amount of Notes surrendered by Holders thereof exceeds the
amount of Excess Proceeds, the Trustee shall select the Notes to be purchased on a pro rata basis.
Holders of Notes that are the subject of an offer to purchase will receive an Asset Sale Offer from
the Company prior to any related purchase date and may elect to have such Notes purchased by
completing the form entitled “Option of Holder to Elect Purchase” on the reverse of the Notes.

8. Notice of Redemption.

Notice of redemption will be mailed at least 30 days but not more than 60 days before the
redemption date to each Holder whose Notes are to be redeemed at its registered address. Notes and
portions of Notes to be redeemed will be in amounts of $1,000 and integral multiples of $1,000 in
excess thereof; provided that no Notes of $2,000 or less shall be redeemed or purchased in part.
On and after the redemption date interest ceases to accrue on Notes or portions thereof called for
redemption.

9. Denominations, Transfer, Exchange.

As provided in the Indenture and subject to certain limitations therein set forth, Notes are
exchangeable for a like aggregate principal amount of Notes and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same. A holder may register
the transfer or exchange of this Note as provided in the Indenture and subject to certain
limitations therein set forth. The Registrar may require a Holder, among other things, to furnish
appropriate endorsements and transfer documents and to pay any taxes and fees required by law or
permitted by the Indenture. The Company need not exchange or register the transfer of any Note or
portion of a Note selected for redemption, except for the unredeemed portion of any Note being
redeemed in part. Also, the Company need not exchange or register the transfer of any Note for a
period of 15 days before a selection of Notes to be redeemed.

10. Persons Deemed Owners.

The registered Holder of a Note may be treated as its owner for all purposes.

11. Amendment, Supplement and Waiver.

Subject to certain exceptions, the Indenture and the Notes may be amended or supplemented with
the consent of the Holders of at least a majority in principal amount of the then outstanding Notes
and any existing default or compliance with any provision may be waived with the consent of the
Holders of a majority in principal amount of the then outstanding Notes. Without the consent of
any Holder of Notes affected by such amendment or supplement, the Indenture and the Notes may be
amended or supplemented to, among other things: (a) cure any ambiguity, defect or inconsistency;
(b) provide for uncertificated Notes in addition to or in place of certificated Notes; (c) provide
for the assumption of the Company’s or a Guarantor’s obligations to Holders of the Notes in case of
a merger or consolidation or sale of substantially all assets; (d) to make any change that would
provide any additional rights or benefits to the Holders of Notes or that does not adversely affect
the legal rights under the Indenture of any Holder; (e) to comply with the requirements of the SEC
in order to effect or maintain the qualification of the Indenture under the Trust Indenture Act;
(f) to allow any Guarantor to execute a supplemental indenture to the Indenture pursuant to Section
4.12 thereof; (g) evidence or provide for acceptance of appointment of a successor Trustee; (h)
mortgage, hypothecate or grant a security interest in favor of the Trustee for the benefit of
the Holders of Notes as additional security for the payment and performance of the Company’s or, if
applicable, the Guarantor’s obligations herein; (i) to release a Guarantor from its Subsidiary
Guarantee pursuant to the terms of the Indenture when permitted or required pursuant to the terms
of the Indenture; or (j) to conform the text of the Indenture, the Notes or the Subsidiary
Guarantees

A-11

 

to any provision of the “Description of Notes” to the extent that such provision was intended
to be a substantially verbatim recitation of a provision of the Indenture, the Notes or the
Subsidiary Guarantee.

12. Defaults and Remedies.

Events of Default include: (a) default for 30 days in the payment when due of interest on the
Notes; (b) default in payment when due of principal of or premium, if any, on the Notes (including
the failure to repurchase the Notes pursuant to a Change of Control Offer or Asset Sale Offer); (c)
failure by the Company or any of its Restricted Subsidiaries to comply with Section 5.01 of the
Indenture; (d) failure by the Company or any of its Restricted Subsidiaries for 60 days after
notice to the Company by the Trustee or the Holders of at least 25% in principal amount of the
Notes then outstanding voting as a single class to comply with certain other agreements in this
Indenture or the Notes; (e) default under certain other agreements relating to Indebtedness of the
Company which default results in the acceleration of such Indebtedness prior to its express
maturity; (f) certain final judgments for the payment of money that remain undischarged for a
period of 60 days; (g) certain events of bankruptcy or insolvency with respect to the Company or
any of its Restricted Subsidiaries that is a Significant Subsidiary; and (h) except as permitted by
the Indenture, any applicable Subsidiary Guarantee or a Significant Subsidiary shall be held in any
judicial proceeding to be unenforceable or invalid or shall cease for any reason to be in full
force and effect or any Guarantor or a Significant Subsidiary or any Person acting on its behalf
shall deny or disaffirm its obligations under such Guarantor’s Subsidiary Guarantee. If any Event
of Default occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount
of the then outstanding Notes may declare all the Notes to be due and payable. Notwithstanding the
foregoing, in the case of an Event of Default arising from certain events of bankruptcy or
insolvency involving the Company, all outstanding Notes will become due and payable without further
action or notice. Holders may not enforce this Indenture or the Notes except as provided in the
Indenture. Subject to certain limitations, Holders of a majority in principal amount of the then
outstanding Notes may direct the Trustee in its exercise of any trust or power. The Trustee may
withhold from Holders of the Notes notice of any continuing Default or Event of Default (except a
Default or Event of Default relating to the payment of principal or interest) if it determines that
withholding notice is in their interest. The Holders of a majority in aggregate principal amount
of the Notes then outstanding by notice to the Trustee may on behalf of the Holders of all of the
Notes waive any existing Default or Event of Default and its consequences under this Indenture
except a continuing Default or Event of Default in the payment of interest on, or the principal of,
the Notes. The Company is required to deliver to the Trustee annually a statement regarding
compliance with the Indenture, and the Company is required upon becoming aware of any Default or
Event of Default, to deliver to the Trustee a statement specifying such Default or Event of
Default.

13. Trustee Dealings with Company.

The Trustee, in its individual or any other capacity, may make loans to, accept deposits from, and
perform services for the Company or its Affiliates, and may otherwise deal with the Company or its
Affiliates, as if it were not the Trustee.

14. No Recourse Against Others.

A director, officer, employee, incorporator or stockholder, of the Company, as such, shall not have
any liability for any obligations of the Company or the Guarantors under the Notes or this
Indenture or for any claim based on, in respect of, or by reason of, such obligations or their
creation. Each Holder by accepting a Note waives and releases all such liability. The waiver and
release are part of the consideration for the issuance of the Notes.

15. Guarantees.

The payment by the Company of the principal of and premium, if any, and interest on this Note is
fully and unconditionally guaranteed on a joint and several basis by each of the Guarantors on the
terms set forth in the Indenture.

A-12

 

16. Authentication.

This Note shall not be valid until authenticated by the manual signature of the Trustee or an
authenticating agent.

17. Abbreviations.

Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN CON (=
tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= Joint tenants with right of
survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to
Minors Act).

18. CUSIP Numbers.

Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification
Procedures, the Company has caused CUSIP numbers to be printed on the Notes and the Trustee may use
CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as
to the accuracy of such numbers either as printed on the Notes or as contained in any notice of
redemption and reliance may be placed only on the other identification numbers placed thereon.

19. Governing Law.

THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THE INDENTURE, THIS
NOTE AND THE SUBSIDIARY GUARANTEES, WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF
LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED
THEREBY.

20. Additional Rights of Holders.

In addition to the rights provided to Holders of the Initial Notes under the Indenture, Holders of
the Initial Notes will have all the rights set forth in the Registration Rights Agreement dated as
of September 23, 2010, among the Company and the other parties named on the signature pages
thereof, including the right to Special Interest as set forth therein, or, in the case of
Additional Notes, Holders thereof will have the rights set forth in one or more registration rights
agreements, if any, among the Company and the other parties thereto, relating to rights given by
the Company to the purchasers of any Additional Notes.

The Company will furnish to any Holder upon written request and without charge a copy of the
Indenture. Requests may be made to:

LifePoint Hospitals, Inc.

103 Powell Court

Brentwood, Tennessee 37027

Attention: Investor Relations

A-13

 

ASSIGNMENT FORM

To assign this Note, fill in the form below:

(I) or (we) assign and transfer this Security to:                                                         
                                       

(Insert assignee’s legal name)                                                                                     

 

(Insert assignee’s soc. sec. or tax I.D. no.)

 

 

 

 

(Print or type assignee’s name, address and zip code)

and irrevocably appoint _____________ to transfer this Note on the books of the Company. The agent
may substitute another to act for him.

Date: _____________

	 	 	 	 	 
	Your Signature: 	

 	 
	 	(Sign exactly as your name appears on the face
of this Note) 	 
	 

Signature Guarantee*: __________________________

 

			
	*	 	Participant in a recognized Signature Guarantee Medallion Program (or other signature
guarantor acceptable to the Trustee).

A-14

 

OPTION OF HOLDER TO ELECT PURCHASE

If you want to elect to have this Note purchased by the Company pursuant to Section 4.08 or 4.11 of
the Indenture, check the appropriate box below:

o  Section 4.08                o  Section 4.11

If you want to elect to have only part of the Note purchased by the Company pursuant to Section
4.08 or Section 4.11 of the Indenture, state the amount you elect to have purchased:

$_________ ($1,000 or an integral multiple thereof, provided that any unpurchased portion of this Note
must be in the minimum denomination of $2,000)

Date: _____________

	 	 	 	 	 
	 	Your Signature: 	 	

 	 
	 	 	(Sign exactly as your name appears on the face
of this Note) 	 
	 	 	 
	 	Tax Identification No.: 	____________________
 	 
	 

Signature Guarantee*: ________________________________

 

			
	*	 	Participant in a recognized Signature Guarantee Medallion Program (or other signature
guarantor acceptable to the Trustee).

A-15

 

SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE*

The following exchanges of a part of this Global Note for an interest in another Global Note or for
a Definitive Note, or exchanges of a part of another Global Note or Definitive Note for an interest
in this Global Note, have been made:

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	Principal Amount of	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	this Global Note	 	Signature
	 	 	 	 	Amount of decrease	 	Amount of increase	 	following such	 	authorized officer
	 	 	 	 	in Principal Amount	 	in Principal Amount	 	decrease (or	 	of Trustee or Note
	Date of Exchange	 	of this Global Note	 	of this Global Note	 	increase)	 	Custodian

 

			
	*	 	This schedule should be included only if the Note is issued in global form.

A-16

 

EXHIBIT B

FORM OF CERTIFICATE OF TRANSFER

LifePoint Hospitals, Inc.

103 Powell Court

Brentwood, Tennessee 37027

The Bank of New York Mellon Trust Company, N.A.

900 Ashwood Parkway, Suite 425

Atlanta, Georgia 30338

Attention: Corporate Finance

Re: 6.625% Notes due 2020 (CUSIP _____)

     Reference is hereby made to the Indenture, dated as of September 23, 2010 (the “Indenture”),
among LifePoint Hospitals, Inc., a Delaware corporation (the “Company”), the Guarantors party
thereto and The Bank of New York Mellon Trust Company, N.A., as trustee. Capitalized terms used
but not defined herein shall have the meanings given to them in the Indenture.

     _______________, (the “Transferor”) owns and proposes to transfer the Note[s] or interest in
such Note[s] specified in Annex A hereto, in the principal amount of $_________ of such Note[s] or
interests (the “Transfer”), to ________________________ (the “Transferee”), as further specified in
Annex A hereto. In connection with the Transfer, the Transferor hereby certifies that:

[CHECK ALL THAT APPLY]

     1. o CHECK IF TRANSFEREE SHALL TAKE DELIVERY OF A BENEFICIAL INTEREST IN THE 144A GLOBAL
NOTE OR A RESTRICTED DEFINITIVE NOTE PURSUANT TO RULE 144A. The Transfer is being effected
pursuant to and in accordance with Rule 144A under the Securities Act of 1933, as amended (the
"Securities Act”), and, accordingly, the Transferor hereby further certifies that the beneficial
interest or Definitive Note is being transferred to a Person that the Transferor reasonably
believes is purchasing the beneficial interest or Definitive Note for its own account, or for one
or more accounts with respect to which such Person exercises sole investment discretion, and such
Person and each such account is a “qualified institutional buyer” within the meaning of Rule 144A
in a transaction meeting the requirements of Rule 144A, and such Transfer is in compliance with any
applicable blue sky securities laws of any state of the United States. Upon consummation of the
proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial
interest or Definitive Note shall be subject to the restrictions on transfer enumerated in the
Private Placement Legend printed on the 144A Global Note and/or the Restricted Definitive Note and
in the Indenture and the Securities Act.

     2. o CHECK IF TRANSFEREE SHALL TAKE DELIVERY OF A BENEFICIAL INTEREST IN THE REGULATION
S GLOBAL NOTE OR A RESTRICTED DEFINITIVE NOTE PURSUANT TO REGULATION S. The Transfer is being
effected pursuant to and in accordance with Rule 903 or Rule 904 under the Securities Act and,
accordingly, the Transferor hereby further certifies that (i) the Transfer is not being made to a
Person in the United States and (x) at the time the buy order was originated, the Transferee was
outside the United States or such Transferor and any Person acting on its behalf reasonably
believed and believes that the Transferee was outside the United States or (y) the
transaction was executed in, on or through the facilities of a designated offshore securities
market and neither such Transferor nor any Person acting on its behalf knows that the transaction
was prearranged with a buyer in the United States, (ii) no directed selling efforts have been made
in contravention of the

B-1

 

requirements of Rule 903(b) or Rule 904(b) of Regulation S under the
Securities Act, (iii) the transaction is not part of a plan or scheme to evade the registration
requirements of the Securities Act and (iv) if the proposed transfer is being made prior to the
expiration of the Restricted Period, the transfer is not being made to a U.S. Person or for the
account or benefit of a U.S. Person (other than an Initial Purchaser). Upon consummation of the
proposed transfer in accordance with the terms of the Indenture, the transferred beneficial
interest or Definitive Note shall be subject to the restrictions on Transfer enumerated in the
Private Placement Legend printed on the Regulation S Global Note and/or the Restricted Definitive
Note and in the Indenture and the Securities Act.

     3. o CHECK AND COMPLETE IF TRANSFEREE SHALL TAKE DELIVERY OF A BENEFICIAL INTEREST IN A
RESTRICTED DEFINITIVE NOTE PURSUANT TO ANY PROVISION OF THE SECURITIES ACT OTHER THAN RULE 144A OR
REGULATION S. The Transfer is being effected in compliance with the transfer restrictions
applicable to beneficial interests in Restricted Global Notes and Restricted Definitive Notes and
pursuant to and in accordance with the Securities Act and any applicable blue sky securities laws
of any state of the United States, and accordingly the Transferor hereby further certifies that
(check one):

          (a) o such Transfer is being effected pursuant to and in accordance with Rule 144 under
the Securities Act; or

          (b) o such Transfer is being effected to the Company or a subsidiary thereof; or

          (c) o such Transfer is being effected pursuant to an effective registration statement
under the Securities Act and in compliance with the prospectus delivery requirements of the
Securities Act.

     4. o CHECK IF TRANSFEREE SHALL TAKE DELIVERY OF A BENEFICIAL INTEREST IN AN UNRESTRICTED
GLOBAL NOTE OR OF AN UNRESTRICTED DEFINITIVE NOTE.

          (a) o CHECK IF TRANSFER IS PURSUANT TO RULE 144. (i) The Transfer is being effected
pursuant to and in accordance with Rule 144 under the Securities Act and in compliance with the
transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any
state of the United States and (ii) the restrictions on transfer contained in the Indenture and the
Private Placement Legend are not required in order to maintain compliance with the Securities Act.
Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the
transferred beneficial interest or Definitive Note shall no longer be subject to the restrictions
on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes, on
Restricted Definitive Notes and in the Indenture.

          (b) o CHECK IF TRANSFER IS PURSUANT TO REGULATION S. (i) The Transfer is being effected
pursuant to and in accordance with Rule 903 or Rule 904 under the Securities Act and in compliance
with the transfer restrictions contained in the Indenture and any applicable blue sky securities
laws of any state of the United States and (ii) the restrictions on transfer contained in the
Indenture and the Private Placement Legend are not required in order to maintain compliance with
the
Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of
the Indenture, the transferred beneficial interest or Definitive Note shall no longer be subject to
the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted
Global Notes, on Restricted Definitive Notes and in the Indenture.

B-2

 

          (c) o CHECK IF TRANSFER IS PURSUANT TO OTHER EXEMPTION. (i) The Transfer is being
effected pursuant to and in compliance with an exemption from the registration requirements of the
Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer
restrictions contained in the Indenture and any applicable blue sky securities laws of any state of
the United States and (ii) the restrictions on transfer contained in the Indenture and the Private
Placement Legend are not required in order to maintain compliance with the Securities Act. Upon
consummation of the proposed Transfer in accordance with the terms of the Indenture, the
transferred beneficial interest or Definitive Note shall not be subject to the restrictions on
transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes or
Restricted Definitive Notes and in the Indenture.

     This certificate and the statements contained herein are made for your benefit and the benefit
of the Company.

	 	 	 	 	 
	 
	 	[Insert Name of Transferor]

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 

B-3

 

ANNEX A TO CERTIFICATE OF TRANSFER

	 	 	 	 	 

	1.	 	The Transferor owns and proposes to transfer the following:
	 
	 

	 	 	 	[CHECK ONE OF (a) OR (b)]
	 
	 	 	 	 
	(a)

	 	o
	 	a beneficial interest in the:
	 
	 	 	 	 
	 

	 	(i)
	 	o     144A Global Note (CUSIP                     ), or
	 
	 	 	 	 
	 

	 	(ii)
	 	o     Regulation S Global Note (CUSIP                     ), or
	 
	 	 	 	 
	(b)

	 	o
	 	a Restricted Definitive Note.
	 
	 	 	 	 
	2.

	 	o
	 	After the Transfer the Transferee shall hold:
	 
	 	 	 	 
	 

	 	 	 	[CHECK ONE]
	 
	 	 	 	 
	(a)

	 	o
	 	a beneficial interest in the:
	 
	 	 	 	 
	 

	 	(i)
	 	o     144A Global Note (CUSIP                     ), or
	 
	 	 	 	 
	 

	 	(ii)
	 	o     Regulation S Global Note (CUSIP                     ), or
	 
	 	 	 	 
	 

	 	(iii)
	 	o     Unrestricted Global Note (CUSIP                     ); or
	 
	 	 	 	 
	(b)

	 	o
	 	a Restricted Definitive Note; or
	 
	 	 	 	 
	(c)

	 	o
	 	an Unrestricted Definitive Note, in accordance with the terms of the Indenture.

B-4

 

EXHIBIT C

FORM OF CERTIFICATE OF EXCHANGE

LifePoint Hospitals, Inc.

103 Powell Court

Brentwood, Tennessee 37027

The Bank of New York Mellon Trust Company, N.A.

900 Ashwood Parkway, Suite 425

Atlanta, Georgia 30338

Attention: Corporate Finance

Re: 6.625% Senior Notes due 2020 (CUSIP _____)

     Reference is hereby made to the Indenture, dated as of September 23, 2010 (the “Indenture”),
among LifePoint Hospitals, Inc., a Delaware corporation (the “Company”), the Guarantors party
thereto and The Bank of New York Mellon Trust Company, N.A., as trustee. Capitalized terms used
but not defined herein shall have the meanings given to them in the Indenture.

     _________________________ (the “Owner”) owns and proposes to exchange the Note[s] or interest
in such Note[s] specified herein, in the principal amount of $_________ of such Note[s] or
interests (the “Exchange”). In connection with the Exchange, the owner hereby certifies that:

     1. EXCHANGE OF RESTRICTED DEFINITIVE NOTES OR BENEFICIAL INTERESTS IN A RESTRICTED GLOBAL NOTE
FOR UNRESTRICTED DEFINITIVE NOTES OR BENEFICIAL INTERESTS IN AN UNRESTRICTED GLOBAL NOTE

          (a) o CHECK IF EXCHANGE IS FROM BENEFICIAL INTEREST IN A RESTRICTED GLOBAL NOTE TO
BENEFICIAL INTEREST IN AN UNRESTRICTED GLOBAL NOTE. In connection with the Exchange of the owner’s
beneficial interest in a Restricted Global Note for a beneficial interest in an Unrestricted Global
Note in an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being
acquired for the owner’s own account without transfer, (ii) such Exchange has been effected in
compliance with the transfer restrictions applicable to the Global Notes and pursuant to and in
accordance with the Securities Act of 1933, as amended (the “Securities Act”), (iii) the
restrictions on transfer contained in the Indenture and the Private Placement Legend are not
required in order to maintain compliance with the Securities Act and (iv) the beneficial interest
in an Unrestricted Global Note is being acquired in compliance with any applicable blue sky
securities laws of any state of the United States.

          (b) o CHECK IF EXCHANGE IS FROM BENEFICIAL INTEREST IN A RESTRICTED GLOBAL NOTE TO
UNRESTRICTED DEFINITIVE NOTE. In connection with the Exchange of the owner’s beneficial interest
in a Restricted Global Note for an Unrestricted Definitive Note, the Owner hereby certifies (i) the
Definitive Note is being acquired for the owner’s own account without transfer, (ii) such Exchange
has been effected in compliance with the transfer restrictions applicable to the Restricted Global
Notes and pursuant to and in accordance with the Securities Act, (iii) the restrictions on transfer
contained in the Indenture and the Private Placement Legend are not required in order to maintain
compliance with the Securities Act and (iv) the Definitive Note is being acquired in compliance
with any applicable blue sky securities laws of any state of the United States.

          (c) o CHECK IF EXCHANGE IS FROM RESTRICTED DEFINITIVE NOTE TO BENEFICIAL INTEREST IN AN
UNRESTRICTED GLOBAL NOTE. In connection with

C-1

 

the owner’s Exchange of a Restricted Definitive Note for a beneficial interest in an Unrestricted Global
Note, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account
without transfer, (ii) such Exchange has been effected in compliance with the transfer restrictions
applicable to Restricted Definitive Notes and pursuant to and in accordance with the Securities Act, (iii)
the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required
in order to maintain compliance with the Securities Act and (iv) the beneficial interest is being acquired in
compliance with any applicable blue sky securities laws of any state of the United States.

          (d) o CHECK IF EXCHANGE IS FROM RESTRICTED DEFINITIVE NOTE TO UNRESTRICTED DEFINITIVE
NOTE. In connection with the owner’s Exchange of a
Restricted Definitive Note for an Unrestricted Definitive Note, the owner hereby certifies (i) the
Unrestricted Definitive Note is being acquired for the owner’s own account without transfer, (ii) such
Exchange has been effected in compliance with the transfer restrictions applicable to Restricted Definitive
Notes and pursuant to and in accordance with the Securities Act, (iii) the restrictions on transfer contained
in the Indenture and the Private Placement Legend are not required in order to maintain compliance with
the Securities Act and (iv) the Unrestricted Definitive Note is being acquired in compliance with any
applicable blue sky securities laws of any state of the United States.

     2. EXCHANGE OF RESTRICTED DEFINITIVE NOTES OR BENEFICIAL INTERESTS IN RESTRICTED GLOBAL NOTES
FOR RESTRICTED DEFINITIVE NOTES OR BENEFICIAL INTERESTS IN RESTRICTED GLOBAL NOTES

          (a) o CHECK IF EXCHANGE IS FROM BENEFICIAL INTEREST IN A RESTRICTED GLOBAL NOTE TO
RESTRICTED DEFINITIVE NOTE. In connection with the Exchange of the Owner’s beneficial interest in
a Restricted Global Note for a Restricted Definitive Note with an equal principal amount, the owner
hereby certifies that the Restricted Definitive Note is being acquired for the Owner’s own account
without transfer. Upon consummation of the proposed Exchange in accordance with the terms of the
Indenture, the Restricted Definitive Note issued shall continue to be subject to the restrictions
on transfer enumerated in the Private Placement Legend printed on the Restricted Definitive Note
and in the Indenture and the Securities Act.

          (b) o CHECK IF EXCHANGE IS FROM RESTRICTED DEFINITIVE NOTE TO BENEFICIAL INTEREST IN A
RESTRICTED GLOBAL NOTE. In connection with the Exchange of the Owner’s Restricted Definitive Note
for a beneficial interest in the [CHECK ONE] o 144A Global Note, o Regulation S Global
Note, with an equal principal amount, the owner hereby certifies (i) the beneficial interest is
being acquired for the Owner’s own account without transfer and (ii) such Exchange has been
effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and
pursuant to and in accordance with the Securities Act, and in compliance with any applicable blue
sky securities laws of any state of the United States. Upon consummation of the proposed Exchange
in accordance with the terms of the Indenture, the beneficial interest issued shall be subject to
the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant
Restricted Global Note and in the Indenture and the Securities Act.

     This certificate and the statements contained herein are made for your benefit and the benefit
of the Company.

[Insert Name of Transferor]

C-2

 

	 	 	 	 	 
	 	 	 
	 	By:  	

 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

Dated:                                                              
         

C-3

 

ANNEX A TO CERTIFICATE OF EXCHANGE

	 	 	 	 	 

	1.	 	The Transferor owns and proposes to exchange the following:
	 
	 

	 	 	 	[CHECK ONE OF (a) OR (b)]
	 
	 	 	 	 
	(a)

	 	o
	 	a beneficial interest in the:
	 
	 	 	 	 
	 

	 	(i)
	 	o     144A Global Note (CUSIP                     ), or
	 
	 	 	 	 
	 

	 	(ii)
	 	o     Regulation S Global Note (CUSIP                     ), or
	 
	 	 	 	 
	(b)

	 	o
	 	a Restricted Definitive Note.
	 
	 	 	 	 
	2.

	 	o
	 	After the Exhange the Transferee shall hold:
	 
	 	 	 	 
	 

	 	 	 	[CHECK ONE]
	 
	 	 	 	 
	(a)

	 	o
	 	a beneficial interest in the:
	 
	 	 	 	 
	 

	 	(i)
	 	o     144A Global Note (CUSIP                     ), or
	 
	 	 	 	 
	 

	 	(ii)
	 	o     Regulation S Global Note (CUSIP                     ), or
	 
	 	 	 	 
	 

	 	(iii)
	 	o     Unrestricted Global Note (CUSIP                     ); or
	 
	 	 	 	 
	(b)

	 	o
	 	a Restricted Definitive Note; or
	 
	 	 	 	 
	(c)

	 	o
	 	an Unrestricted Definitive Note, in accordance with the terms of the Indenture.

C-4

 

EXHIBIT D

FORM OF SUPPLEMENTAL INDENTURE

TO BE DELIVERED BY SUBSEQUENT GUARANTORS

          Supplemental Indenture (this “Supplemental Indenture”), dated as                     , among
                     (the “Guaranteeing Subsidiary”), a subsidiary of LifePoint Hospitals, Inc. (or its
permitted successor), a Delaware corporation (the “Company”), the Company and The Bank of New York
Mellon Trust Company, N.A., as trustee under the Indenture referred to below (the “Trustee”).

W I T N E S S E T H

          WHEREAS, the Company has heretofore executed and delivered to the Trustee an indenture dated
as of September 23, 2010, (the “Indenture”), providing for the issuance of 6.625% Senior Notes due
2020 (the “Notes”);

          WHEREAS, this Indenture provides that under certain circumstances the Guaranteeing Subsidiary
shall execute and deliver to the Trustee a supplemental indenture pursuant to which the
Guaranteeing Subsidiary shall unconditionally guarantee all of the Company’s Obligations under the
Notes and the Indenture on the terms and conditions set forth herein (the “Note Guarantee”); and

          WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and
deliver this Supplemental Indenture.

          NOW THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiary, the
Company and the Trustee mutually covenant and agree for the equal and ratable benefit of the
Holders of the Notes as follows:

          1. Capitalized Terms. Capitalized terms used herein without definition shall have the
meanings assigned to them in the Indenture.

          2. Agreement to Guarantee. The Guaranteeing Subsidiary hereby agrees as follows:

          (a) Along with all Guarantors named in the Indenture, to jointly and severally Guarantee to
each Holder of a Note authenticated and delivered by the Trustee and to the Trustee and its
successors and assigns, that:

     (i) the principal of, premium, if any, and interest on the Notes will be
promptly paid in full when due, whether at maturity, by acceleration, redemption or
otherwise, and interest on the overdue principal of and interest on the Notes, if
any, if lawful, and all other obligations of the Company to the Holders or the
Trustee under the Notes or the Indenture will be promptly paid in full or performed,
all in accordance with the terms hereof and thereof; and

     (ii) in case of any extension of time of payment or renewal of any Notes or any
of such other obligations, that same will be promptly paid in full when due or
performed in accordance with the terms of the extension or renewal, whether at
stated maturity, by acceleration or otherwise. Failing payment when due of any
amount so guaranteed or any performance so guaranteed for whatever reason, the
Guarantors shall be jointly and severally obligated to pay the same immediately.

D-1

 

          (b) The obligations of the Guaranteeing Subsidiary hereunder shall be unconditional,
irrespective of the validity, regularity or enforceability of the Notes or the Indenture, the
absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with
respect to any provisions hereof or thereof, the recovery of any judgment against the Company,
any action to enforce the same or any other circumstance which might otherwise constitute a
legal or equitable discharge or defense of a guarantor.

          (c) The following is hereby waived: diligence, presentment, demand of payment, filing of
claims with a court in the event of insolvency or bankruptcy of the Company, any right to
require a proceeding first against the Company, protest, notice and all demands whatsoever.

          (d) This Note Guarantee shall not be discharged except by complete performance of the
obligations contained in the Notes and the Indenture, and the Guaranteeing Subsidiary accepts
all obligations of a Guarantor under this Indenture.

          (e) If any Holder or the Trustee is required by any court or otherwise to return to the
Company, the Guarantors, or any Custodian, trustee, liquidator or other similar official acting
in relation to either the Company or the Guarantors, any amount paid by either to the Trustee or
such Holder, this Note Guarantee, to the extent theretofore discharged, shall be reinstated in
full force and effect.

          (f) The Guaranteeing Subsidiary shall not be entitled to any right of subrogation in
relation to the Holders in respect of any obligations guaranteed hereby until payment in full of
all obligations guaranteed hereby.

          (g) As between the Guarantors, on the one hand, and the Holders and the Trustee, on the
other hand, (x) the maturity of the obligations guaranteed hereby may be accelerated as provided
in Article 6 of the Indenture for the purposes of this Note Guarantee, notwithstanding any stay,
injunction or other prohibition preventing such acceleration in respect of the obligations
guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations
as provided in Article 6 of the Indenture, such obligations (whether or not due and payable)
shall forthwith become due and payable by the Guarantors for the purpose of this Note Guarantee.

          (h) The Guarantors shall have the right to seek contribution from any non-paying Guarantor
so long as the exercise of such right does not impair the rights of the Holders under the
Guarantee.

          (i) Pursuant to Section 10.03 of the Indenture, after giving effect to any maximum amount
and any other contingent and fixed liabilities that are relevant under any applicable bankruptcy
or fraudulent conveyance laws, and after giving effect to any collections from, rights to
receive contribution from or payments made by or on behalf of any other Guarantor in respect of
the obligations of such other Guarantor under Article 10 of the Indenture, this new Note
Guarantee shall be limited to the maximum amount permissible such that the obligations of such
Guarantor under this Note Guarantee will not constitute a fraudulent transfer or conveyance.

          (j) This Note Guarantee is a guarantee of payment and not of collection.

          3. Execution and Delivery. Each Guaranteeing Subsidiary agrees that the Note Guarantees shall
remain in full force and effect notwithstanding any failure to endorse on each Note a notation of
such Note Guarantee.

          4. Guaranteeing Subsidiary may Consolidate, etc. on Certain Terms. A Guarantor may not sell
or otherwise dispose of all or substantially all of its assets to, or consolidate with or merge
with or into (whether or not such Guarantor is the surviving Person), another Person, other than
the Company or another Guarantor, unless:

D-2

 

          (a) immediately after giving effect to that transaction, no Default or Event of Default
exists; and

          (b) subject to the provisions of Section 10.04 of the Indenture, the Person acquiring the
property in any such sale or disposition or the Person formed by or surviving any such
consolidation or merger assumes all the obligations of that Guarantor under the Indenture and
its Subsidiary Guarantee pursuant to a supplemental indenture in form satisfactory to the
Trustee.

          In case of any such consolidation, merger, sale or conveyance and upon the assumption by the
successor corporation, by supplemental indenture, executed and delivered to the Trustee and
satisfactory in form to the Trustee, of the due and punctual performance of all of the covenants
and conditions of the Indenture to be performed by the Guarantor, such successor corporation shall
succeed to and be substituted for the Guarantor with the same effect as if it had been named herein
or therein as a Guarantor. All the Subsidiary Guarantees so issued shall in all respects have the
same legal rank and benefit under the Indenture as the Subsidiary Guarantees theretofore and
thereafter issued in accordance with the terms of the Indenture as though all of such Subsidiary
Guarantees had been issued at the date of the execution thereof.

          Except as set forth in Articles 4 and 5 of the Indenture, and notwithstanding clauses (a) and
(b) above, nothing contained in the Indenture or in any of the Notes shall prevent any
consolidation or merger of a Guarantor with or into the Company or another Guarantor, or shall
prevent any sale or conveyance of the property of a Guarantor as an entirety or substantially as an
entirety to the Company or another Guarantor.

          5. Releases. The Note Guarantee of a Guarantor will be released, and any Person acquiring
assets (including by way of merger or consolidation) or Capital Stock of a Guarantor shall not be
required to assume the obligations of any such Guarantor:

          (a) in connection with any sale or other disposition of all or substantially all of the
assets of that Guarantor (including by way of merger or consolidation) to a Person that is not
(either before or after giving effect to such transaction) a Restricted Subsidiary, if the sale
or other disposition complies with Sections 3.09 and 4.08 of the Indenture;

          (b) in connection with any sale of a majority of the Capital Stock of a Guarantor to a
Person that is not (either before or after giving effect to such transaction) a Restricted
Subsidiary, if the sale complies with Sections 3.09 and 4.08 of the Indenture;

          (c) if the Company designates any Restricted Subsidiary that is a Guarantor to be an
Unrestricted Subsidiary or an Excluded Subsidiary in accordance with the Indenture;

          (d) if any Guarantor is otherwise no longer obligated to provide a Subsidiary Guarantee
pursuant to the Indenture;

          (e) upon the Company’s exercise of its legal defeasance option or covenant defeasance
option as described under Article 8 of the Indenture or if the Company’s obligations under the
Indenture and the Notes are discharged in accordance with the terms of the Indenture; or

          (f) pursuant to Section 4.15 of the Indenture.

          Any Guarantor not released from its obligations under its Note Guarantee shall remain liable
for the full amount of principal of, premium, if any, and interest on the Notes and for the other
obligations of any Guarantor under the Indenture as provided in Article 10 of the Indenture.

          6. No Recourse Against Others. No past, present or future director, officer, employee,
incorporator, stockholder or agent of the Guaranteeing Subsidiary, as such, shall have any
liability for any obligations of the Company or any Guarantor under the Notes, any Subsidiary
Guarantees, the Indenture

D-3

 

or this Supplemental Indenture or for any claim based on, in respect of, or by reason of, such
obligations or their creation. Each Holder of the Notes by accepting a Note waives and releases all
such liability. The waiver and release are part of the consideration for issuance of the Notes.
Such waiver may not be effective to waive liabilities under the federal securities laws and it is
the view of the SEC that such a waiver is against public policy.

          7. NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED
TO CONSTRUE THIS SUPPLEMENTAL INDENTURE BUT WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF
CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE
REQUIRED THEREBY.

          8. Counterparts. The parties may sign any number of copies of this Supplemental Indenture.
Each signed copy shall be an original, but all of them together represent the same agreement.

          9. Effect of Headings. The Section headings herein are for convenience only and shall not
affect the construction hereof.

          10. The Trustee. The Trustee shall not be responsible in any manner whatsoever for or in
respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the
recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary and
the Company.

D-4

 

     IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed, all as of the date first above written.

Dated:                     

	 	 	 	 	 
	 	[Guaranteeing Subsidiary]

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	LifePoint Hospitals, Inc.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	The Bank of New York Mellon Trust Company, N.A., as

Trustee

 	 
	 	By:  	 	 
	 	 	Authorized Signatory 	 
	 	 	 	 
	 

D-5exv4w2

Exhibit
4.2

 

REGISTRATION RIGHTS AGREEMENT

Dated as of September 23, 2010

by and among

LIFEPOINT HOSPITALS, INC.

THE GUARANTORS LISTED ON SCHEDULE I HERETO

and

BARCLAYS CAPITAL INC.

 

 

 

          This Registration Rights Agreement (this “Agreement”) is made and entered into as of September
23, 2010, by and among LifePoint Hospitals, Inc., a Delaware corporation (the “Company”), the
guarantors listed on Schedule I hereto (the “Guarantors”) and Barclays Capital Inc., as
representative (the “Representative”) of the several initial purchasers named in Schedule I
attached to the Purchase Agreement (as defined below (each such initial purchaser, an “Initial
Purchaser” and, together, the “Initial Purchasers”), each of whom has agreed to purchase the
Company’s 6.625% Senior Notes due 2020 (the “Notes”), which will be guaranteed on an unsecured
basis by each of the Guarantors (the “Guarantees” and together with the Notes, the “Initial Notes”)
pursuant to the Purchase Agreement (as defined below).

          This Agreement is made pursuant to the Purchase Agreement, dated September 20, 2010 (the
“Purchase Agreement”), by and among the Company, the Guarantors and the Representative. In order
to induce the Initial Purchasers to purchase the Initial Notes, the Company and the Guarantors have
agreed to provide the registration rights set forth in this Agreement. The execution and delivery
of this Agreement is a condition to the obligations of the Initial Purchasers set forth in Section
7 of the Purchase Agreement. Capitalized terms used herein and not otherwise defined shall have
the meaning assigned to them in the Indenture, dated as of September 23, 2010, among the Company,
the Guarantors and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the
Initial Notes and the Exchange Notes (the “Indenture”).

          The parties hereby agree as follows:

SECTION 1. DEFINITIONS

          As used in this Agreement, the following capitalized terms shall have the following meanings:

          Act: The Securities Act of 1933, as amended, and the rules and regulations of the Commission
promulgated thereunder.

          Affiliate: As defined in Rule 144 of the Act.

          Broker-Dealer: Any broker or dealer registered under the Exchange Act.

          Business Day: Any day other than a Saturday, a Sunday or a day on which banking institutions
in the City of New York or at a place of payment are authorized by law, regulation or executive
order to remain closed.

          Closing Date: The date hereof.

          Commission: The Securities and Exchange Commission.

          Consummate: An Exchange Offer shall be deemed “Consummated” for purposes of this Agreement
upon the occurrence of (a) the filing and effectiveness under the Act of the Exchange Offer
Registration Statement relating to the Exchange Notes to be issued in the Exchange Offer, (b) the
maintenance of such Exchange Offer Registration Statement continuously effective and the keeping of
the Exchange Offer open for a period not less than the period required pursuant to

 

 

Section 3(b) hereof, and (c) the delivery by the Company to the Registrar under the Indenture
of Exchange Notes in the same aggregate principal amount as the aggregate principal amount of
Initial Notes tendered by Holders thereof pursuant to the Exchange Offer.

          Consummation Deadline: As defined in Section 3(b) hereof.

          Exchange Act: The Securities Exchange Act of 1934, as amended, and the rules and regulations
of the Commission promulgated thereunder.

          Exchange Notes: The Company’s 6.625% Senior Notes due 2020 along with related Guarantees to
be issued pursuant to the Indenture: (i) in the Exchange Offer or (ii) as contemplated by Section 4
hereof.

          Exchange Offer: The exchange and issuance by the Company of a principal amount of Exchange
Notes (which shall be registered pursuant to the Exchange Offer Registration Statement) equal to
the outstanding principal amount of Initial Notes that are validly tendered and not withdrawn by
such Holders in connection with such exchange and issuance.

          Exchange Offer Registration Statement: The Registration Statement relating to the Exchange
Offer, including the related Prospectus.

          Free Writing Prospectus: Each offer to sell or solicitation of an offer to buy the Initial
Notes or the Exchange Notes that would constitute a “free writing prospectus” as defined in Rule
405 under the Securities Act, prepared by or on behalf of the Company or used or referred to by the
Company in connection with the sale of the Initial Notes or the Exchange Notes.

          Holders: As defined in Section 2 hereof.

          Interest Payment Date: As defined in the Initial Notes and Exchange Notes.

          Prospectus: The prospectus included in a Registration Statement at the time such Registration
Statement is declared effective, as amended or supplemented by any prospectus supplement and by all
other amendments thereto, including post-effective amendments, and all material incorporated by
reference into such Prospectus.

          Recommencement Date: As defined in Section 6(d) hereof.

          Registration Default: As defined in Section 5 hereof.

          Registration Statement: Any registration statement of the Company and the Guarantors relating
to (a) an offering of Exchange Notes pursuant to an Exchange Offer or (b) the registration for
resale of Transfer Restricted Securities pursuant to the Shelf Registration Statement, in each
case, (i) that is filed pursuant to the provisions of this Agreement, (ii) including the Prospectus
included therein, and (iii) including all amendments and supplements thereto (including
post-effective amendments) and all exhibits and material incorporated by reference therein.

          Rule 144: Rule 144 promulgated under the Act.

-2-

 

          Shelf Registration Statement: As defined in Section 4 hereof.

          Special Interest: As defined is Section 5 hereof.

          Suspension Notice: As defined in Section 6(d) hereof.

          Suspension Rights: As defined in Section 6(c)(i) hereof.

          TIA: The Trust Indenture Act of 1939 (15 U.S.C. Section 77aaa-77bbbb) as in effect on the
date of the Indenture.

          Transfer Restricted Securities: Each Initial Note until the earliest to occur of (a) the date
on which such Initial Note has been exchanged in the Exchange Offer by a Person other than a
Broker-Dealer for an Exchange Note entitled to be resold to the public by the Holder thereof
without complying with the prospectus delivery requirements of the Act, (b) following the exchange
by a Broker-Dealer in the Exchange Offer of an Initial Note for an Exchange Note, the date on which
such Exchange Note is sold to a purchaser who receives from such Broker-Dealer on or prior to the
date of such sale a copy of the Prospectus contained in the Exchange Offer Registration Statement,
(c) the date on which such Initial Note has been effectively registered under the Act and disposed
of in accordance with the Shelf Registration Statement (and the purchasers thereof have been issued
Exchange Notes), or (d) the date on which such Initial Note is distributed to the public pursuant
to Rule 144.

SECTION 2. HOLDERS

          A Person is deemed to be a holder of Transfer Restricted Securities (each, a “Holder”)
whenever such Person owns Transfer Restricted Securities.

SECTION 3. REGISTERED EXCHANGE OFFER

          (a) The Company and the Guarantors shall (i) use their commercially reasonable efforts to file
with the Commission the Exchange Offer Registration Statement on an appropriate form and cause such
Exchange Offer Registration Statement to become effective, (ii) in connection with the foregoing,
(A) file all pre-effective amendments to such Exchange Offer Registration Statement as may be
necessary in order to cause it to become effective, (B) file, if applicable, a post-effective
amendment to such Exchange Offer Registration Statement, and (C) cause all necessary filings, if
any, in connection with the registration and qualification of the Exchange Notes to be made under
the Blue Sky laws of such jurisdictions as are necessary to permit Consummation of the Exchange
Offer, and (iii) unless the Exchange Offer shall not be permitted by applicable law or Commission
policy (after the procedures set forth in Section 6(a)(i) below have been complied with), upon the
effectiveness of such Exchange Offer Registration Statement, commence and Consummate the Exchange
Offer. The Exchange Offer shall be on the appropriate form permitting (i) registration of the
Exchange Notes to be offered in exchange for the Initial Notes that are Transfer Restricted
Securities and (ii) resales of Exchange Notes by Broker-Dealers that tendered into the Exchange
Offer Initial Notes that such Broker-Dealer acquired for its own account as a result of
market-making activities or other trading activities (other than Initial Notes acquired directly
from the Company or any of its Affiliates) as contemplated by Section 3(c) below.

-3-

 

          (b) The Company and the Guarantors shall use all commercially reasonable efforts to cause the
Exchange Offer Registration Statement to be effective continuously, and shall keep the Exchange
Offer open for a period of not less than the minimum period required under applicable federal and
state securities laws to Consummate the Exchange Offer; provided, however, that in no event shall
such period be less than 20 Business Days. The Company and the Guarantors shall cause the Exchange
Offer to comply with all applicable federal and state securities laws. No securities other than
the Exchange Notes shall be included in the Exchange Offer Registration Statement. The Company and
the Guarantors shall use all commercially reasonable efforts to cause the Exchange Offer to be
Consummated on the earliest practicable date after the Exchange Offer Registration Statement has
become effective, but in no event later than the 360th day following the Closing Date (or if such
360th day is not a Business Day, the next succeeding Business Day (such 360th day, or such later
date required by the federal securities laws, being the “Consummation Deadline”)).

          (c) The Company shall include a “Plan of Distribution” section in the Prospectus contained in
the Exchange Offer Registration Statement and indicate therein that any Broker-Dealer who holds
Transfer Restricted Securities that were acquired for the account of such Broker-Dealer as a result
of market-making activities or other trading activities (other than Initial Notes acquired directly
from the Company or any Affiliate of the Company), may exchange such Transfer Restricted Securities
pursuant to the Exchange Offer. Such “Plan of Distribution” section shall also contain all other
information with respect to such sales by such Broker-Dealers that the Commission may require in
order to permit such sales pursuant thereto, but such “Plan of Distribution” shall not name any
such Broker-Dealer or disclose the amount of Transfer Restricted Securities held by any such
Broker-Dealer, except to the extent required by the Commission as a result of a change in policy,
rules or regulations after the date of this Agreement. See the Shearman & Sterling
no-action letter (available July 2, 1993).

          Because such Broker-Dealer may be deemed to be an “underwriter” within the meaning of the Act
and must, therefore, deliver a prospectus meeting the requirements of the Act in connection with
its initial sale of any Exchange Notes received by such Broker-Dealer in the Exchange Offer, the
Company and Guarantors shall permit the use of the Prospectus contained in the Exchange Offer
Registration Statement by such Broker-Dealer to satisfy such prospectus delivery requirement. To
the extent necessary to ensure that the Prospectus contained in the Exchange Offer Registration
Statement is available for sales of Exchange Notes by Broker-Dealers, the Company and the
Guarantors agree to use all commercially reasonable efforts to keep the Exchange Offer Registration
Statement continuously effective, supplemented, amended and current as required by and subject to
the provisions of Sections 6(a) and (c) hereof and in conformity with the requirements of this
Agreement, the Act and the policies, rules and regulations of the Commission as announced from time
to time, for a period of 90 days from the Consummation Deadline or such shorter period as will
terminate when all Transfer Restricted Securities covered by such Registration Statement have been
sold pursuant thereto. The Company and the Guarantors shall provide sufficient copies of the
latest version of such Prospectus to such Broker-Dealers, promptly upon request, and in no event
later than two Business Days after such request, at any time during such period.

-4-

 

SECTION 4. SHELF REGISTRATION

          (a) Shelf Registration. If (i) the Company and the Guarantors are not permitted to
Consummate the Exchange Offer because the Exchange Offer is not permitted by applicable law or
Commission policy (after the Company and the Guarantors have complied with the procedures set forth
in Section 6(a)(i) below), (ii) the Exchange Offer is not Consummated on or prior to the
Consummation Deadline or (iii) any Holder notifies the Company prior to the 20th Business Day
following Consummation of the Exchange Offer that (A) such Holder is prohibited by law or
Commission policy from participating in the Exchange Offer, (B) such Holder may not resell the
Exchange Notes acquired by it in the Exchange Offer to the public without delivering a prospectus
and the Prospectus contained in the Exchange Offer Registration Statement is not appropriate or
available for such resales by such Holder or (C) such Holder is a Broker-Dealer and holds Initial
Notes acquired directly from the Company or any of its Affiliates, then the Company and the
Guarantors, subject to the Suspension Rights set forth in Section 6(c)(i) below, shall:

     (x) use all commercially reasonable efforts after the earlier of (i) the date as of which the
Company determines that the Exchange Offer Registration Statement will not be or cannot be
Consummated, as the case may be and (ii) the date on which the Company receives the notice
specified in clause (a)(iii) above (the “Shelf Filing Deadline”), to file a shelf registration
statement pursuant to Rule 415 under the Act (which may be an amendment to the Exchange Offer
Registration Statement (the “Shelf Registration Statement”)), covering the resale of all Transfer
Restricted Securities, and

     (y) use all commercially reasonable efforts to cause such Shelf Registration Statement to
become effective on the earliest practicable date after the Shelf Filing Deadline for the Shelf
Registration Statement, but in no event later than the 90th day after the Shelf Filing Deadline for
the Shelf Registration Statement (such 90th day the “Shelf Effectiveness Deadline”).

          If, after the Company and the Guarantors have filed an Exchange Offer Registration Statement
that satisfies the requirements of Section 3(a) above, the Company and the Guarantors are required
to file and make effective a Shelf Registration Statement solely because the Exchange Offer is not
permitted under applicable federal law (i.e., clause (a)(i)(B) above), then the filing of the
Exchange Offer Registration Statement shall be deemed to satisfy the requirements of clause (x)
above; provided that, in such event, the Company and the Guarantors shall remain obligated to meet
the Shelf Effectiveness Deadline set forth in clause (y).

          To the extent necessary to ensure that the Shelf Registration Statement is available for sales
of Transfer Restricted Securities by the Holders thereof entitled to the benefit of this Section
4(a) and the other securities required to be registered therein pursuant to Section 6(b)(ii)
hereof, the Company and the Guarantors shall use all commercially reasonable efforts to keep any
Shelf Registration Statement required by this Section 4(a) continuously effective, supplemented,
amended and current as required by and subject to the provisions of Sections 6(b) and 6(c) hereof
and in conformity with the requirements of this Agreement, the Act and the policies, rules and
regulations of the Commission as announced from time to time, for a period of at least one year
from the effective date of the Shelf Registration Statement (as extended pursuant to Section
6(c)(i) or 6(d)), or such shorter period as will terminate when all Transfer

-5-

 

Restricted Securities covered by such Shelf Registration Statement have been sold pursuant
thereto or are no longer Transfer Restricted Securities.

          (b) Provision by Holders of Certain Information in Connection with the Shelf Registration
Statement. No Holder may include any of its Transfer Restricted Securities in any Shelf
Registration Statement pursuant to this Agreement unless and until such Holder furnishes to the
Company in writing, within 15 days after receipt of a request therefor, the information specified
in Item 507 or 508 of Regulation S-K, as applicable, of the Act, or other information reasonably
requested by the Company and required by Regulation S-K of the Act, for use in connection with any
Shelf Registration Statement or Prospectus or preliminary Prospectus included therein. No Holder
shall be entitled to Special Interest pursuant to Section 5 hereof unless and until (and from and
after such time) such Holder shall have provided all such information. Each selling Holder agrees
to promptly furnish additional information required to be disclosed in order to make the
information previously furnished to the Company by such Holder not materially misleading and shall
promptly supply such other information as the Company may from time to time reasonably request.

SECTION 5. SPECIAL INTEREST

          Subject to the Suspension Rights referred to in Section 6(c)(i) below, if (i) the Exchange
Offer has not been Consummated by the Consummation Deadline, (ii) any Shelf Registration Statement
has not been filed with the Commission by the applicable Shelf Filing Deadline, (iii) any such
Shelf Registration Statement has not been declared effective by the Commission on or prior to the
Shelf Effectiveness Deadline, or (iv) any Registration Statement required by this Agreement is
filed and declared effective but shall thereafter cease to be effective or fail to be usable for
its intended purpose (each such event referred to in clauses (i) through (iv), a “Registration
Default”), then the Company and the Guarantors hereby jointly and severally agree to pay to each
Holder affected thereby special interest (“Special Interest”) in an amount equal to 0.25% per annum
of the principal amount of Transfer Restricted Securities held by such Holder for the first 90-day
period immediately following the occurrence of such Registration Default. The amount of the
Special Interest shall increase by an additional 0.25% per annum of the principal amount of
Transfer Restricted Securities with respect to each subsequent 90-day period until all Registration
Defaults have been cured, up to a maximum amount of Special Interest of 1.00% per annum of the
principal amount of Transfer Restricted Securities; provided that the Company and the Guarantors
shall in no event be required to pay Special Interest for more than one Registration Default at any
given time. Notwithstanding anything to the contrary set forth herein, upon the earlier of (i) the
cure of all Registration Defaults relating to the particular Transfer Restricted Securities or (ii)
the date the particular Initial Notes are no longer Transfer Restricted Securities, the Special
Interest payable with respect to the Transfer Restricted Securities as a result of such clause (i),
(ii), (iii), or (iv), as applicable, shall cease.

          All accrued Special Interest shall be paid by the Company and the Guarantors (or the Company
and the Guarantors will cause the Paying Agent to make such payment on their behalf) to the Holders
entitled thereto, in the manner provided for the payment of interest in the Indenture, on each
Interest Payment Date, as more fully set forth in the Indenture, the Initial Notes and the Exchange
Notes. Notwithstanding the fact that any securities for which Special Interest are due cease to be
Transfer Restricted Securities, all obligations of the Company and the

-6-

 

Guarantors to pay Special Interest with respect to securities that accrued prior to the time
that such securities ceased to be Transfer Restricted Securities shall survive until such time as
such obligations with respect to such securities shall have been satisfied in full.

SECTION 6. REGISTRATION PROCEDURES

          (a) Exchange Offer Registration Statement. In connection with the Exchange Offer, the
Company and the Guarantors shall (x) comply with all applicable provisions of Section 6(c) below,
(y) use all commercially reasonable efforts to effect such exchange and to permit the resale of
Exchange Notes by Broker-Dealers that tendered in the Exchange Offer Initial Notes that such
Broker-Dealer acquired for its own account as a result of its market-making activities or other
trading activities (other than Initial Notes acquired directly from the Company or any of its
Affiliates) being sold in accordance with the intended method or methods of distribution thereof,
and (z) comply with all of the following provisions:

          (i) If, following the date hereof there has been announced a change in Commission
policy with respect to exchange offers such as the Exchange Offer, that in the reasonable
opinion of counsel to the Company raises a substantial question as to whether the Exchange
Offer is permitted by applicable federal law, the Company and the Guarantors hereby agree
either to (x) seek a no-action letter or other favorable decision from the Commission
allowing the Company and the Guarantors to Consummate an Exchange Offer for such Transfer
Restricted Securities, or (y) file, in accordance with Section 4(a) hereof, a Shelf
Registration Statement to permit the registration and/or resale of the Transfer Restricted
Securities that would otherwise be covered by the Exchange Offer Registration Statement but
for the announcement of a change in Commission policy. In the case of clause (x) above, the
Company and the Guarantors hereby agree to pursue the issuance of such a decision to the
Commission staff level but shall not be required to take action not commercially reasonable
to affect a change of Commission policy. In connection with the foregoing, the Company and
the Guarantors hereby agree to take all such other actions as may be requested by the
Commission or otherwise required in connection with the issuance of such decision, including
without limitation (A) participating in telephonic conferences with the Commission, (B)
delivering to the Commission staff an analysis prepared by counsel to the Company setting
forth the legal bases, if any, upon which such counsel has concluded that such an Exchange
Offer should be permitted, and (C) diligently pursuing a resolution (which need not be
favorable) by the Commission staff.

          (ii) As a condition to its participation in the Exchange Offer, each Holder (including,
without limitation, any Holder who is a Broker-Dealer) shall furnish, upon the request of
the Company, prior to the Consummation of the Exchange Offer, a written representation to
the Company and the Guarantors (which may be contained in the letter of transmittal
contemplated by the Exchange Offer Registration Statement) to the effect that (A) it is not
an Affiliate of the Company, (B) it is not engaged in, and does not intend to engage in, and
has no arrangement or understanding with any person to participate in, a distribution of the
Exchange Notes to be issued in the Exchange Offer, (C) it is acquiring the Exchange Notes in
its ordinary course of business, and (D) only if such Holder is a Broker-Dealer that will
receive Exchange Notes in exchange for Initial Notes

-7-

 

that such Broker-Dealer acquired for its own private account as a result of market
making or other trading activities, it will deliver a Prospectus, as required by law, in
connection with any sale of such Exchange Notes. As a condition to its participation in the
Exchange Offer each Holder using the Exchange Offer to participate in a distribution of the
Exchange Notes shall acknowledge and agree that, if the resales are of Exchange Notes
obtained by such Holder in exchange for Initial Notes acquired directly from the Company or
an Affiliate thereof, it (1) could not, under Commission policy as in effect on the date of
this Agreement, rely on the position of the Commission enunciated in Morgan Stanley and
Co., Inc. (available June 5, 1991) and Exxon Capital Holdings Corporation
(available May 13, 1988), as interpreted in the Commission’s letter to Shearman &
Sterling dated July 2, 1993, and similar no-action letters (including, if applicable,
any no-action letter obtained pursuant to clause (i) above), and (2) must comply with the
registration and prospectus delivery requirements of the Act in connection with a secondary
resale transaction and that such a secondary resale transaction must be covered by an
effective registration statement containing the selling security holder information required
by Item 507 or 508, as applicable, of Regulation S-K.

          (iii) Prior to effectiveness of the Exchange Offer Registration Statement, the Company
and the Guarantors shall provide a supplemental letter to the Commission (A) stating that
the Company and the Guarantors are registering the Exchange Offer in reliance on the
position of the Commission enunciated in Exxon Capital Holdings Corporation
(available May 13, 1988), Morgan Stanley and Co., Inc. (available June 5, 1991) as
interpreted in the Commission’s letter to Shearman & Sterling dated July 2, 1993,
and, if applicable, any no-action letter obtained pursuant to clause (i) above, (B)
including a representation that the Company and Guarantor have not entered into any
arrangement or understanding with any Person to distribute the Exchange Notes to be received
in the Exchange Offer and that, to the best of the Company’s and each Guarantor’s
information and belief, each Holder participating in the Exchange Offer is acquiring the
Exchange Notes in its ordinary course of business and has no arrangement or understanding
with any Person to participate in the distribution of the Exchange Notes received in the
Exchange Offer, and (C) any other undertaking or representation required by the Commission
as set forth in any no-action letter obtained pursuant to clause (i) above, if applicable.

          (b) Shelf Registration Statement. In connection with the Shelf Registration Statement,
the Company and the Guarantors shall:

          (i) comply with all the provisions of Section 6(c) below and use all commercially
reasonable efforts to effect such registration to permit the sale of the Transfer Restricted
Securities being sold in accordance with the intended method or methods of distribution
thereof (as indicated in the information furnished to the Company pursuant to Section 4(b)
hereof), and pursuant thereto the Company and the Guarantors will prepare and file with the
Commission a Registration Statement relating to the registration on any appropriate form
under the Act, which form shall be available for the sale of the Transfer Restricted
Securities in accordance with the intended method or

-8-

 

methods of distribution thereof within the time periods and otherwise in accordance
with the provisions hereof, and

          (ii) issue to any Holder or purchaser of Initial Notes covered by any Shelf
Registration Statement contemplated by this Agreement, upon the request of any such Holder
or purchaser, registered Initial Notes having an aggregate principal amount equal to the
aggregate principal amount of Initial Notes in the names as such Holder or purchaser shall
designate.

          (c) General Provisions. In connection with any Registration Statement and any related
Prospectus required by this Agreement, the Company and the Guarantors shall:

          (i) use all commercially reasonable efforts to keep such Registration Statement
continuously effective and provide all requisite financial statements for the period
specified in Section 3 or 4 of this Agreement, as applicable. Upon the occurrence of any
event that would cause any such Registration Statement or the Prospectus contained therein
(A) to contain an untrue statement of material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein not misleading, or
(B) not to be effective and usable for resale of Transfer Restricted Securities during the
period required by this Agreement, the Company and the Guarantors shall file promptly an
appropriate amendment to such Registration Statement curing such defect, and, if Commission
review is required, use all commercially reasonable efforts to cause such amendment to be
declared effective as soon as practicable. Notwithstanding the foregoing, the Company and
the Guarantors may allow the Exchange Offer Registration Statement, at any time after
Consummation of the Exchange Offer (if otherwise required to keep it effective), or the
Shelf Registration Statement and the related Prospectus to cease to remain effective and
usable or may delay the filing or the effectiveness of the Shelf Registration Statement if
not then filed or effective, as applicable (“Suspension Rights”), for one or more periods of
90 days in aggregate in any twelve month period if (x) in its reasonable discretion, the
board of directors of the Company (or a duly-appointed committee of the board of directors
having power over the subject matter) determines that it is appropriate for the Company not
to disclose the existence of or facts surrounding any proposed or pending corporate
development, and the Company mails notification to the Holders within five Business Days
after the board of directors makes such determination (specifying the availability of
Suspension Rights without specifying the reason therefor), or (y), in the reasonable
judgment of the Company, the Prospectus contained in the Exchange Offer Registration
Statement or the Shelf Registration Statement, as the case may be, contains an untrue
statement of the material fact or omits to state a material fact necessary in order to make
the statements therein, in light of the circumstances under which they were made, not
misleading; provided that the 90-day period referred to in Section 3(c) during which the
Exchange Offer Registration Statement is required to be effective and usable or the one-year
period referred to in Section 4(a) hereof during which the Shelf Registration Statement is
required to be effective and usable shall be extended by the number of days during which
such Registration Statement was not effective or usable pursuant to the foregoing provisions
(which such extension shall be the Holders’ sole remedy for the exercise by the Company of
the Suspension Rights during the time period permitted

-9-

 

hereunder, but only to the extent that any suspension period does not violate the
90-day period set forth above).

          (ii) subject to the Suspension Rights set forth in Section 6(c)(i) above, prepare and
file with the Commission such amendments and post-effective amendments to the applicable
Registration Statement as may be necessary to keep such Registration Statement effective for
the applicable period set forth in Section 3 or 4 hereof, as the case may be; cause the
Prospectus to be supplemented by any required Prospectus supplement, and as so supplemented
to be filed pursuant to Rule 424 under the Act, and to comply fully with Rules 424, 430A,
and 462, as applicable, under the Act in a timely manner; and comply with the provisions of
the Act with respect to the disposition of all securities covered by such Registration
Statement during the applicable period in accordance with the intended method or methods of
distribution by the sellers thereof set forth in such Registration Statement or supplement
to the Prospectus;

          (iii) advise (a) each Holder whose Transfer Restricted Securities have been included in
a Shelf Registration Statement (in the case of a Shelf Registration Statement), and (b) each
Holder who has provided notice to the Company promptly and, if requested by such Holder,
confirm such advice in writing, (A) when the Prospectus or any Prospectus supplement or
post-effective amendment has been filed, and, with respect to any applicable Registration
Statement or any post-effective amendment thereto, when the same has become effective, (B)
of any request by the Commission for amendments to the Registration Statement or amendments
or supplements to the Prospectus or for additional information relating thereto, (C) of the
issuance by the Commission of any stop order suspending the effectiveness of the
Registration Statement under the Act or of the suspension by any state securities commission
of the qualification of the Transfer Restricted Securities for offering or sale in any
jurisdiction, or the initiation of any proceeding for any of the preceding purposes, and (D)
of the happening of any event that requires the Company to make changes in the Registration
Statement or the Prospectus in order that the Registration Statement or the Prospectus, any
amendment or supplement thereto or any document incorporated by reference therein do not
contain an untrue statement of material fact nor omit to state a material fact required to
be stated therein or necessary to make the statements therein (in the case of the
Prospectus, in light of the circumstances under which they were made) not misleading, which
notice may, at the discretion of the Company, state that it constitutes the exercise of
Suspension Rights under the provisions of Section 6(c). If at any time the Commission shall
issue any stop order suspending the effectiveness of the Registration Statement, or any
state securities commission or other regulatory authority shall issue an order suspending
the qualification or exemption from qualification of the Transfer Restricted Securities
under state securities or Blue Sky laws, the Company and the Guarantors shall use all
commercially reasonable efforts to obtain the withdrawal or lifting of such order at the
earliest possible time;

          (iv) subject to the Suspension Rights, if any fact or event contemplated by Section
6(c)(iii)(D) above shall exist or have occurred, prepare a supplement or post-effective
amendment to the Registration Statement or related Prospectus or any document incorporated
therein by reference or file any other required document so that, as

-10-

 

thereafter delivered to the purchasers of Transfer Restricted Securities, the
Prospectus will not contain an untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading;

          (v) furnish to each Holder whose Transfer Restricted Securities have been included in a
Shelf Registration Statement (in the case of a Shelf Registration Statement) in connection
with such exchange, registration or sale, if any, before filing with the Commission, copies
of any Registration Statement or any Prospectus included therein or any amendments or
supplements to any such Registration Statement or Prospectus (including all documents
incorporated by reference after the initial filing of such Registration Statement), which
documents will be subject to the reasonable review and comment of such Holders in connection
with such sale, if any, for a period of at least three Business Days, and the Company will
not file any such Registration Statement or Prospectus or any amendment or supplement to any
such Registration Statement or Prospectus (including all such documents incorporated by
reference) to which such Holders shall reasonably object within three Business Days after
the receipt thereof; provided that any Holder receiving such information shall agree to be
bound by reasonable and customary confidentiality agreements and procedures with respect
thereto. A Holder shall be deemed to have reasonably objected to such filing if such
Registration Statement, amendment, Prospectus or supplement, as applicable, as proposed to
be filed, contains an untrue statement of a material fact or omits to state any material
fact necessary to make the statements therein not misleading or fails to comply with the
applicable requirements of the Act;

          (vi) [Reserved];

          (vii) make available, at a location where they are normally maintained and during
normal business hours, for inspection by each Holder whose Transfer Restricted Securities
have been included in a Shelf Registration Statement (in the case of a Shelf Registration
Statement) and any attorney or accountant retained by such Holders, all financial and other
records, pertinent corporate documents of the Company and the Guarantors reasonably
requested and use its commercially reasonable efforts to cause the Company’s and the
Guarantors’ officers, directors and employees to supply all information reasonably requested
by any such Holder, attorney or accountant in connection with such Registration Statement or
any post-effective amendment thereto subsequent to the filing thereof and prior to its
effectiveness; provided that any Holder or representative thereof requesting or receiving
such information shall agree to be bound by reasonable and customary confidentiality
agreements and procedures with respect thereto; provided, however, that the foregoing
inspection and information gathering shall be coordinated (i) on behalf of the Initial
Purchaser through the Representative and (ii) on behalf of any other parties by one counsel
designated by and on behalf of such other parties as described in Section 7 hereof;

          (viii) if requested by any Holders whose Transfer Restricted Securities have been
included in a Shelf Registration Statement (in the case of a Shelf Registration Statement)
in connection with such exchange, registration or sale, promptly include in

-11-

 

any Registration Statement or Prospectus, pursuant to a supplement or post-effective
amendment if necessary, such information as such Holders may reasonably request to have
included therein, including, without limitation, information relating to the “Plan of
Distribution” of the Transfer Restricted Securities and the use of the Registration
Statement or Prospectus for market making activities; and make all required filings of such
Prospectus supplement or post-effective amendment as soon as practicable after the Company
is notified of the matters to be included in such Prospectus supplement or post-effective
amendment;

          (ix) furnish to each Holder whose Transfer Restricted Securities have been included in
a Shelf Registration Statement (in the case of a Shelf Registration Statement) in connection
with such exchange, registration or sale, without charge, at least one copy of the
Registration Statement, as first filed with the Commission, and of each amendment thereto,
including all documents incorporated by reference therein and all exhibits (including
exhibits incorporated therein by reference);

          (x) deliver to each Holder whose Transfer Restricted Securities have been included in a
Shelf Registration Statement (in the case of a Shelf Registration Statement) without charge,
as many copies of the Prospectus (including each preliminary prospectus) and any amendment
or supplement thereto as such Holders reasonably may request; the Company and the Guarantors
hereby consent to the use (in accordance with law and subject to Section 6(d) hereof and any
Suspension Rights) of the Prospectus and any amendment or supplement thereto by each selling
Holder in connection with the offering and the sale of the Transfer Restricted Securities
covered by the Prospectus or any amendment or supplement thereto;

          (xi) enter into such agreements (including an underwriting agreement), and make such
representations and warranties, and take all such other actions in connection therewith in
order to expedite or facilitate the disposition of the Transfer Restricted Securities
pursuant to any Registration Statement contemplated by this Agreement, all to such extent as
may be customarily and reasonably requested by the Initial Purchasers or, in the case of
registration for resale of Transfer Restricted Securities pursuant to the Shelf Registration
Statement, by any Holder or Holders of Transfer Restricted Securities who hold at least 50%
in aggregate principal amount of such class of Transfer Restricted Securities; provided,
that, the Company and the Guarantors shall not be required to enter into any such agreement
more than once with respect to all of the Transfer Restricted Securities and, in the case of
a Shelf Registration Statement, may delay entering into such agreement if, in its reasonable
discretion, the Board of Directors of the Company determines it is appropriate for the
Company and the Guarantors not to disclose the existence of or facts surrounding any
proposed or pending development. In such connection, the Company and the Guarantors shall:

          (A) upon the request of any Holder, furnish (or in the case of paragraphs (2)
and (3), use its commercially reasonable efforts to cause to be furnished) to each
such Holder (in the case of the Shelf Registration Statement) and any underwriter,
upon Consummation of the Exchange Offer or the effectiveness of the Shelf
Registration Statement, as the case may be:

-12-

 

          (1) a certificate, in customary form, dated such date, signed on behalf
of the Company and each Guarantor by (x) the Chief Executive Officer or any
Vice President, and (y) a principal financial or accounting officer of the
Company and such Guarantor, confirming, as of the date thereof, such matters
as such Holders may reasonably request;

          (2) an opinion, dated the date of Consummation of the Exchange Offer or
the date of effectiveness of the Shelf Registration Statement, as the case
may be, of counsel for the Company and the Guarantors in customary form and
covering such other matters as such Holder may reasonably request, and in
any event including a statement to the effect that such counsel has
participated in conferences with officers and other representatives of the
Company and the Guarantors and representatives of the independent public
accountants for the Company and the Guarantors and representatives of the
underwriters, if any, and their counsel at which the contents of the
Registration Statement and related matters were discussed and, although such
counsel need not pass upon or assume responsibility for the accuracy,
completeness or fairness of such statements (relying as to materiality to
the extent such counsel deems appropriate upon the statements of officers
and other representatives of the Company and the Guarantors and without
independent check or verification), no facts came to such counsel’s
attention that caused such counsel to believe that the applicable
Registration Statement, at the time such Registration Statement or any
post-effective amendment thereto became effective and, in the case of the
Exchange Offer Registration Statement, as of the date of Consummation of the
Exchange Offer, contained an untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary to make
the statements therein not misleading, or that the Prospectus contained in
such Registration Statement as of its date and, in the case of the opinion
dated the date of Consummation of the Exchange Offer, as of the date of
Consummation, contained an untrue statement of a material fact or omitted to
state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading.
Such counsel may state further that such counsel assumes no responsibility
for, and has not independently verified, the accuracy, completeness or
fairness of the financial statements, schedules or other financial data and
statistical data derived therefrom included in any Registration Statement
contemplated by this Agreement or the related Prospectus and need express no
view as to the accounting or financial records from which such financial
statements, schedules and data are derived; and

          (3) a customary comfort letter, dated the date of Consummation of the
Exchange Offer, or as of the date of effectiveness of the Shelf Registration
Statement, as the case may be, from the Company’s independent accountants,
in the customary form and covering matters of

-13-

 

the type customarily covered in comfort letters to underwriters in
connection with underwritten offerings, and affirming the matters set forth
in the comfort letters delivered pursuant to Section 8(e) of the Purchase
Agreement; and

     (B) deliver such other customary documents and certificates as may be
reasonably requested by the selling Holders to evidence compliance with the matters
covered in clause (A) above and with any customary conditions contained in any
agreement entered into by the Company and the Guarantors pursuant to this clause
(xi);

     (xii) prior to any public offering of Transfer Restricted Securities, cooperate with
the selling Holders and their counsel in connection with the registration and qualification
of the Transfer Restricted Securities under the securities or Blue Sky laws of such
jurisdictions as the selling Holders may reasonably request and do any and all other acts or
things necessary or advisable to enable the disposition in such jurisdictions of the
Transfer Restricted Securities covered by the applicable Registration Statement; provided,
however, that the Company and the Guarantors shall not be required to register or qualify as
a foreign corporation where it is not now so qualified or to take any action that would
subject it to the service of process in suits or to taxation in excess of a nominal amount
in respect of doing business in such jurisdiction, other than as to matters and transactions
relating to the Registration Statement, in any jurisdiction where it is not now so subject;

     (xiii) in connection with any sale of Transfer Restricted Securities that will result
in such securities no longer being Transfer Restricted Securities, cooperate with the
Holders to facilitate the timely preparation and delivery of certificates representing
Transfer Restricted Securities to be sold and not bearing any restrictive legends; and to
register such Transfer Restricted Securities in such denominations and such names as the
selling Holders may request at least two Business Days prior to such sale of Transfer
Restricted Securities;

     (xiv) use all commercially reasonable efforts to cause the disposition of the Transfer
Restricted Securities covered by the Registration Statement to be registered with or
approved by such other governmental agencies or authorities as may be necessary to enable
the seller or sellers thereof to consummate the disposition of such Transfer Restricted
Securities, subject to the proviso contained in clause (xii) above;

     (xv) provide a CUSIP number for all Transfer Restricted Securities not later than the
effective date of a Registration Statement covering such Transfer Restricted Securities and
provide the Trustee under the Indenture with printed certificates for the Transfer
Restricted Securities which are in a form eligible for deposit with the Depository Trust
Company;

     (xvi) otherwise use all commercially reasonable efforts to comply with all applicable
rules and regulations of the Commission, and make generally available to its security
holders with regard to any applicable Registration Statement, as soon as

-14-

 

practicable, a consolidated earnings statement meeting the requirements of Rule 158
under the Act (which need not be audited) covering a twelve-month period beginning after the
effective date of the Registration Statement (as such term is defined in paragraph (c) of
Rule 158 under the Act);

          (xvii) cause the Indenture to be qualified under the TIA not later than the effective
date of the first Registration Statement required by this Agreement and, in connection
therewith, cooperate with the Trustee and the Holders to effect such changes to the
Indenture as may be required for such Indenture to be so qualified in accordance with the
terms of the TIA; and execute and use its commercially reasonable efforts to cause the
Trustee to execute, all documents that may be required to effect such changes and all other
forms and documents required to be filed with the Commission to enable such Indenture to be
so qualified in a timely manner; and

          (xviii) provide promptly to each Holder, upon request, each document filed with the
Commission pursuant to the requirements of Section 13 or Section 15(d) of the Exchange Act.

          (d) Restrictions on Holders. Each Holder agrees by acquisition of a Transfer
Restricted Security that, upon receipt of the notice referred to in Section 6(c)(i) or 6(c)(iii)(C)
or any notice from the Company of the existence of any fact of the kind described in Section
6(c)(iii)(D) hereof (in each case, a “Suspension Notice”), such Holder will forthwith discontinue
disposition of Transfer Restricted Securities pursuant to the applicable Registration Statement
until (i) such Holder has received copies of the supplemented or amended Prospectus contemplated by
Section 6(c)(iv) hereof, or (ii) such Holder is advised in writing by the Company that the use of
the Prospectus may be resumed, and has received copies of any additional or supplemental filings
that are incorporated by reference in the Prospectus (in each case, the “Recommencement Date”).
Each Holder receiving a Suspension Notice hereby agrees that it will either (i) destroy any
Prospectuses, other than permanent file copies, then in such Holder’s possession which have been
replaced by the Company with more recently dated Prospectuses, or (ii) deliver to the Company (at
the Company’s expense) all copies, other than permanent file copies, then in such Holder’s
possession of the Prospectus covering such Transfer Restricted Securities that was current at the
time of receipt of the Suspension Notice. The time period regarding the effectiveness of such
Registration Statement set forth in Section 3 or 4 hereof, as applicable, shall be extended by a
number of days equal to the number of days in the period from and including the date of delivery of
the Suspension Notice to the Recommencement Date.

SECTION 7. REGISTRATION EXPENSES

          (a) All expenses incident to the Company’s and the Guarantors’ performance of or compliance
with this Agreement will be borne by the Company, regardless of whether a Registration Statement
becomes effective, including without limitation: (i) all registration and filing fees and expenses;
(ii) all fees and expenses of compliance with federal securities and state Blue Sky or securities
laws; (iii) all expenses of printing (including printing certificates for the Exchange Notes to be
issued in the Exchange Offer and printing of Prospectuses), messenger and delivery services and
telephone; (iv) all fees and disbursements of counsel for the Company and

-15-

 

the Guarantors and one counsel for all of the Holders of Transfer Restricted Securities
selected by the Holders of a majority in principal amount of Transfer Restricted Securities being
registered; (v) all application and filing fees in connection with listing the Exchange Notes on a
national securities exchange or automated quotation system pursuant to the requirements hereof; and
(vi) all fees and disbursements of independent certified public accountants of the Company and the
Guarantors (including the expenses of any special audit and comfort letters required by or incident
to such performance); provided, however, that in no event shall the Company or the Guarantors be
responsible for any underwriting discounts, commissions or fees attributable to the sale or other
disposition of Transfer Restricted Securities.

          The Company will, in any event, bear its and the Guarantors’ internal expenses (including,
without limitation, all salaries and expenses of its officers and employees performing legal or
accounting duties), the expenses of any annual audit and the fees and expenses of any Person,
including special experts, retained by the Company or the Guarantors.

          (b) In connection with any Registration Statement required by this Agreement (including,
without limitation, the Exchange Offer Registration Statement and the Shelf Registration
Statement), the Company and the Guarantors will reimburse the Initial Purchasers and the Holders of
Transfer Restricted Securities who are tendering Initial Notes in the Exchange Offer and/or selling
or reselling Initial Notes or Exchange Notes pursuant to the “Plan of Distribution” contained in
the Exchange Offer Registration Statement or the Shelf Registration Statement, as applicable, for
the reasonable fees and disbursements of not more than one counsel that shall be chosen by the
Holders of a majority in principal amount of the Transfer Restricted Securities for whose benefit
such Registration Statement is being prepared, if any.

SECTION 8. INDEMNIFICATION

          (a) The Company and the Guarantors agree, jointly and severally, to indemnify and hold
harmless each Holder, its directors, officers and each Person, if any, who controls such Holder
(within the meaning of Section 15 of the Act or Section 20 of the Exchange Act), from and against
any and all losses, claims, damages, liabilities or judgments, (including without limitation, any
legal or other expenses incurred in connection with investigating or defending any matter,
including any action that could give rise to any such losses, claims, damages, liabilities or
judgments) caused by any untrue statement or alleged untrue statement of a material fact contained
in any Registration Statement, preliminary prospectus or Prospectus, Free Writing Prospectus or any
“issuer information” (as defined in Rule 433 of the Securities Act) filed or required to be filed
pursuant to Rule 433(d) under the Securities Act (or any amendment or supplement thereto), or
caused by any omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading, except insofar as such losses, claims, damages, liabilities or
judgments are caused by an untrue statement or omission or alleged untrue statement or omission
that is based upon information relating to any of the Holders furnished in writing to the Company
by or on behalf of any of the Holders.

          (b) Each Holder agrees, severally and not jointly, to indemnify and hold harmless the Company
and the Guarantors, and their respective directors and officers, and each Person, if any, who
controls (within the meaning of Section 15 of the Act or Section 20 of the Exchange Act)

-16-

 

the Company, or the Guarantors to the same extent as the foregoing indemnity from the Company
and the Guarantors set forth in section (a) above, but only with reference to information relating
to such Holder furnished in writing to the Company by or on behalf of such Holder expressly for use
in any Registration Statement. In no event shall any Holder, its directors, officers or any Person
who controls such Holder be liable or responsible for any amount in excess of the amount by which
the total amount received by such Holder with respect to its sale of Transfer Restricted Securities
pursuant to a Registration Statement exceeds the sum of: (i) the amount paid by such Holder for
such Transfer Restricted Securities plus (ii) the amount of any damages that such Holder,
its directors, officers or any Person who controls such Holder has otherwise been required to pay
by reason of such untrue or alleged untrue statement or omission or alleged omission.

          (c) In case any action shall be commenced involving any person in respect of which indemnity
may be sought pursuant to Section 8(a) or 8(b) (the “indemnified party”), the indemnified party
shall promptly notify the person against whom such indemnity may be sought (the “indemnifying
party”) in writing and the indemnifying party shall assume the defense of such action, including
the employment of counsel reasonably satisfactory to the indemnified party and the payment of all
fees and expenses of such counsel, as incurred (except that in the case of any action in respect of
which indemnity may be sought pursuant to both Sections 8(a) and 8(b), a Holder shall not be
required to assume the defense of such action pursuant to this Section 8(c), but may employ
separate counsel and participate in the defense thereof, but the fees and expenses of such counsel,
except as provided below, shall be at the expense of the Holder). Any indemnified party shall have
the right to employ separate counsel in any such action and participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of the indemnified party unless (i)
the employment of such counsel has been specifically authorized in writing by the indemnifying
party, (ii) the indemnifying party has failed to assume the defense of such action or employ
counsel reasonably satisfactory to the indemnified party, or (iii) the named parties to any such
action (including any impleaded parties) include both the indemnified party and the indemnifying
party, and the indemnified party has been advised by such counsel that there may be one or more
legal defenses available to it which are different from or additional to those available to the
indemnifying party (in which case the indemnifying party shall not have the right to assume the
defense of such action on behalf of the indemnified party). In any such case, the indemnifying
party shall not, in connection with any one action or separate but substantially similar or related
actions in the same jurisdiction arising out of the same general allegations or circumstances, be
liable for the fees and expenses of more than one separate firm of attorneys (in addition to any
local counsel) for all indemnified parties and all such fees and expenses shall be reimbursed as
they are incurred. Such firm shall be designated in writing by a majority of the Holders, in the
case of the parties indemnified pursuant to Section 8(a), and by the Company and Guarantors, in the
case of parties indemnified pursuant to Section 8(b). The indemnifying party shall indemnify and
hold harmless the indemnified party from and against any and all losses, claims, damages,
liabilities and judgments by reason of any settlement of any action effected with (i) its written
consent, or (ii) effected without its written consent if the settlement is entered into more than
20 Business Days after the indemnifying party received a request from the indemnified party for
reimbursement for the fees and expenses of counsel (in any case where such fees and expenses are at
the expense of the indemnifying party) and, prior to the date of such settlement, the indemnifying
party has failed to comply with such reimbursement request. No indemnifying party shall, without
the prior written consent of the

-17-

 

indemnified party (which consent shall not be unreasonably withheld), effect any settlement or
compromise of, or consent to the entry of judgment with respect to, any pending or threatened
action in respect of which the indemnified party is or could have been a party and indemnity or
contribution may be or could have been sought hereunder by the indemnified party, unless such
settlement, compromise or judgment (i) includes an unconditional release of the indemnified party
from all liability on claims that are or could have been the subject matter of such action, and
(ii) does not include a statement as to or an admission of fault, culpability or a failure to act,
by or on behalf of the indemnified party.

          (d) To the extent that the indemnification provided for in this Section 8 is unavailable to an
indemnified party in respect of any losses, claims, damages, liabilities or judgments referred to
therein, then each indemnifying party, in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a result of such losses,
claims, damages, liabilities or judgments (i) in such proportion as is appropriate to reflect the
relative benefits received by the Company and the Guarantors, on the one hand, and the Holders, on
the other hand, from their sale of Transfer Restricted Securities, or (ii) if the allocation
provided by clause 8(d)(i) above is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause 8(d)(i) above but also
the relative fault of the Company and the Guarantors, on the one hand, and of the Holder, on the
other hand, in connection with the statements or omissions which resulted in such losses, claims,
damages, liabilities or judgments, as well as any other relevant equitable considerations. The
relative fault of the Company and the Guarantors, on the one hand, and of the Holder, on the other
hand, shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a material fact relates
to information supplied by the Company or such Guarantor, on the one hand, or by the Holder, on the
other hand, and the parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. The amount paid or payable by a party as a result
of the losses, claims, damages, liabilities and judgments referred to above shall be deemed to
include, subject to the limitations set forth in Section 8(c) hereof, any legal or other fees or
expenses reasonably incurred by such party in connection with investigating or defending any action
or claim.

          The Company, the Guarantors and each Holder agree that it would not be just and equitable if
contribution pursuant to this Section 8(d) were determined by pro rata allocation (even if the
Holders were treated as one entity for such purpose) or by any other method of allocation that does
not take account of the equitable considerations referred to in the immediately preceding
paragraph. The amount paid or payable by an indemnified party as a result of the losses, claims,
damages, liabilities or judgments referred to in the immediately preceding paragraph shall be
deemed to include, subject to the limitations set forth above, any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating or defending any
matter, including any action that could have given rise to such losses, claims, damages,
liabilities or judgments. Notwithstanding the provisions of this Section 8, no Holder, its
directors, its officers or any Person, if any, who controls such Holder shall be required to
contribute, in the aggregate, any amount in excess of the amount by which the total amount received
by such Holder with respect to the sale of Transfer Restricted Securities pursuant to a
Registration Statement exceeds the sum of: (i) the amount paid by such Holder for such Transfer
Restricted Securities plus (ii) the amount of any damages that such Holder has

-18-

 

otherwise paid or become liable to pay by reason of any untrue or alleged untrue statement or
omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty
of such fraudulent misrepresentation. The Holders’ obligations to contribute pursuant to this
Section 8(d) are several in proportion to the respective principal amount of Transfer Restricted
Securities held by each Holder hereunder and not joint.

SECTION 9. RULE 144A AND RULE 144

          The Company and each Guarantor agrees with each Holder, for so long as any Transfer Restricted
Securities remain outstanding and during any period in which the Company or such Guarantor (i) is
not subject to Section 13 or 15(d) of the Exchange Act, to make available, upon request of any
Holder, to such Holder or beneficial owner of Transfer Restricted Securities in connection with any
sale thereof and any prospective purchaser of such Transfer Restricted Securities designated by
such Holder or beneficial owner, the information required by Rule 144A(d)(4) under the Act in order
to permit resales of such Transfer Restricted Securities pursuant to Rule 144A under the Act.

SECTION 10. MISCELLANEOUS

          (a) Remedies. The Company and the Guarantors acknowledge and agree that any failure
by the Company and/or the Guarantors to comply with their respective obligations under Sections 3
and 4 hereof may result in material irreparable injury to the Initial Purchasers or the Holders for
which there is no adequate remedy at law, that it will not be possible to measure damages for such
injuries precisely and that, in the event of any such failure, the Initial Purchasers or any Holder
may obtain such relief as may be required to specifically enforce the Company’s and the Guarantors’
obligations under Sections 3 and 4 hereof. The Company and the Guarantors further agree to waive
the defense in any action for specific performance that a remedy at law would be adequate.

          (b) Free Writing Prospectus. The Company represents, warrants and covenants that it
(including its agents and representatives) will not prepare, make, use, authorize, approve or refer
to any “written communication” (as defined in Rule 405 under the Securities Act) in connection with
the issuance and sale of the Initial Notes and the Exchange Notes, other than (i) any communication
pursuant to Rule 134, Rule 135 or Rule 135c under the Securities Act, (ii) any document
constituting an offer to sell or solicitation of an offer to buy the Initial Notes or the Exchange
Notes that falls within the exception from the definition of prospectus in Section 2(a)(10)(a) of
the Securities Act, or (iii) a prospectus satisfying the requirements of section 10(a) of the
Securities Act or of Rule 430, Rule 430A, Rule 430B, Rule 430C or Rule 431 under the Securities
Act.

          (c) No Inconsistent Agreements. The Company and any Guarantor will not, on or after
the date of this Agreement, enter into any agreement with respect to its securities that is
inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts with
the provisions hereof. The Company and any Guarantor have not previously entered into, nor is
currently a party to, any agreement granting any registration rights with respect to its securities
to any Person that would require such securities to be included in any Registration Statement filed

-19-

 

hereunder. The rights granted to the Holders hereunder do not in any way conflict with and
are not inconsistent with the rights granted to the holders of the Company’s and the Guarantors’
securities under any agreement in effect on the date hereof.

          (d) Amendments and Waivers. The provisions of this Agreement may not be amended,
modified or supplemented, and waivers or consents to or departures from the provisions hereof may
not be given unless (i) in the case of Section 5 hereof and this Section 10(d)(i), the Company has
obtained the written consent of Holders of all outstanding Transfer Restricted Securities, and (ii)
in the case of all other provisions hereof, the Company has obtained the written consent of Holders
of a majority of the outstanding principal amount of Transfer Restricted Securities (excluding
Transfer Restricted Securities held by the Company or its Affiliates). Notwithstanding the
foregoing, a waiver or consent to departure from the provisions hereof that relates exclusively to
the rights of Holders whose Transfer Restricted Securities are being tendered pursuant to the
Exchange Offer, and that does not affect directly or indirectly the rights of other Holders whose
Transfer Restricted Securities are not being tendered pursuant to such Exchange Offer, may be given
by the Holders of a majority of the outstanding principal amount of Transfer Restricted Securities
subject to such Exchange Offer.

          (e) Additional Guarantors. The Company shall cause any of its Restricted Subsidiaries
(as defined in the Indenture) that becomes, prior to the consummation of the Exchange Offer, a
Guarantor in accordance with the terms and provisions of the Indenture to become a party to this
Agreement as a Guarantor.

          (f) Third Party Beneficiary. The Holders shall be third party beneficiaries to the
agreements made hereunder between the Company and the Guarantors, on the one hand, and the Initial
Purchasers, on the other hand, and shall have the right to enforce such agreements directly to the
extent they may deem such enforcement necessary or advisable to protect its rights or the rights of
Holders hereunder.

          (g) Notices. All notices and other communications provided for or permitted hereunder
shall be made in writing by hand-delivery, first-class mail (registered or certified, return
receipt requested), telex, telecopier or air courier guaranteeing overnight delivery:

          (i) if to a Holder, at the address set forth on the records of the Registrar under the
Indenture, with a copy to the Registrar under the Indenture; and

          (ii) if to the Company or the Guarantors:

LifePoint Hospitals, Inc.

103 Powell Court

Brentwood, Tennessee 37027

Attention: Chief Legal Officer and Chief Financial Officer

Facsimile: (615) 695-8414

-20-

 

With a copy to:

Dewey & LeBoeuf LLP

1301 Avenue of the Americas

New York, New York 10019

Attention: Frank Adams, Esq.

Facsimile: (212) 259-6333

          All such notices and communications shall be deemed to have been duly given: at the time
delivered by hand, if personally delivered; five Business Days after being deposited in the mail,
postage prepaid, if mailed; when receipt acknowledged, if telecopied; and on the next Business Day,
if timely delivered to an air courier guaranteeing overnight delivery.

          Copies of all such notices, demands or other communications shall be concurrently delivered by
the Person giving the same to the Trustee at the address specified in the Indenture.

          (h) Successors and Assigns. This Agreement shall inure to the benefit of and be
binding upon the successors and assigns of each of the parties, including without limitation and
without the need for an express assignment, subsequent Holders; provided that nothing herein shall
be deemed to permit any assignment, transfer or other disposition of Transfer Restricted Securities
in violation of the terms hereof or of the Purchase Agreement or the Indenture. If any transferee
of any Holder shall acquire Transfer Restricted Securities in any manner, whether by operation of
law or otherwise, such Transfer Restricted Securities shall be held subject to all of the terms of
this Agreement, and by taking and holding such Transfer Restricted Securities such Person shall be
conclusively deemed to have agreed to be bound by and to perform all of the terms and provisions of
this Agreement, including the restrictions on resale set forth in this Agreement and, if
applicable, the Purchase Agreement, and such Person shall be entitled to receive the benefits
hereof.

          (i) Counterparts. This Agreement may be executed in any number of counterparts and by
the parties hereto in separate counterparts (which may be delivered in original form or by
telecopier), each of which when so executed shall be deemed to be an original and all of which
taken together shall constitute one and the same agreement.

          (j) Headings. The headings in this Agreement are for convenience of reference only
and shall not limit or otherwise affect the meaning hereof.

          (k) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW RULES THEREOF.

          (l) Severability. In the event that any one or more of the provisions contained
herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable,
the validity, legality and enforceability of any such provision in every other respect and of the
remaining provisions contained herein shall not be affected or impaired thereby.

-21-

 

     (m) Entire Agreement. This Agreement is intended by the parties as a final expression
of their agreement and intended to be a complete and exclusive statement of the agreement and
understanding of the parties hereto in respect of the subject matter contained herein. There are
no restrictions, promises, warranties or undertakings, other than those set forth or referred to
herein with respect to the registration rights granted with respect to the Transfer Restricted
Securities. This Agreement supersedes all prior agreements and understandings between the parties
with respect to such subject matter.

(Signature Page Follows.)

-22-

 

          IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above.

	 	 	 	 	 
	 	LIFEPOINT HOSPITALS, INC.

 	 
	 	By:  	/s/ Jeffrey S. Sherman
 	 
	 	 	Name:  	Jeffrey S. Sherman 	 
	 	 	Title:  	Executive Vice President and Chief Financial
Officer 	 
	 

ON BEHALF OF:

AMERICA MANAGEMENT COMPANIES, LLC

AMG-CROCKETT, LLC

AMG-HILCREST, LLC

AMG-HILLSIDE, LLC

AMG-LIVINGSTON, LLC

AMG-LOGAN, LLC

AMG-SOUTHERN TENNESSEE, LLC

AMG-TRINITY, LLC

ANDALUSIA PHYSICIAN PRACTICES, LLC

ASHLAND PHYSICIAN SERVICES, LLC

ASHLEY VALLEY MEDICAL CENTER, LLC

ASHLEY VALLEY PHYSICIAN PRACTICE, LLC

ATHENS PHYSICIANS PRACTICE, LLC

ATHENS REGIONAL MEDICAL CENTER, LLC

BARROW MEDICAL CENTER, LLC

BARTOW GENERAL PARTNER, LLC

BARTOW MEMORIAL LIMITED PARTNER, LLC

BOLIVAR PHYSICIAN PRACTICES, LLC

BOURBON COMMUNITY HOSPITAL, LLC

BOURBON PHYSICIAN PRACTICE, LLC

BRIM HOSPITALS, INC.

BUFFALO TRACE RADIATION ONCOLOGY ASSOCIATES, LLC

CARE HEALTH COMPANY, INC.

CASTLEVIEW HOSPITAL, LLC

CASTLEVIEW MEDICAL, LLC

CASTLEVIEW PHYSICIAN PRACTICE, LLC

CLINCH PROFESSIONAL PHYSICIAN SERVICES, LLC

CLINCH VALLEY ENDOCRINOLOGY, LLC

CLINCH VALLEY MEDICAL CENTER, INC.

CLINCH VALLEY PULMONOLOGY, LLC

CLINCH VALLEY UROLOGY, LLC

COLORADO PLAINS PHYSICIAN PRACTICES, LLC

COMMUNITY HOSPITAL OF ANDALUSIA, INC.

COMMUNITY MEDICAL, LLC

S-1

 

COMMUNITY-BASED SERVICES, LLC

CROCKETT HOSPITAL, LLC

CROCKETT PHO, LLC

DANVILLE DIAGNOSTIC IMAGING CENTER, LLC

DANVILLE PHYSICIAN PRACTICES, LLC

DANVILLE REGIONAL MEDICAL CENTER SCHOOL OF HEALTH PROFESSIONS, LLC

DANVILLE REGIONAL MEDICAL CENTER, LLC

DODGE CITY HEALTHCARE PARTNER, INC.

GEORGETOWN COMMUNITY HOSPITAL, LLC

GEORGETOWN REHABILITATION, LLC

GUYAN VALLEY HOSPITAL, LLC

HALSTEAD HOSPITAL, LLC

HCK LOGAN MEMORIAL, LLC

HDP ANDALUSIA, LLC

HDP GEORGETOWN, LLC

HILLSIDE HOSPITAL, LLC

HISTORIC LIFEPOINT HOSPITALS, INC.

HRMC, LLC

HST PHYSICIAN PRACTICE, LLC

HTI GEORGETOWN, LLC

HTI PINELAKE, LLC

HURRICANE HEALTHCARE PARTNER, LLC

INTEGRATED PHYSICIAN SERVICES, LLC

KANSAS HEALTHCARE MANAGEMENT COMPANY, INC.

KANSAS HEALTHCARE MANAGEMENT SERVICES, LLC

KENTUCKY HOSPITAL, LLC

KENTUCKY MEDSERV, LLC

KENTUCKY MSO, LLC

KENTUCKY PHYSICIAN SERVICES, INC.

LAKE CUMBERLAND CARDIOLOGY ASSOCIATES, LLC

LAKE CUMBERLAND PHYSICIAN PRACTICES, LLC

LAKE CUMBERLAND REGIONAL HOSPITAL, LLC

LAKE CUMBERLAND REGIONAL PHYSICIAN HOSPITAL ORGANIZATION, LLC

LAKELAND COMMUNITY HOSPITAL, LLC

LAKELAND PHYSICIAN PRACTICES, LLC

LANDER VALLEY AMBULATORY SURGERY CENTER, LLC

LANDER VALLEY MEDICAL CENTER, LLC

LANDER VALLEY PHYSICIAN PRACTICES, LLC

LAS CRUCES PHYSICIAN PRACTICES, LLC

LCMC MRI, LLC

LCMC PET, LLC

LHSC, LLC

LIFEPOINT ACQUISITION CORP.

LIFEPOINT BILLING SERVICES, LLC

LIFEPOINT CSGP, LLC

LIFEPOINT CSLP, LLC

LIFEPOINT HOLDINGS 2, LLC

S-2

 

LIFEPOINT HOLDINGS 3, INC.

LIFEPOINT HOSPITALS HOLDINGS, INC.

LIFEPOINT MEDICAL GROUP — HILLSIDE, INC

LIFEPOINT OF GAGP, LLC

LIFEPOINT OF KENTUCKY, LLC

LIFEPOINT OF LAKE CUMBERLAND, LLC

LIFEPOINT RC, INC.

LIFEPOINT VA HOLDINGS, INC.

LIFEPOINT WV HOLDINGS, INC.

LIVINGSTON REGIONAL HOSPITAL, LLC

LOGAN GENERAL HOSPITAL, LLC

LOGAN HEALTHCARE PARTNER, LLC

LOGAN MEDICAL, LLC

LOGAN MEMORIAL HOSPITAL, LLC

LOGAN PHYSICIAN PRACTICE, LLC

LOS ALAMOS PHYSICIAN PRACTICES, LLC

MARTINSVILLE PHYSICIAN PRACTICES, LLC

MEADOWVIEW PHYSICIAN PRACTICE, LLC

MEADOWVIEW REGIONAL MEDICAL CENTER, LLC

MEADOWVIEW RIGHTS, LLC

MEMORIAL HOSPITAL OF MARTINSVILLE & HENRY COUNTY AMBULATORY

 SURGERY CENTER, LLC

MEXIA-PRINCIPAL, INC.

MINDEN PHYSICIAN PRACTICES, LLC

NORTHEASTERN NEVADA PHYSICIAN PRACTICES, LLC

NORTHWEST MEDICAL CENTER-WINFIELD, LLC

NWMC-WINFIELD PHYSICIAN PRACTICES, LLC

OHIO HOSPITAL, LLC

OPELOUSAS IMAGING CENTER PARTNER, LLC

OPELOUSAS PET/CT IMAGING CENTER, LLC

ORTHOPEDICS OF SOUTHWEST VIRGINIA, LLC

PALESTINE-PRINCIPAL G.P., INC.

PHC HOSPITALS, LLC

PHC-AVIATION, INC.

PHC-BELLE GLADE, INC.

PHC-CLEVELAND, INC.

PHC-DOCTORS’ HOSPITAL, INC.

PHC-ELKO, INC.

PHC-FORT MOHAVE, INC.

PHC-FORT MORGAN, INC.

PHC-INDIANA, INC.

PHC-KNOX, INC.

PHC-LAKE HAVASU, INC.

PHC-LAKEWOOD, INC.

PHC-LAS CRUCES, INC.

PHC-LOS ALAMOS, INC.

PHC-LOUISIANA, INC.

S-3

 

PHC-MARTINSVILLE, INC.

PHC-MINDEN G.P., INC.

PHC-MORGAN LAKE, INC.

PHC-PALESTINE, INC.

PHC-SELMA, LLC

PHC-TENNESSEE, INC.

PINELAKE PHYSICIAN PRACTICE, LLC

PINELAKE REGIONAL HOSPITAL, LLC

POITRAS PRACTICE, LLC

PRHC-ALABAMA, LLC

PRHC-ENNIS G.P., INC.

PRINCIPAL HOSPITAL COMPANY OF NEVADA, INC.

PRINCIPAL KNOX, L.L.C.

PRINCIPAL-NEEDLES, INC.

PROVINCE HEALTHCARE COMPANY

PUTNAM AMBULATORY SURGERY CENTER, LLC

PUTNAM COMMUNITY MEDICAL CENTER, LLC

PUTNAM PHYSICIAN PRACTICES, LLC

R. KENDALL BROWN PRACTICE, LLC

RALEIGH GENERAL HOSPITAL, LLC

RIVER PARISHES HOLDINGS, LLC

RIVER PARISHES HOSPITAL, LLC

RIVER PARISHES PARTNER, LLC

RIVER PARISHES PHYSICIAN PRACTICES, LLC

RIVERTON AMBULATORY SURGERY CENTER, LLC

RIVERTON MEMORIAL HOSPITAL, LLC

RIVERTON ONCOLOGY PRACTICE, LLC

RIVERTON PHYSICIAN PRACTICES, LLC

RIVERVIEW MEDICAL CENTER, LLC

ROCKDALE HOSPITAL, LLC

ROCKDALE PHYSICIAN PRACTICES, LLC

RUSSELLVILLE HOSPITAL, LLC

RUSSELLVILLE PHYSICIAN PRACTICES, LLC

SELECT HEALTHCARE, LLC

SELMA DIAGNOSTIC IMAGING, LLC

SILETCHNIK PRACTICE, LLC

SMITH COUNTY MEMORIAL HOSPITAL, LLC

SOMERSET SURGERY PARTNER, LLC

SOUTHERN TENNESSEE EMS, LLC

SOUTHERN TENNESSEE MEDICAL CENTER, LLC

SOUTHERN TENNESSEE PHO, LLC

SPRING VIEW HOSPITAL, LLC

SPRING VIEW PHYSICIAN PRACTICES, LLC

SPRINGHILL MEDICAL CENTER, LLC

STARKE PHYSICIAN PRACTICES, LLC

SUMNER PHYSICIAN PRACTICES, LLC

SUMNER REAL ESTATE HOLDINGS, LLC

S-4

 

SUMNER REGIONAL MEDICAL CENTER, LLC

TEXAS SPECIALTY PHYSICIANS

THE MRI CENTER OF NORTHWEST ALABAMA, LLC

THM PHYSICIAN PRACTICE, LLC

TROUSDALE MEDICAL CENTER, LLC

VALLEY VIEW PHYSICIAN PRACTICES, LLC

VAUGHAN PHYSICIAN PRACTICES, LLC

VILLE PLATTE MEDICAL CENTER, LLC

VILLE PLATTE PHYSICIAN PRACTICES, LLC

WEST VIRGINIA MANAGEMENT SERVICES ORGANIZATION, INC.

WESTERN PLAINS PHYSICIAN PRACTICES, LLC

WESTERN PLAINS REGIONAL HOSPITAL, LLC

WOODFORD HOSPITAL, LLC

WYOMING HOLDINGS, LLC

WYTHE COUNTY COMMUNITY HOSPITAL, LLC

WYTHE COUNTY PHYSICIAN PRACTICES, LLC

ZONE, INCORPORATED

	 	 	 	 	 
	 	 	 
	 	                                                      /s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-5

 

	 	 	 	 	 

On Behalf of:

LIFEPOINT ASSET MANAGEMENT COMPANY, INC.

	 	 	 	 	 
	 	 	 
	 	                                  /s/ Christopher J. Monte
 	 
	 	Name:  	Christopher J. Monte 	 
	 	Title:  	Vice President 	 

S-6

 

	 	 	 	 	 

On Behalf of:

BARTOW HEALTHCARE SYSTEM, LTD.

	 	 	 	 	 
	 	Bartow General Partner, LLC, as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 
	 	Bartow Memorial Limited Partner, LLC, as limited

partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-7

 

	 	 	 	 	 

On Behalf of:

LAMAR SURGERY CENTER, LP

	 	 	 	 	 
	 	Northwest Medical Center-Winfield, LLC, as

general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-8

 

	 	 	 	 	 

On Behalf of:

LIFEPOINT CORPORATE SERVICES GENERAL PARTNERSHIP

	 	 	 	 	 
	 	LifePoint CSLP, LLC, as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 
	 	LifePoint CSGP, LLC, as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-9

 

	 	 	 	 	 

On Behalf of:

LIFEPOINT OF GEORGIA, LIMITED PARTNERSHIP

	 	 	 	 	 
	 	LifePoint Hospitals Holdings, Inc., as limited

partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 
	 	LifePoint of GAGP, LLC, as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-10

 

	 	 	 	 	 

On Behalf of:

MEXIA PRINCIPAL HEALTHCARE LIMITED PARTNERSHIP

	 	 	 	 	 
	 	Mexia-Principal, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 
	 	Principal Hospital Company of Nevada, Inc., as

limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-11

 

	 	 	 	 	 

On Behalf of:

PALESTINE PRINCIPAL HEALTHCARE LIMITED PARTNERSHIP

	 	 	 	 	 
	 	Palestine Principal G.P., Inc., as general

partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 
	 
	 	Principal Hospital Company of Nevada, Inc., as

limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

S-12

 

On Behalf of:

PHC-ASHLAND, L.P.

	 	 	 	 	 
	 	PHC-Tennessee, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

	 	 	 	 	 
	 	Principal Hospital Company of Nevada, Inc., as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-13

 

	 	 	 	 	 

On Behalf of:

PHC-CHARLESTOWN, L.P.

	 	 	 	 	 
	 	PHC-Indiana, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

	 	 	 	 	 
	 	PHC Hospitals, LLC, as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-14

 

	 	 	 	 	 

On Behalf of:

PHC-MINDEN, L.P.

	 	 	 	 	 
	 	PHC-Minden G.P., Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

	 	 	 	 	 
	 	PHC-Louisiana, Inc., as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-15

 

	 	 	 	 	 

On Behalf of:

PHC-MORGAN CITY, L.P.

	 	 	 	 	 
	 	PHC-Lakewood, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

	 	 	 	 	 
	 	PHC-Morgan Lake, Inc, as limited partner.

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-16

 

	 	 	 	 	 

On Behalf of:

PHC-OPELOUSAS, L.P.

	 	 	 	 	 
	 	PHC-Doctors’ Hospital, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

	 	 	 	 	 
	 	PHC-Louisiana, Inc., as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-17

 

	 	 	 	 	 

On Behalf of:

PRHC-ENNIS, L.P.

	 	 	 	 	 
	 	PRHC-Ennis G.P., Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

	 	 	 	 	 
	 	Principal Hospital Company of Nevada, Inc., as

limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-18

 

	 	 	 	 	 

On Behalf of:

PRINCIPAL KNOX, L.P.

	 	 	 	 	 
	 	PHC-Knox, Inc., as general partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 
	 

	 	 	 	 	 
	 	Province Healthcare Company, as limited partner

 	 
	 	/s/ Michael S. Coggin
 	 
	 	Name:  	Michael S. Coggin 	 
	 	Title:  	Senior Vice President and Treasurer 	 

S-19

 

	 	 	 	 	 

	 	 	 	 	 
	 	BARCLAYS CAPITAL INC.

As representative of the several Initial Purchasers

     named in Schedule 1 of the Purchase Agreement

 	 
	 	By:  	BARCLAYS CAPITAL INC.
 	 
	 
	 	 	 
	 	By  	                       /s/ Benjamin J. Burton
 	 
	 	 	Name:  	Benjamin J. Burton 	 
	 	 	Title:  	Managing Director 	 
	 

S-20

 

SCHEDULE I

America Management Companies, LLC

AMG-Crockett, LLC

AMG-Hilcrest, LLC

AMG-Hillside, LLC

AMG-Livingston, LLC

AMG-Logan, LLC

AMG-Southern Tennessee, LLC

AMG-Trinity, LLC

Andalusia Physician Practices, LLC

Ashland Physician Services, LLC

Ashley Valley Medical Center, LLC

Ashley Valley Physician Practice, LLC

Athens Physicians Practice, LLC

Athens Regional Medical Center, LLC

Barrow Medical Center, LLC

Bartow General Partner, LLC

Bartow Healthcare System, Ltd.

Bartow Memorial Limited Partner, LLC

Bolivar Physician Practices, LLC

Bourbon Community Hospital, LLC

Bourbon Physician Practice, LLC

Brim Hospitals, Inc.

Buffalo Trace Radiation Oncology Associates, LLC

Care Health Company, Inc.

Castleview Hospital, LLC

Castleview Medical, LLC

Castleview Physician Practice, LLC

Clinch Professional Physician Services, LLC

Clinch Valley Endocrinology, LLC

Clinch Valley Medical Center, Inc.

Clinch Valley Pulmonology, LLC

Clinch Valley Urology, LLC

Colorado Plains Physician Practices, LLC

Community Hospital of Andalusia, Inc.

Community Medical, LLC

Community-Based Services, LLC

Crockett Hospital, LLC

Crockett PHO, LLC

Danville Diagnostic Imaging Center, LLC

Danville Physician Practices, LLC

Danville Regional Medical Center School of Health Professions, LLC

Danville Regional Medical Center, LLC

Dodge City Healthcare Partner, Inc.

Georgetown Community Hospital, LLC

 

 

Georgetown Rehabilitation, LLC

Guyan Valley Hospital, LLC

Halstead Hospital, LLC

HCK Logan Memorial, LLC

HDP Andalusia, LLC

HDP Georgetown, LLC

Hillside Hospital, LLC

Historic LifePoint Hospitals, Inc.

HRMC, LLC

HST Physician Practice, LLC

HTI Georgetown, LLC

HTI PineLake, LLC

Hurricane Healthcare Partner, LLC

Integrated Physician Services, LLC

Kansas Healthcare Management Company, Inc.

Kansas Healthcare Management Services, LLC

Kentucky Hospital, LLC

Kentucky Medserv, LLC

Kentucky MSO, LLC

Kentucky Physician Services, Inc.

Lake Cumberland Cardiology Associates, LLC

Lake Cumberland Physician Practices, LLC

Lake Cumberland Regional Hospital, LLC

Lake Cumberland Regional Physician Hospital Organization, LLC

Lakeland Community Hospital, LLC

Lakeland Physician Practices, LLC

Lamar Surgery Center, LP

Lander Valley Ambulatory Surgery Center, LLC

Lander Valley Medical Center, LLC

Lander Valley Physician Practices, LLC

Las Cruces Physician Practices, LLC

LCMC MRI, LLC

LCMC PET, LLC

LHSC, LLC

LifePoint Acquisition Corp.

LifePoint Asset Management Company, Inc.

LifePoint Billing Services, LLC

LifePoint Corporate Services General Partnership

LifePoint CSGP, LLC

LifePoint CSLP, LLC

LifePoint Holdings 2, LLC

LifePoint Holdings 3, Inc.

LifePoint Hospitals Holdings, Inc.

LifePoint Medical Group — Hillside, Inc

LifePoint of GAGP, LLC

LifePoint of Georgia, Limited Partnership

 

 

LifePoint of Kentucky, LLC

LifePoint of Lake Cumberland, LLC

LifePoint RC, Inc.

LifePoint VA Holdings, Inc.

LifePoint WV Holdings, Inc.

Livingston Regional Hospital, LLC

Logan General Hospital, LLC

Logan Healthcare Partner, LLC

Logan Medical, LLC

Logan Memorial Hospital, LLC

Logan Physician Practice, LLC

Los Alamos Physician Practices, LLC

Martinsville Physician Practices, LLC

Meadowview Physician Practice, LLC

Meadowview Regional Medical Center, LLC

Meadowview Rights, LLC

Memorial Hospital of Martinsville & Henry County Ambulatory Surgery Center, LLC

Mexia Principal Healthcare Limited Partnership

Mexia-Principal, Inc.

Minden Physician Practices, LLC

Northeastern Nevada Physician Practices, LLC

Northwest Medical Center-Winfield, LLC

NWMC-Winfield Physician Practices, LLC

Ohio Hospital, LLC

Opelousas Imaging Center Partner, LLC

Opelousas PET/CT Imaging Center, LLC

Orthopedics of Southwest Virginia, LLC

Palestine Principal Healthcare Limited Partnership

Palestine-Principal G.P., Inc.

PHC Hospitals, LLC

PHC-Ashland, L.P.

PHC-Aviation, Inc.

PHC-Belle Glade, Inc.

PHC-Charlestown, L.P.

PHC-Cleveland, Inc.

PHC-Doctors’ Hospital, Inc.

PHC-Elko, Inc.

PHC-Fort Mohave, Inc.

PHC-Fort Morgan, Inc.

PHC-Indiana, Inc.

PHC-Knox, Inc.

PHC-Lake Havasu, Inc.

PHC-Lakewood, Inc.

PHC-Las Cruces, Inc.

PHC-Los Alamos, Inc.

PHC-Louisiana, Inc.

 

 

PHC-Martinsville, Inc.

PHC-Minden G.P., Inc.

PHC-Minden, L. P.

PHC-Morgan City, L.P.

PHC-Morgan Lake, Inc.

PHC-Opelousas, L.P.

PHC-Palestine, Inc.

PHC-Selma, LLC

PHC-Tennessee, Inc.

PineLake Physician Practice, LLC

PineLake Regional Hospital, LLC

Poitras Practice, LLC

PRHC-Alabama, LLC

PRHC-Ennis G.P., Inc.

PRHC-Ennis, L.P.

Principal Hospital Company of Nevada, Inc.

Principal Knox, L.L.C.

Principal Knox, L.P.

Principal-Needles, Inc.

Province Healthcare Company

Putnam Ambulatory Surgery Center, LLC

Putnam Community Medical Center, LLC

Putnam Physician Practices, LLC

R. Kendall Brown Practice, LLC

Raleigh General Hospital, LLC

River Parishes Holdings, LLC

River Parishes Hospital, LLC

River Parishes Partner, LLC

River Parishes Physician Practices, LLC

Riverton Ambulatory Surgery Center, LLC

Riverton Memorial Hospital, LLC

Riverton Oncology Practice, LLC

Riverton Physician Practices, LLC

Riverview Medical Center, LLC

Rockdale Hospital, LLC

Rockdale Physician Practices, LLC

Russellville Hospital, LLC

Russellville Physician Practices, LLC

Select Healthcare, LLC

Selma Diagnostic Imaging, LLC

Siletchnik Practice, LLC

Smith County Memorial Hospital, LLC

Somerset Surgery Partner, LLC

Southern Tennessee EMS, LLC

Southern Tennessee Medical Center, LLC

Southern Tennessee PHO, LLC

 

 

Spring View Hospital, LLC

Spring View Physician Practices, LLC

Springhill Medical Center, LLC

Starke Physician Practices, LLC

Sumner Physician Practices, LLC

Sumner Real Estate Holdings, LLC

Sumner Regional Medical Center, LLC

Texas Specialty Physicians

The MRI Center of Northwest Alabama, LLC

THM Physician Practice, LLC

Trousdale Medical Center, LLC

Valley View Physician Practices, LLC

Vaughan Physician Practices, LLC

Ville Platte Medical Center, LLC

Ville Platte Physician Practices, LLC

West Virginia Management Services Organization, Inc.

Western Plains Physician Practices, LLC

Western Plains Regional Hospital, LLC

Woodford Hospital, LLC

Wyoming Holdings, LLC

Wythe County Community Hospital, LLC

Wythe County Physician Practices, LLC

Zone, Incorporated

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00178-of-00352.parquet"}]]